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Abstract 
Polymeric carriers for drug and gene delivery have been successfully used in clinical applications, 
and developing to achieve greater efficacy. A successful polymeric carrier must not only protect the 
therapeutics from degradation but also increase the pharmacokinetic and biopharmaceutical 
properties of the therapeutic agents. Furthermore, releasing the therapeutic agents from nanocarriers 
at the desired target sites and with the correct dosage is important to enhance patient outcomes. 
Numerous polymeric systems for drug and gene delivery that can release bioactive agents through 
response to external (e.g., light, electric or magnetic source, and ultrasound) or internal triggers 
(e.g., pH, enzyme, and redox) have been designed. However, release mechanism using these 
triggers is restrictive in terms of in vivo applications as there is limited accessibility of external 
stimuli to tissues or organs; and the efficiency of internal triggers are variable between cell lines and 
even within the same tissue or organ. Some carriers are not degradable, raising the important issue 
of toxicity due to accumulation in the body and healthy cells. In addition, the time of release is 
mostly uncontrollable. The main aim of this thesis is to synthesize and study of novel non-triggered 
and timed-release polymeric carriers, such as micelles and hydrogel, based on thermoresponsive 
PNIPAM and self-degradable PDMAEA. In particular, we developed the understanding of the self-
assembly and disassembly properties of thermoresponsive PNIPAM copolymerized with the self-
degradable PDMAEA and hydrophobic components. This is one of the first examples where the 
disassembly time can be controlled on-demand in a wide range of experimental conditions. 
Initially, the self-catalysed hydrolysis of PDMAEA together with hydrophobic polymers were 
employed to finely tune the LCST and disassembly time of thermoresponsive PNIPAM and thus 
control the release time of oligo DNA (i.e., mimic of siRNA) from the polymer complex. The 
diblock thermoresponsive copolymers were synthesized by Reversible addition-fragmentation chain 
transfer (RAFT) polymerization, which consisted of a hydrophilic block (e.g., PDMA) for 
stabilization and a second thermoresponsive block with three components (e.g., NIPAM, DMAEA, 
and BA or Styrene) for self-assembly and disassembly. The copolymers were fully water-soluble 
below LCST and self-assembled into core-shell spherical particles with an average diameter of 
approximately 25 nm above LCST (e.g., 37 
o
C) and with a narrow particle size distribution. When 
the amount of acid groups from degradation of cationic DMAEA units was sufficiently high to 
increase LCST of the copolymer above 37 °C, the polymer nanoparticles sharply disassembled to 
unimers (i.e., the core of the copolymer became water soluble). These nanoparticles showed 
excellent binding to oligo DNA without any leakage until full disassembly to unimers. Interestingly, 
the disassembly time of the nanoparticles and consequently the release time of oligo DNA could be 
precisely controlled. These particles could be easily modified with folic acid to enhance cellular 
uptake by osteosarcoma cells. 
 ii 
 
In the next step, we studied the influence in the change in the number of self-degradable DMAEA 
and hydrophobic BA units in the copolymer composition on the disassembly time (tstart) and time 
from the start of disassembly to full unimer formation (tdegrade). The results showed a dependence of 
the tstart and tdegrade on the BA and DMAEA units. The mechanism of degradation was postulated to 
result from the degradation of the PDMAEA side groups to acrylic acid groups, which by increasing 
the LCST of the polymer to over 37 
o
C over time. Additionally, the polymer nanoparticles could be 
designed to self-assemble over a wide range of pHs and disassemble below a pH of 7.3. The 
polymer nanoparticles have potential for application in drug and gene delivery where timed 
controlled release is required. 
The stabilization and self-disassembly of nanoparticles self-assembled from random 
thermoresponsive copolymers was further investigated in the presence of Sodium dodecyl sulphate 
(SDS) surfactant. Random copolymers of P(NIPAM-co-DMAEA-co-BA) and P(NIPAM-co-
DMAEA-co-STY) were synthesized by RAFT polymerization. The polymers could self-assemble 
into nanoparticles stabilized by SDS with very narrow size distribution. The polymer particle size 
increased with the increase in SDS concentration, and these nanoparticles were stable under 
dilution. Increasing the amount of SDS, the LCST of copolymers were also increased due to more 
SDS molecules bound to PNIPAM molecules. In addition, the presence of SDS exhibited no 
influence on the self-degradation of DMAEA as well as self-disassembly characteristic of the 
polymer nanoparticles. 
Based on the understanding of controllably timed-release polymer nanoparticle, non-triggerred 
degradable polymeric hydrogel was further designed. Random copolymers of thermoresponsive 
PNIPAM, self-catalysed hydrolysis PDMAEA, hydrophilic PEGMEA, and hydrophobic PBA were 
synthesized via RAFT polymerization. The thermoresponsive copolymers could form stable gel at 
temperature higher than the gelation point (e.g., 37 
o
C) and then self-degraded into sol state after 
different times without the need of any trigger. Moreover, the gelation temperature and degradation 
time were dependent on the number of DMAEA units. Gold nanoparticles coated with PDMA were 
encapsulated in the hydrogel and subsequently released at different rates through the degradation of 
the hydrogels. This novel non-triggered release hydrogel may find potential in applications where 
controlled-release is beneficial. 
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Chapter 1-Introduction 
 
1.1 Drug and gene delivery 
Development of pharmaceuticals over the past two decades has found that the fundamental issue of 
drug development is in the method of delivery. Proper distribution of the drug and other therapeutic 
agents within the patient‘s body is one of the most important issues in the medicine.1-5  Therapeutic 
agents such as drugs, proteins, DNA, and siRNA can be degraded in the low pH medium of 
stomach as well as by enzymes in the gastrointestinal (GI) tract.
6
 Furthermore, some drugs are 
cytotoxic. Therefore, it is necessary to design and develop a suitable drug delivery system that can 
deliver bioactive therapeutic compounds to the human body effectively and safely.  
 
1.1.1  The importance of delivery  
Application of nanotechnology in the field of medicine is called nanomedicine and has been 
developed over the past few years. It has highlighted the importance of disease diagnostic and 
treatment that has high precision and remarkable efficacy. Recent advancements in nanomedicine 
have shown that many nanostructures and nanodevices have been employed to diagnose, treat, and 
prevent diseases.
1, 5, 7-14
 Including the development of carriers for drug and gene delivery systems 
which has received significant attention over the past few decades.
3, 5, 7, 15-23
 
An optimal drug delivery carrier should ensure that the bioactive agents are well protected against 
degradation by enzymes.
7, 24-27
 Moreover, circulation, absorption, and solubility of the therapeutics 
need to be enhanced. Furthermore, drug delivery systems have to make sure that the bioactive 
agents are available at the sites of interest and at the required concentration for the precise time and 
required duration. The combination of these factors could result in the reduction in the frequency of 
drug administration decreasing drug toxicity as well as improving patient compliance.  
 
1.1.2 Polymeric systems for drugs and genes delivery 
Studies in the past two decades have shown that polymers are becoming the most promising class of 
biomaterials and are widely used in various medical applications.
28-30
 Since the concept of polymer-
drug conjugates in drug delivery pioneered by Ringsdorf in 1975, research in this field has been 
remarkable.
31
 Along with the advancement of nanotechnology, polymeric materials have made 
significant progress in biomedical applications; for example drug and gene delivery, tissue 
engineering, biosensors, contact lens, vascular grafts, dental materials, and sophisticated artificial 
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organs. The vast number of developments in polymeric materials for biomedical application has 
been documented in some excellent books and journal reviews.
32-36
 
Synthetic polymers are the most common platforms to create novel systems and methods for 
medical applications especially in the field of gene and drug delivery.
37-51
 The structure of the 
synthetic polymers can be modified, thus it can be used to design systems for various applications 
in drug and gene delivery. Different approaches such as encapsulation, conjugation and complexion 
have been used to combine synthetic polymers with small molecular drugs or bio-macromolecules 
for use in drug delivery systems. The polymer provides an enhancement in the pharmacokinetic of 
the therapeutics as it not only protects the drug and gene from fast clearance in the blood circulation 
but also preserves the drug for a programmable time interval before going to targeted sites. The 
carriers can be designed to release the therapeutics at specific locations so that the concentration of 
these compounds can be increased to the threshold to enhance the treatment efficacy.
38
 
A variety of different polymeric delivery systems such as polymersomes,
52-55
 dendrimers,
56-58
 
micelles/particles,
59-72
 and hydrogels,
73-83
 film,
84, 85
 etc. have been designed to be used in drug/gene 
delivery systems. However the micelles/particles and hydrogels are the most popular carriers 
utilized in the area of drug and gene delivery. 
 
1.1.2.1 Polymeric micelles/particles 
Polymeric micelles can be formed by self-assembly of amphiphilic copolymers in aqueous 
solution.
63, 67, 68, 86-89
 These micelles have a core–shell structure, where the inner core is formed by 
the segregation of hydrophobic segment from the aqueous exterior and the outer shell is composed 
from the extension of the hydrophilic segments building a palisade around the inner core.
68, 71
 Many 
different kinds of drugs and genes with varying characteristics can be incorporated into the micelles 
via different approaches such as encapsulation, conjugation, and complexion.
68, 70, 90-117
  Therefore, 
the strength of interaction of polymeric micelles and therapeutics is able to be designed. In addition, 
as a soluble drug carrier with the size range of several tens of nanometer, polymeric micelles can 
preferentially accumulate in the target location due to the enhanced permeability and retention 
(EPR) effect (see Figure 1.1).   
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Figure 1.1 Polymer nanoparticles in drug delivery.
118 
 
Moreover, hydrophobic drug can be embedded in the inner core, thus the plasma degradation of 
therapeutics is significantly avoided.
13, 68, 71, 119, 120
 These water soluble polymeric carriers also 
increase the solubility of the hydrophobic drugs. Furthermore, the stealth properties of the corona 
can prevent the micelles from recognition by reticuloendothelial system (RES) which may result in 
a longer blood circulation time leading to a better chance of targeting to a specific site.  
 
1.1.2.2 Polymeric hydrogels 
A hydrogel is a three-dimensional polymeric network with good permeability, high water content, 
biocompatibility, and tissue-like mechanical properties. There are two main types of hydrogels: 
physical and covalent cross-linked hydrogels.
74, 75, 79, 121, 122
  In physical cross-linked hydrogels, the 
formation of hydrogel can be controlled by hydrogen bond, crystallized domains, aggregation, 
hydrophobic interaction, host-guest interaction, self-assembly, and temperature-induced sol-gel 
transition.
123-155
 These hydrogels can undergo a reversible volume phase transition or sol-gel 
transitions in response to external (physical) stimuli, and thus have great potential in biomedical 
applications such as drug delivery, gene delivery, and tissue engineering. In drug and gene delivery, 
the therapeutics can be loaded into the gel matrix and protected from hydrolysis and enzyme 
degradation.
74, 75, 77, 78, 80, 121, 154
 Through the application of proper stimuli on hydrogels, the 
physically cross-linked hydrogels are able to reverse to the corresponding solution state or change 
to degradation products that support the release of the therapeutic compounds.  
With the emerging development in drug delivery the physiological environment needs to be 
considered in order to produce an effective polymeric drug delivery system. Therefore, smart 
polymers that are able to respond to the change of the physiological conditions within the human 
body have been persistently studied in the field of drug delivery over many decades. 
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Thermoresponsive polymers, a representative of smart polymers, are the most extensively exploited 
polymers in the designing of polymeric carriers for drug and gene delivery.
156
 
 
1.1.3 Thermoresponsive polymers (TP) for drug and gene delivery 
1.1.3.1 Thermoresponsive polymers 
Thermoresponsive polymers are classified as one of the smart materials which can respond to 
changes in temperature. 
37, 121, 156
 Thermoresponsive polymers include two main types: Lower 
critical solution temperature (LCST) and Upper critical solution temperature (UCST). Polymers that 
become insoluble upon heating have a LCST. In contrast, polymers which become soluble upon 
heating have an UCST (Figure 1.2). The phase transition of the polymers reflects the competition 
between the hydrogen bonding interaction of the polymer molecules with surrounding water 
molecules and the intra-/intermolecules hydrogen bonding between the polymer molecules. When 
the intra/intermolecular hydrogen bonding interactions between polymer molecules predominate 
upon heating, the solubility of the polymer decreases.   LCST and UCST can be explained by the 
free energy system in the Gibbs equation ∆G = ∆H - T∆S (G: Gibbs free energy, H: enthalpy, and 
S: entropy). It is noted that the LCST is affected by entropy while the UCST is driven by enthalpy. 
Polymers that exhibited a LCST such as Poly(N-isopropylacrylamide) (PNIPAM) are the most 
heavily studied.  
 
Figure 1.2 Temperature vs. polymer volume fraction, ϕ. Schematic illustration of phase diagrams 
for polymer solution (a) lower critical solution temperature (LCST) behavior and (b) upper critical 
solution temperature (UCST) behavior.
121
 
 
1.1.3.2 Poly(N-isopropylacrylamide) (PNIPAM) 
PNIPAM was reported as early as 1967 by Scarpa to possess a LCST near physiological 
temperature at 32-33 
o
C.
156
 Many properties of PNIPAM (e.g., tuneable LCST, interactions with 
surfactants, etc.) and mechanism of its phase separation have been well-characterised and 
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understood over the last two decades. Moreover, PNIPAM have been using for many applications 
including biomedical materials.
72, 80, 81, 121, 156
 Therefore, in this thesis, PNIPAM is chosen as a 
thermoresponsive polymer to investigate the novel self-disassembly strategy although it is slightly 
toxic.
157
 This polymer is water soluble below its LCST through predominant hydrogen bonding 
interactions with the surrounding water molecules. When heating to above the LCST, the hydrogen 
bonding with water is disrupted leading to aggregation and collapse of the polymer chains (Figure 
1.3).
156, 158-160
 The LCST of PNIPAM can be manipulated by incorporating hydrophilic/hydrophobic 
components to shift the hydrophilic/hydrophobic balance. For example, incorporation of PNIPAM 
with a hydrophilic monomer increases the LCST, whereas with a hydrophobic monomer decreases 
the LCST. Based on this concept, several thermoresponsive micellar drug carriers prepared from 
PNIPAM containing copolymers have been reported.
161-166
 
 
Figure 1.3 Illustration of temperature induced PNIPAM phase transition.
167
 
 
1.1.3.3 Application of thermoresponsive property or polymer in drug and gene 
delivery and challenges 
Thermoresponsive micelles in drug and gene delivery and challenges 
Drug carriers prepared from block copolymers, where one of the blocks is able to undergo a lower 
critical solution temperature (LCST) phase transition, like PNIPAM, have drawn a lot of 
attention.
89, 168-174
 Over the last couple of decades, many PNIPAM based micelles have been studied 
such as the thermoresponsive micelle poly(N-isopropylacryamide-co-methacrylic acid-co-octadecyl 
acrylate (P(NIPAM-co-MAA-co-ODA)). The polymer micelles can be formed at 20 
o
C, and are 
able to encapsulate 50-60% of aluminum chloride phthalocyanin.
86
 Furthermore, micelles prepared 
from block copolymers poly(N-isopropylacryamide-b-styrene) (P(NIPAM-b-STY)) and poly(N-
isopropylacryamide-b-butyl methacrylate) (P(NIPAM-b-BMA)), which have a hydrophobic core 
originating from the PSTY or PBMA and a hydrophilic shell formed by PNIPAM, have been 
employed to test the release of  Adriamycin (ADR) in vitro.
175
 However, the polymers were not 
degradable, which may cause toxicity problems, as the polymers may not be able to be eliminated 
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from the body. Degradable poly(D,L-lactide) (PLA) was employed to synthesize poly(N-
isopropylacrylamide-co-N, N-dimethylacrylamide)-b-poly(DL-lactide) (P((NIPAM-co-DMA)-b-
LA)) to address the degradation issues. The LCST of the polymer was adjustable to meet the 
requirement for a specific delivery system. The resulting micelles were used to investigate the 
loading and release of ADR. Nevertheless, the drug release rate was too slow (only 15 % release in 
6 days) accompanying a high cytotoxic.
172
 Another biodegradable polymer, poly(ε-caprolactone) 
(PCL), was utilized as a hydrophobic block in the copolymer P((NIPAM-co-DMA)-b-CL). In 10 h, 
80% of Doxorubicin was released, which demonstrated a quick drug release behaviour.
176
 Another 
micelle system of a triblock copolymer biotin-poly(ethylene glycol)-block-poly(N-
isopropylacrylamide-co-N-hydroxymethylacrylamide) (Biotin-PEG-b-P(NIPAAm-co-HMAAm)-b-
PMMA) exhibited 10% entrapment efficiency of Methotrexate (MTX) drug with pre-targeting 
property and was able to release 92% of the drug in 96 h, exhibiting a high potential as a drug 
delivery system.
177
 However, the release of these cargos should only fall between 37 and 42 
o
C 
because denaturation and disruption of fine anatomical structure of some bioactive agents can 
happen at temperatures above this range.
178
 Moreover, these micelles were prepared in the presence 
of an organic solvent which may cause toxicity. In addition, the encapsulated drugs release 
uncontrollably above copolymers LCST rather than below since the micelles were deformed above 
the LCST. Furthermore, the deformation of the micelles can be controlled by the temperature such 
as hyperthermia that may cause limitations on the application of these systems in vivo.
89, 176
  
Micelle systems from diblock copolymers of PNIPAM and hydrophilic polymers can self-assemble 
without involving an organic solvent. The diblock copolymer can self-assemble in aqueous solution 
to form micelles in which the PNIPAM is the inner core andother hydrophilic block as outer 
hydrophilic shell, for example poly(N-isopropylacrylamide)-block- poly(ethylene glycol) 
(P(NIPAM-b-PEG)),
174
 poly(N-isopropylacryamide-b- N,N-dimethylacrylamide) (P(NIPAM-b-
DMA)),
179, 180
 poly(N-isopropylacrylamide)-block- poly(acrylic acid) (P(NIPAM-b-AA)).
181
  The 
micelles formed from self-assembly of diblock P(NIPAM-b-AA) in water were able to encapsulate 
doxorubicin (DOX). The release of DOX was investigated in different pH media. The drug released 
faster at pH 4 (90 % of in 10h) and slower in pH 7.2 (40 % in 40 h). However, in order to release 
the encapsulated drug in vivo, higher temperature was also required to deform the micelles as well 
as to enhance the drug release.
181
 In addition, the release rate and release time of compounds from 
these micelles were not controllable. This may cause a negative effect to the efficacy of in-vivo 
applications. 
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Thermoresponsive hydrogels in drug and gene delivery and challenges 
Thermoreponsive polymers are also widely used as hydrogels.
80-82, 161
 The entanglement of the 
polymer chains or bridging of the self-assembled amphiphilic micelles at high concentration in 
solutions and above the LCST of thermoresponsive polymers results in the reversible in-situ 
formation of the physical hydrogel without the need of toxic cross-linkers (Figure 1.4). 
Furthermore, without cross-linkers, the micelle solutions are injectable before gelation at 
temperatures below its LCST. While heating to a temperature higher than its LCST results in the 
polymer solution transitioning to a gel state.
80-82, 161
 
 
Figure 1.4 Mechanism of in situ physical gelation driven by hydrophobic interactions.
75 
 
Based on this concept, thermoresponsive hydrogels have been widely applied in drug and gene 
delivery systems where the active compounds can be mixed with polymer solution at below the 
polymer‘s LCST and firmly held inside carriers at above the LCST. For example, hydrogel 
achieved from random copolymer of PNIPAM and Oligolatide-(2-hydroxylmethyl methacrylate) 
(PNIPAM-co-oligoLA-HEMA) showed high encapsulation efficiency and sustained release of 
insulin to the retina over a 7 day period.
182, 183
 PNIPAM also blended with poly(dimethyl siloxane) 
(PDMS) for protein delivery.
184
 Nevertheless, these hydrogel systems were not able to degrade, 
which is the biggest issue for PNIPAM based hydrogels. Degradable polymers such as 
biodegradable poly(l-glutamic acid)  was successfully introduced to PNIPAM based copolymers to 
form a degradable hydrogel.
185
 However, the side product of degradation is toxic, limiting the 
application of these hydrogels in vivo. The Guan and Vernon groups built a novel hydrogel system 
from biodegradable PNIPAM copolymers which are poly(N-isopropylacrylamide)-co-poly(acrylic 
acid)-co-poly(dimethyl-γ-butyrolactone)-co-poly(hydroxylethyl methacrylate-co-poly(trimethylene 
carbonate)) (P(NIPAM-co-AA-co-DBA-co-HEMAPTMC)) and poly(N-isopropylacrylamide)-co- 
poly(acrylic acid)-co-poly(2-hydroxylethyl methacrylactate) (P(NIPAM-co-AA-co-HEMA-
lactate)), respectively. The polymer solutions were able to form gel in-situ and then degrade. 
80, 161, 
186
 In these systems, the hydrogels were formed at body temperature, 37 
o
C, yet became soluble at 
this temperature after degradation, allowing the by-product to be dissolved and excreted from body. 
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The hydrogel can be applied for both the delivery of genes and drugs.
186
 Nevertheless, the 
degradation time of the hydrogel was not well-controlled which may affect the encapsulated agents 
(e.g, reduction in the bioactivity) as well as the efficacy of administration (e.g., insufficient dose at 
the required times). 
 
1.2 Controlled release in drug and gene delivery 
One of the most important features of delivery carriers is the ability to release the therapeutic agents 
in a controlled manner.
178, 187, 188
 This raises the need of a facile approach to release the therapeutics 
in response to change of stimuli or in the surrounding environment. However, most of the 
traditional carriers are not able to respond to stimuli. Recently, stimuli-responsive polymers as 
delivery carriers have been extensively developed to produce carriers that can respond to the 
extracellular environment to release the cargo. The stimuli-responsive carriers can sharply response 
to the applied stimuli by undergoing physical and chemical changes.  In other words, the release of 
the encapsulated bioactive agents can be triggered by the alteration in the structure of the carriers. 
The stimuli can be mainly divided into three categories, which are physical (e.g., light, temperature, 
ultrasound, magnetic, mechanical, electrical), chemical (e.g., solvent, ionic strength, 
electrochemical, pH), and biological (e.g., enzymes, receptors). 
 
1.2.1 Physical (external) stimuli induced release 
Physical stimuli that can alter the properties and supramolecular structure of the polymers such as 
light, temperature, electric field, magnetic field and ultrasound have been studied over the past 
decades.  
 
1.2.1.1 Light 
Light responsive polymers are a kind of smart polymer that are able to respond to either UV or 
visible light, to release encapsulated bioactive agents in a triggered manner (Figure 1.5). This 
allows for spatial and temporal control over the triggering period. The encapsulated compound can 
be released after the body is irradiated with a light source.
188-194
 For example, sensitive light 
molecules such as leuco derivative and chromophore were introduced to the polymer to prepare a 
UV-light or visible light responsive carrier.
194-197
 Photo cleavable linkers such as 2-nitrobenzyl ester 
linker was also employed to design light sensitive polymersomes for release of encapsulated 
fluorescin.
198
 These carriers are able to respond according to the activation or deactivation of the 
irradiation resulting in the release of the encapsulated guests. However, the guest molecules can 
only be released when the tissue is able to absorb the light. In addition, this delivery system has 
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some common problems such as high initial release, low penetration depth of irradiation light, slow 
response of carriers towards the stimuli, and long application periods.
188
 Moreover, there are some 
requirements for this delivery system that can cause adverse effects to patients during treatment. For 
example the patients have to stay in a dark place for a certain period of time to avoid early release 
and activation of the drug. However, the dark condition is also harmful for the patient.
178
 
 
 
Figure 1.5 Schematic illustration of the difference between placing a photobreakable unit at only 
the block junction and repeatedly on the hydrophobic block.
199
 
 
1.2.1.2 Ultrasound 
Applying ultrasound as an external trigger to activate the release of active molecules from the 
polymeric matrix has been widely used and attracted much attention in the drug delivery field 
during the last decades.
192, 200-203
 Some bioerodible polymers such as polyglycolide, polylactide, 
poly(bis(p-carboxyphenoxy)) alkane-anhydrides, etc, can be introduced to prepare ultrasound 
sensitive carriers for drug and gene delivery (Figure 1.6).
200, 204-206
 The general mechanism of 
ultrasound regulated drug/gene delivery is that the ultrasound creates the thermal energy though 
micro–convection and inertia cavitation, causing cell membrane perturbation as well as increases 
the permeability of blood capillaries.
207
 Although a number of ultrasound sensitive carriers 
including polymeric ultrasound contrast agents have been explored there are still several major 
issues with this method.
204, 208, 209
 These include that the  release controlled by ultrasound requires 
specialized equipment and should only be applied once the amount of carrier containing the 
encapsulated drugs is sufficiently accumulated at the target site, which depends on the 
pharmacokinetics of the delivery system.
178, 188, 192
 In addition, high efficiency of induced release 
depends on the suitability of the ultrasound power, and the depth of the ultrasound impulse to the 
target site. Surgical implantation is sometimes required for non-biodegradable delivery systems.
188
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Figure 1.6 Ultrasound-responsive drug delivery from triblock copolymer micelles of poly(ethylene 
oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) (PEO-b-PPO-b- PEO).
210
 
 
1.2.1.3 Magnetic 
Several magnetic stimuli carriers have been developed for drug and gene delivery.
211-214
 Magnetic 
release involves the utilization of a magnetic field to trigger the release of contents embedded into 
the polymeric scaffold.
215-217
 For example, magnetite nanocrystals were embedded in 
Pluronic/poly(ethylene imine) shell crosslinked nanocapsules to trigger the delivery of siRNA.
218
 
To release the model guests from the carriers, a certain high frequency magnetic field is always 
required. However, the intensity of the magnetic field may be different among specific sites of 
action.
219
 Moreover, there is a problem in scaling up the application from small animals with near 
surface targets to larger animals or humans because the depth of the magnetic field may have to be 
varied. In addition, the accumulation of the magnetic particles can block blood flow resulting in 
embolization. High concentration of the magnetic particles in the liver may also occur.
219
 
 
1.2.1.4 Electrical field 
The release of bioactive agents entrapped in the carrier triggered by electrical field application is 
also an attractive method in drug delivery.
220-222
 This external stimulus provides control over the 
current magnitude, the electrical pulses duration, and the interval between pulses. Polyelectrolytes, 
which are ionisable, are common platforms for preparation of this delivery system. The delivery 
systems are able to shrink or swell under the influence of electric field due to anisotropic, thereby 
releasing the encapsulated agents.
223, 224
 For example, fluorescein (or daunorubicin) was 
encapsulated in a nanoparticle prepared from conducting polymer (e.g., polypyrrole). These 
particles was suspended in a thermoresponsive hydrogel of poly((d,l-lactic acid)-co-(glycolic acid))-
b-poly(ethylene oxide)-b-poly((d,l-lactic acid)-co-(glycolic acid)) (PLGA-PEG-PLGA).
225
 The 
release of the drug from the nanoparticles was regulated by electric field application, which allowed 
the drug to diffuse through the hydrogel to the surroundings (Figure 1.7).   However, one issue is 
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that it is necessary to maintain the level of the remote trigger to the specific location over the 
triggering period. Furthermore, the selection of electric current for triggering the drug release 
without stimulating the nerve endings in the surrounding tissue is also a major issue that needs to be 
considered.
188 
 
Figure 1.7 General schemes for the application of this system. (a) The nanoparticle polymer 
solution is (b) subcutaneously injected into a mouse, followed by (c) application of a DC electric 
field to induce release of the drug cargo inside the nanoparticles.
225
 
 
1.2.2 Chemical and biological induced release 
Chemical stimuli can trigger the release through molecular interactions between the polymers and 
these stimuli. Generally, this kind of carrier is classified into three types: pH responsive, ion 
responsive, and redox responsive carriers. The most studied chemical sensitive carriers for drug 
delivery are the pH responsive and redox responsive polymers. 
 
1.2.2.1 pH  
A sharp gradient change in the pH of the biological systems in cellular compartment and 
physiological environment motivated the design and development of pH sensitive carriers in drug 
and gene delivery systems.
38, 178, 188, 226
 All pH sensitive polymers are polyelectrolytes that contain 
pendant acidic or basic groups that are ionisable in response to changes in environmental pH. 
Therapeutics can be loaded into the polymeric carriers via encapsulation, conjugation (e.g., 
conjugation of therapeutics to polymer via pH-dependent cleavable linkage), and complexation. In 
the proper pH environment, the protonation/deprotonation of the polymer can induce disassembly 
of micelles or the cleavage of labile linkage between polymer and the therapeutic agents result in 
the triggered release of the transported drugs (Figure 1.8).
116
 There are two strategies used to 
control and trigger the release of loaded compounds. Each depends on the alteration of the pH of the 
environment. The strategy is either extracellular or intracellular release methods.
38, 178, 187
 The pH of 
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physiological environment is 7.4 while the intracellular pH of cancer tissue can be 6.5-7.2 or even 
lower for some certain cancers.  The pH of the intracellular compartments can also vary.  For 
example, the pH value in the early endosome is 5-6, while for the late lysosome it drops to about 4-
5.
 
Taking advantage of pH gradient of extra- and intracellular environments, numerous polymer 
based pH responsive systems have been designed to selectively release therapeutics at target 
sites.
227-244
 For example, Kataoka and colleagues designed polymeric micelles that self-assembled 
from poly(ethylene glycol)-poly-(aspartate hydrazone adriamycin), in which the anticancer drug, 
adriamycin, was conjugated to the hydrophobic segments through acid-sensitive hydrazone 
linkers.
245, 246
 The micelles were stable and able to preserve the drugs under physiological 
conditions (pH 7.4) and selectively released them through the cleavage of the hydrazone linkers in 
response to the decrease in the intracellular pH of the endosomes and lysosomes (pH 5-6). 
However, differences in extracellular pH between normal and tumor tissues are not significant 
enough to obtain effective release of therapeutics.  The non-specific and early release of the payload 
is not avoidable.
178
   
 
Figure 1.8 Two types of pH-sensitive micelles. (A) pH-induced disintegration of polymeric 
micelles; (B) pH-induced drug cleavage from polymers.
116
 
 
1.2.2.2 Redox  
It is well-established that the redox potential between extracellular and intracellular compartments 
is different.
247
 The concentration of glutathione in the intracellular space is higher than in the 
extracellular space revealing a promising approach for the development of redox-sensitive carriers 
for intracellular delivery.
247
 Therefore, in drug and gene delivery applications, the bioactive agents 
have to be protected by the carriers as they cross the cell membrane and become internalised by the 
cell before being disintegrated in the intracellular environment.
38, 178, 248
 Polymers containing labile 
groups such as disulfide, which can be cleaved in reducing environments, have been employed in 
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designing many redox-sensitive carriers for drug and gene delivery systems (Figure 1.9).
249-259
 For 
example, the Amiji group prepared thiolated gelatin by covalent modification of the primary amino 
groups of type B gelatin using 2-iminothiolane (Traut's reagent) for delivery of plasmid DNA in 
response to glutathione.
260, 261
  Nevertheless, early breakdown of the carrier may occur because 
glutathione is also present in the extracellular environment.
178
 Furthermore, the efficacy of delivery 
depends on the concentration of the intracellular redox potential which should be sufficient to 
trigger the degradation of the carriers. Additionally, differences in the trigger level in various cell 
lines is the challenge for this delivery system.
262
 
 
 
Figure 1.9 Schematic representation of stimuli-responsive micellar disassembly and guest 
release.
263
 
 
1.2.3 Biologically induced release 
The two representatives of biologically induced release are enzyme responsive and glucose 
responsive carriers.  
 
1.2.3.1 Enzyme  
Enzymes are potentially specific triggers that can be provided with large quantity while maintaining 
its high selectivity in triggering the delivery of drug and gene. The mechanism of this delivery 
system depends on the degradation carrier via the cleavage of ester or short peptide sequences by 
esterase or proteases triggered by enzymes in the living system.
178
 In this kind of drug delivery 
system, enzymes are used to disrupt the polymer structure via polymer degradation, leading to 
dissociation or change in the morphology of the carriers. Enzyme degradable polymers or enzyme 
degradable linkages with different purposes have been used to design delivery platforms such as 
micelles and hydrogels (Figure 1.10).
51, 178, 264-267
 Hennink and co-workers reported the preparation 
of micelles from triblock poly(oligo(ethylene glycol) monomethyl ether methacrylate)-b-peptide-b-
poly(N-isopropylacryl) (POEGMA-b-peptide-b-PNIPAM).
268
 The peptide can be selectively 
cleaved in the presence of matrix metalloproteinase (MMP) owing to the presence of an MMP-
specific amino acid sequence in the middle peptide block of the triblock copolymer resulting in 
destabilization of the micellar nanoparticles. This makes these systems potentially suitable for 
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enzyme-triggered drug delivery. Although the degradation can work under mild conditions, the 
existence of enzyme is always required. Furthermore, the initial response time of this system is not 
precisely controlled.
226
 
 
Figure 1.10 Enzyme-responsive nanomaterials for drug delivery.
267
  
 
1.2.3.2 Glucose  
Glucose responsive carriers for drug delivery such as insulin delivery has attracted remarkable 
attention over the past decades.
269
 In this system, glucose oxidase (GOC) and glucose catalase 
(CAT) have been incorporated into the carrier loaded with insulin.
178
 Glucose responsive polymer 
can combine with other responsive polymers such pH sensitive polymer, or enzyme sensitive 
polymer to engineer dual responsive carriers that have potential in insulin delivery (Figure 1.11).
270-
272
 In glucose environments, glucose oxidase (GOC) oxidizes glucose to gluconic acid which 
triggers the cleavage of the linkage of polymer and insulin or changes the conformation of the dual 
responsive carriers (e.g., pH and glucose responsive carrier) leading to release of the loaded insulin. 
However, the cleavage of the linkages or the change in the conformation is mainly regulated by the 
level of glucose in the body which may not be controllable. This drawback, therefore, may limit the 
application of this kind of carrier in designing systems for drug delivery. 
 
Figure 1.11 Schematic illustration of the structural changes in response to glucose and pH.
270
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1.2.4 The importance of timed-release and challenges 
Generally, the release mechanism of the drug delivery systems mostly depends on either external 
(remote) or internal (environmental) stimuli. Nevertheless, accessibility of remote stimuli to tissues 
or organs is limited, and the level of environmental triggers can be different between cell lines and 
even within the same tissue or organ. Some smart polymer based delivery systems are thus limited 
in application, in complicated in vivo environments, although these systems may work very well in 
vitro.
273
 Therefore, it is necessary to build up delivery system which is able to load and release 
bioactive agents independent of any external or internal stimuli in a controlled approach. 
Recently, the Monteiro group has reported a novel polymeric carrier based on Poly(2-
dimethylaminoethyl acrylate) (PDMAEA) that is able to release genetic material without any 
external or internal trigger. PDMAEA is a cationic polymer that can degrade through a self-
catalyzed hydrolysis process independent of both the polymer molecular weight and solution pH.
274, 
275
 This self-catalyzed hydrolysis process of PDMAEA creates poly(acrylic acid) and 2-
(dimethylamino) ethanol, both of which cause little or no toxicity to cells. The polymer can strongly 
bind, protect, and then release oligo DNA (a mimic for siRNA) in a time dependent manner. This 
polymer was also incorporated in the block copolymer poly(2-di methylaminoethyl acrylate)-b-P(N-
(3-(1H-imidazol-1-yl)propyl) acrylamide-co-poly(butyl acrylate) (P(DMAEA-b-(ImPAA-co-BA))) 
to build up the carrier for the delivery of siRNA.
276
 The polymer carrier is able to mimic the 
influenza virus escape mechanism from endosome and can timely release the siRNA to the cytosol 
through the degradation of PDMAEA.  The polymer can degrade to benign products that showed no 
toxicity even at N/P of 300 exhibiting the potential for repeatable doses and long-term treatment of 
diseases.
277
 This work suggested that siRNA delivery can specifically kill cells without the need of 
a dual delivery system that delivers both siRNA and a chemo-therapeutics. Furthermore, this block 
copolymer P(DMAEA-b-(ImPAA-co-BA)) was used to bind/complex, protect ,and release of 
plasmid DNA (pDNA). 
278
 Both entry pathways of the plasmid DNA/polymer complexes into the 
cell and the nucleus were investigated. The polyplex was taken up by HEK293 cells via clathrin-
mediated endocytosis (CME) pathway and then rapidly escaped the endosome at a specific time, 
and facilitated the transport of the pDNA for the occurrence gene expression. pDNA was delivered 
to nucleus 7 times higher than commercial PEI Max after 24h. Although the release manner is time-
dependent, the release time of these polymeric carriers is not able to control. Therefore, developing 
novel timed-release delivery systems that can release therapeutics in a controllable manner is the 
utmost priority in the field of timed-release materials.  
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1.3 RAFT polymerization  
The Reversible addition−fragmentation chain-transfer polymerization (RAFT) is considered a 
powerful synthetic tool in polymer synthesis. In the RAFT technique, chain transfer agent (CTA) 
including dithioester, xanthate, dithiocarbamates, and trithiocarbonates compounds can be used to 
polymerize a wide range of monomers as well as reaction condition.
279, 280
 The trithiocarbonates 
compound which is non-toxic can be applied in biomedical fields. The nature of the Z and R groups 
(Figure 1.12) which are the key to the structural features of this agent determines the effectiveness 
and its versatility. Based on these advantages, numerous polymer architectures such as functional 
polymer, gradient polymer, star polymers, cyclopolymers and block copolymers with controlled 
molecular weight and polydispersity have been synthesized by the RAFT technique.
281, 282
 
Therefore, RAFT is the technique utilized for polymer synthesis in this project. 
 
 
Figure 1.12 Mechanism of RAFT polymerization.
281
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1.4 Objectives and outlines of thesis 
The main objective of the work described in this thesis was to synthesize and study novel timed-
release polymeric nanoparticles and hydrogels based on thermoresponsive PNIPAM and self-
degradable PDMAEA. In particular, efforts were made towards understanding the self-assembly 
and self-disassembly characteristics of thermoresponsive PNIPAM in the presence of self-
degradable components and other factors such as hydrophilic and hydrophobic contents as well as 
surfactants. Such understanding established some general design principles to serve as guidelines 
for developing the next generation of nanocarriers with controllable timed-release characteristics. 
 
Chapter 2 demonstrates the use of self-degradable PDMAEA together with hydrophobic 
components to finely tune the LCST and disassembly time of thermoresponsive PNIPAM as well as 
to control the release time of oligo DNA or siRNA from the polymer complex. The polymers 
consists of a hydrophilic block (e.g., PDMA) for stabilization and a second thermoresponsive block 
with three components (e.g., NIPAM, DMAEA and Styrene or BA) for self-assembly and 
disassembly. The diblock copolymer is fully water-soluble at temperatures below the second 
block‘s LCST, and when heated to 37 °C. The polymer self-assembles into a narrow size 
distribution of nanoparticles with an average diameter of approximately 25 nm. The nanoparticles 
are able to disassemble to unimers when the amount of acids groups from degradation of cationic 
DMAEA units is sufficiently high to increase the LCST of the second block above 37 °C. The 
nanoparticles show excellent binding to oligo DNA without any leakage until full disassembly to 
unimers and can only be taken up by osteosarcoma cells when coated with a transfection agent, 
folic acid. 
 
Chapter 3 details the effect of the number of self-catalyzed degradable DMAEA and hydrophobic 
units (e.g., butyl acrylate and styrene) on both micelle disassembly time (tstart) and time from the 
start of disassembly to full unimer formation (tdegrade) of the novel timed-release nanoparticles. The 
tstart increases linearly with an increase in the number of hydrophobic BA units in the second block 
due to the decrease in LCST. By controlling the second block‘s composition, tstart therefore could be 
predicted. Additionally, the tdegrade decreases when increasing the amount of DMAEA units in the 
second block. The ability to tune both tstart and tdegrade allows the use of such timed-release 
nanoparticles for a wide range of applications. 
 
Chapter 4 investigates the influence of surfactant on the formation of the polymeric micelles as 
well as LCST and the disassembly profile of the random polymers of thermoresponsive PNIPAM 
with self-degradable and hydrophobic components. At temperatures above the copolymer LCST, 
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SDS can stabilize the nanoparticles. The nanoparticle sizes have a very narrow distribution and can 
be controlled by manipulating SDS concentration. Moreover, the LCST of copolymers increases 
when the amount of SDS increases. The nanoparticles are stable when diluted. Furthermore, the 
addition of SDS does not affect the self-degradation of DMAEA as well as self-disassembly 
characteristic of the copolymer. 
 
Chapter 5 describes the synthesis of a novel non-trigger release hydrogel system based on a series 
of self-degradable random copolymers synthesized from thermoresponsive NIPAM, self-catalysed 
hydrolysis DMAEA, hydrophilic PEGMEA, and hydrophobic BA. The thermoresponsive 
copolymers can form a stable gel at temperatures higher than the gelation point and then self-
degrade into sol state after different times without the need of triggers. Moreover, the gelation 
temperature and degradation time can be controlled by manipulating the DMAEA units. Gold 
nanoparticles coated with PDMA can be encapsulated in the hydrogel and subsequently are able to 
be released at different rates. This novel non-trigger release hydrogel may find potential for 
applications where controlled-release is beneficial. 
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Triggered-release of encapsulated therapeutics from nanoparticles without remote or environmental 
triggers was demonstrated in this work. Disassembly of the polymer nanoparticles to unimers at 
precise times allowed the controlled release of oligo DNA. The polymers used in this study 
consisted of a hydrophilic block for stabilization and second thermoresponsive block for self-
assembly and disassembly. At temperatures below the second block‘s LCST (i.e., below 37 °C for 
in vitro assays), the diblock copolymer was fully water-soluble, and when heated to 37 °C, the 
polymer self-assembled into a narrow size distribution of nanoparticles with an average diameter of 
approximately 25 nm. The thermoresponsive nature of the second block could be manipulated in 
situ by the self-catalyzed degradation of cationic 2-(dimethylamino) ethyl acrylate (DMAEA) units 
to negatively charged acrylic acid groups and when the amount of acid groups was sufficiently high 
to increase the LCST of the second block above 37 °C. The disassembly of the nanoparticles could 
be controlled from 10 to 70 h. The use of these nanoparticles as a combined therapy, in which one 
or more agents can be released in a predetermined way, has the potential to improve the personal 
point of care treatment of patients. 
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2.1 Introduction 
Triggered-release of encapsulated materials from nanoparticles has attracted considerable attention 
for the on-demand release of compounds.
1-4
 The potential applications range from drug delivery, to 
fragrance release, to self-healing materials.
5-7
 Degradation or disassembly of nanoparticles can be 
activated either remotely through external light,
8-10
 electric or magnetic sources,
11-13
 or through 
environmental triggers such as in vivo biological changes (e.g., pH changes
14-16
 or localized enzyme 
activity.
17-19
 While these triggers represent elegant methods for selective release, there are still 
many applications where remotely activated triggers cannot be used. Environmental triggers (such 
as pH, enzymatic degradation, temperature) have other issues due to their variability within cell 
lines and within the same tissue.
20, 21
 In such cases, new nontriggered release delivery materials are 
required that would act in an environment independent manner. We believe that nanoparticles, 
which release their payload at specific times in the absence of an external trigger, would be of great 
interest for the controlled release of small molecules and biological therapeutic agents. Therefore, 
nanoparticles must be designed to encapsulate and release the therapeutic agent on-demand to 
impart a rapid effect. These nanoparticles after release should be nontoxic, allowing the application 
of multiple doses for high effective therapeutic effects. Thermoresponsive polymer (e.g., poly(N-
isopropylacrylamide); PNIPAM) nanoparticles have been used for such a purpose,
22
 in which 
polymeric micelles degrade to unimers through an acid or base hydrolysis process. However, even a 
small change in pH (from 7.5 to 7.2) could slow the degradation rate by a factor of 2.
23
 If such 
polymer nanoparticles were used in vivo, the variability of pH within cells and at, for example, 
tumors will cause the noncontrolled release of the therapeutic. To overcome this significant hurdle, 
we will incorporate a self-catalyzed polymer (poly (2 (dimethylamino)-ethyl acrylate); PDMAEA) 
into the second hydrophobic block with PNIPAM. The degradation rate in water of PDMAEA to 
poly(acrylic acid) is independent of the physiological pH ranging from 5.5 to 10.1,
24
 making such 
timed-release micelles ideal for many biological applications where precise release of the payload is 
required within any physiological environment.  
 
2.1.1 Aim of the Chapter 
The aim of this chapter was to design polymer nanoparticles to disassemble and thus release their 
payload at a desired time independent of the local microenvironment. We synthesized diblock 
thermoresponsive copolymers PDMA-b-P(NIPAM-co-DMAEA-co-BA) and PDMA-b-P(NIPAM-
co-DMAEA-co-STY) by Reversible addition-fragmentation chain transfer  (RAFT) polymerization. 
The polymers are water soluble below their lower critical solution temperature (LCST, < 37 °C), 
and when heated to 37 °C (i.e., above the polymers‘ LCST), self-assemble to form small 
nanoparticles of approximately 20 nm with narrow size distribution. Through the self-catalyzed 
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hydrolysis of PDMAEA, the polymer nanoparticles rapidly disassemble after desired times to 
biologically nontoxic negatively charged diblock unimers (see Scheme 2.1). The self-assembly of 
the polymers in water above the polymers‘ LCST was investigated by Dynamic Light Scattering 
(DLS). Furthermore, the disassembly of the polymer nanoparticles was monitored over time. In 
addition, the binding and release of oligo DNA (a mimic of siRNA) and cell uptake of the polymer 
nanoparticle into osteosarcoma cells were studied. 
 
2.2 Experimental 
2.2.1 Materials 
Dioxane (Alrich, 99%), carbondisulfide (Alrich, 99%), 1-butanethiol (Alrich, 99%), methyl 
bromopropionate (Alrich, 98%), and dimethyl sulfoxide (DMSO, Alrich >99.9%), N, N-
dimethylformamide (DMF: Labscan, AR grade), dichloromethane (DCM: Labscan, AR grade), N-
(t-BOC-aminopropyl)methacrylamide (Polysciences, 100%),  trifluoroacetic acid (TFA: Merck, AR 
grade), triethylamine (TEA: Fluka, 98%), tri(2-carboxyethyl) phosphine hydrochloride solution 
(TCEP: Aldrich, 98 %), N-Ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC.HCl: Alrich, premium), N-hydroxysuccinimide (NHS: Alrich, 98 %), Hexylamine (Alrich, 99 
%), Folic acid (Alrich, ≥ 97 %) were used as received. Styrene (STY, Aldrich, 99 %), 
dimethylacrylamide (DMA, Aldrich, 99 %), 2-(dimethylamino) ethyl acrylate (DMAEA, Sigma-
Aldrich, 98%), and butyl acrylate (BA, Aldrich, 99%) were passed through a column of basic 
alumina (activity I) to remove inhibitor. N-isopropylacrylamide (NIPAM, Aldrich, 97 %) was 
recrystallized from hexane. Azobisisobutyronitrile (AIBN) was also recrystallized twice from 
methanol prior to use. 9-27 Oligo DNA was synthesized by Invitrogen, 9-27F+R–MW=14998 
(23bp), Sense: 5‘-GTCAGAAATAGAAACTGGTCATC-3‘ Antisense: 5‘-
GATGACCAGTTTCTATTTCTGAC3‘. Milli-Q Water (18.2 MΩcm-1) was generated using a 
Millipore Milli-Q academic water purification system. All other chemicals and solvents used were 
of at least analytical grade and used as received. 
 
2.2.2 Synthetic procedures 
2.2.2.1 Synthesis of the Chain Transfer Agent (CTA), Methyl 2-(butylthiocarbonothioylthio) 
propanoate (MCEBTTC).The synthesized MCEBTTC was carried out according to the literature 
procedure.
25
 Carbondisulfide (3.1 mL, 0.051 mol) in dichloromethane (50 mL) was added dropwise 
to a stirred solution of 1-butanethiol (5 mL, 0.047 mol) and triethylamine (7.2 mL, 0.051 mol) in 
dichloromethane (25 mL) over 30 min at 0 
o
C under an argon atmosphere. The solution gradually 
turned yellow during the addition. After complete addition, the solution was stirred at room 
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temperature for 30 min. Methyl bromopropionate (5.7 mL, 0.051 mol) in dichloromethane (25 mL) 
was then added dropwise over 30 min and the solution stirred for 2 h. The dichloromethane was 
removed under nitrogen and the residue dissolved in diethylether. The solution was then washed 
with cold 10% HCl solution (3 x 50 mL) and Milli-Q water (3 x 50 mL) and dried over anhydrous 
MgSO4. The ether was removed under vacuum, and the residual yellow oil was purified by column 
chromatography (19:1 petroleum ether/ethyl acetate on silica, second band) (yield = 76 %). 
1
H 
NMR (CDCl3) δ 0.90 (t, J = 7.5 Hz, 3H, CH3), 1.40 (m, J = 7.5 Hz, 2H, CH2), 1.57 (d, J = 7.5 Hz, 
3H, CH3), 1.66 (q, J = 7.5 Hz, 2H, CH2), 3.34 (t, J = 7.5 Hz, 2H, CH2), 3.73 (s, 3H, CH3), 4.80 (q, J 
= 7.5 Hz, 1H, CH). 
 
2.2.2.2 Synthesis of poly (N, N-diethylacrylamide) macro chain transfer agent (PDMA macro-
CTA). DMA (10.40 mL, 0.10 mol), MCEBTTC (25.42 mg, 1.01 x 10
-3
 mol), and AIBN (14.10 mg, 
8.57 x 10
-5
 mol) were dissolved in DMSO in a 50 mL dry Schlenk flask equipped with a magnetic 
stirrer bar. The mixture was deoxygenated by purging with Argon for 30 min and then heated to 60 
o
C for 2 h. The reaction was stopped by cooling to 0 
o
C in an ice bath and exposed to the air. The 
solution was then diluted with dichloromethane (500 mL) and washed with brine (3x100 mL). The 
DCM was then dried over anhydrous MgSO4, filtered and reduced in volume by rotary evaporation. 
The polymer was recovered by precipitation into large excess of diethyl ether (1 L), and isolated by 
filtration. The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-
dissolving and precipitation process was repeated 2 times. The polymer was filtered and then dried 
under high vacuum for 24 h at room temperature to give a yellow powder product (yield = 71%). 
Mn = 8200, PDI = 1.14 (SEC-RI calibrated using PSTY Standards in DMAc solution containing 
0.03 wt% of LiCl), Mn = 10000 (SEC-Triple Detection, dn/dc = 0.081); Mn = 9769 (
1
H NMR). 
1
H 
NMR (500 MHz, CDCl3): δ 0.87 (CH3CH2CH2-), 1.09 (CH3-(CH-COO)-), 2.84-3.05 ((CH3)2-N-), 
3.29 (-CH2-S-(C=S)-S-), 3.60 (CH3O-(C=O)-), 5.14 (-(C=S)-S-CH-). 
 
2.2.2.3 Synthesis of block copolymers of NIPAM and DMAEA from PDMA macro-CTA (A). 
NIPAM (1.00 g, 8.85 x 10
-3
 mol), DMAEA (0.34 mL, 2.21 x 10
-3
 mol), PDMA macro-CTA (725.66 
mg, 8.85 x 10
-5
 mol) and AIBN (1.45 mg, 8.85 x 10
-6 
mol) were dissolved in 20 mL of dioxane in a 
50 mL dry Schlenk flask equipped with a magnetic stirrer bar. The mixture was deoxygenated by 
purging with Argon for 30 min and then heated to 60 
o
C for 7 h under Argon. The reaction was 
stopped by cooling to 0 
o
C in an ice bath and exposed to air. The solution was precipitated in diethyl 
ether (500 mL) and filtered. The polymer was re-dissolved in acetone and precipitated in diethyl 
ether. The re-dissolving and precipitating process were repeated twice. The yellow powder product 
was dried under high vacuum at room temperature for 48 h (yield = 78 %).  
Chapter 2 
37 
 
2.2.2.4 Synthesis of block copolymers of NIPAM, DMAEA, and BA from PDMA macro-CTA (B1, 
B2). For a polymerization with 5.04 % of BA in the second block, NIPAM (1.00 g, 8.85 x 10
-3
 
mol), DMAEA (0.34 mL, 2.21 x 10
-3
 mol), BA (0.083 mL, 5.75 x 10
-4
 mol), PDMA macro-CTA 
(725.66 mg, 8.85 x 10
-5
 mol) and AIBN (1.45 mg, 8.85 x 10
-6 
mol) were dissolved in 20 mL of 
dioxane in a 50 mL dry Schlenk flask equipped with a magnetic stirrer bar. The mixture was 
deoxygenated by purging with Argon for 30 min and then heated to 60 
o
C for 8 h under Argon. The 
reaction was stopped by cooling to 0 
o
C in an ice bath and exposed to air. The solution was 
precipitated in diethyl ether (500 mL) and filtered. The polymer was re-dissolved in acetone and 
precipitated in diethyl ether. Re-dissolving and precipitating were repeated twice. The yellow 
powder product was dried under high vacuum at room temperature for 48 h (yield = 75 %). For a 
polymerization with 9.38 % of BA in the second block, the same procedure was performed as above 
but with double the amount of BA (0.18 mL, 1.24 x 10
-3
 mol) (yield = 72 %). 
 
2.2.2.5 Synthesis of block copolymers of NIPAM, DMAEA, and STY from PDMA macro-CTA (C1, 
C2). For a polymerization with 4.50 % of STY in the second block, NIPAM (1.00 g, 8.85 x 10
-3
 
mol), DMAEA (0.34 mL, 2.21 x 10
-3
 mol), STY (0.067 mL, 5.75 x 10
-4
 mol), PDMA macro-CTA 
(725.66 mg, 8.85 x 10
-5
 mol) and AIBN (1.45 mg, 8.85 x 10
-6 
mol) were dissolved in 20 mL of 
dioxane in a 50 mL dry Schlenk flask equipped with a magnetic stirrer bar. The mixture was 
deoxygenated by purging with Argon for 30 min and then heated to 60 
o
C for 45 h under Argon. 
The reaction was stopped by cooling to 0 
o
C in an ice bath and exposed to air. The solution was 
precipitated in diethyl ether (500 mL) and filtered. The polymer was re-dissolved in acetone and 
precipitated in diethyl ether. Re-dissolving and precipitating were repeated twice. The yellow 
powder product was dried under high vacuum at room temperature for 48 h (yield = 76 %). For a 
polymerization with 19.11 % of STY in the second block, the same procedure was performed as 
above, but with double the amount of STY (0.14 mL, 1.24 x 10
-3
 mol) and for reaction time of 60 h 
(yield = 78 %). 
 
2.2.2.6 Lower Critical Solution Temperature (LCST) of the Block Copolymer as determined by 
DLS. Polymer samples were weighed in vials and dissolved in cold Milli-Q water at the 
concentration 10 mg/mL. These solutions were immediately kept in an ice bath, and then filtered 
directly into DLS curvets using 0.45 μm cellulose syringe filter. For measurement of the LCST, the 
polymer solutions were cooled to 5 
o
C by DLS machine, and the measurements were carried out by 
slowly increasing the temperature of DLS machine from 5 
o
C to 60 
o
C using Standard operating 
procedures (SOP) software.  
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2.2.2.7 Disassembly Kinetics of Block Copolymer Nanoparticles at 37 oC by DLS. The number-
average particle diameter was measured for each sample to determine the disassembly time of the 
nanoparticles. Polymer samples were weighed in vials and dissolved in cold Milli-Q water at the 
concentration 5 mg/mL. These solutions were immediately kept in ice bath, and then filtered 
directly into DLS curvets using 0.45 μm cellulose syringe filter. The samples were kept at 37 oC 
water bath and the particle size at different time intervals was measured. The particles size and 
polydispersity index (PDIDLS) were calculated based on five measurements. With polymer sample 
coded A, the sample was heated and kept at 45 
o
C for measurement.  
 
2.2.2.8 Lower Critical Solution Temperature (LCST) of the Block Copolymer after the polymers 
particles fully degraded by DLS. Polymer B1, B2, C1, and C2 were weighed in vials and dissolved 
in cold Milli-Q water at the concentration 10 mg/mL. These solutions were then cooled in an ice 
bath, and filtered directly into DLS curvets using 0.45 μm cellulose syringe filter. These polymer 
solutions B1, B2, C1, and C2 were then kept in water bath at 37 
o
C for 27 h, 73 h, 26 h, and 53 h, 
respectively before being measured polymer particle sizes by DLS. The measurements of LCST 
were carried out by slowly increasing the temperature of DLS machine from 5 
o
C to 70 
o
C using 
SOP software.  
 
2.2.2.9 Studying of binding ability of Oligo DNA 9-27 and thermoresponsive block copolymers at 
different nitrogen-to-phosphorus (N/P) ratios. 1.0 μg of Oligo DNA 9-27 (0.5 μg/μL) was 
complexed with each block copolymers at different nitrogen-to-phosphorus (N/P) ratios 0.5, 1, 2, 5 
and 10 in a total amount volume of 100 μL of Milli-Q water. After shaking with a vortexer, the 
mixtures were allowed to complex without stirring for 30 min in an ice bath. The polymers/oligo 
DNA complexes were then kept at 37 
o
C in a water bath for another 15 min and run at the same 
time on one gel. In preparation for the gel, the complexes (20 μL) were quickly mixed with 5 μL of 
DNA loading dye, and immediately loaded into a 2 % agarose gel containing TAE buffer and 
ethidium bromide. The gels were immersed in 1x TAE buffer (heated to 50 
o
C). Oligo DNA 9-27 
(1.0 μg) without polymer as a control. The gels were set to run in this preheat buffer for 12 min at 
80 V before being visualized using a UV transilluminator. The other complexes at different 
nitrogen-to-phosphorus (N/P) ratios 0.5, 1, 2, 5 and 10 in a total amount volume of 100 μL of Milli-
Q water were prepared with the same protocol and polymer particle sizes measured by DLS. 
 
2.2.2.10 Studying of binding and release of Oligo DNA 9-27 / thermoresponsive block copolymers 
complexes. 1.0 μg of Oligo DNA 9-27 (0.5 μg/μL) was complexed with polymer at a nitrogen-to-
phosphorus (N/P) ratio of 10 in a total amount volume of 100 μL of Milli-Q water. After shaking 
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with a vorterxer, the mixtures were allowed to complex without stirring for 30 min in an ice bath. 
The polymers/oligo DNA complexes were kept at 37 
o
C in a water bath for different times and run 
at the same time on one gel. The complexes (20 μL) were quickly mixed with 5 μL of DNA loading 
dye, and immediately loaded into a 2% agarose gel containing TAE buffer and ethidium bromide 
(Bio-rad). The gels were immersed in 1x TAE buffer (preheated to 50 
o
C). Oligo DNA 9-27 (1.0 
μg) without polymer as a control. The gels were run in 1x TAE buffer (heated to 50 oC) for 12 min 
at 80 V before being visualized using a UV transilluminator. 
 
2.2.2.12 Synthesis of Folic acid conjugated to a thermoresponsive polymer (H).  
Synthesis of random copolymer P(NIPAM-co-BA) (D) by RAFT polymerization. NIPAM (2.00 g, 
1.77 x 10
-2
 mol), BA (0.38 mL, 2.65 x 10
-3
 mol), MCEBTTC (44.68 mg, 1.77 x 10
-4
 mol), and 
AIBN (2.90 mg, 1.77 x 10
-5 
mol) were dissolved in 12 mL of dioxane in a 50 mL dry Schlenk flask 
equipped with a magnetic stirrer bar. The mixture was deoxygenated by purging with Argon for 30 
min and then heated to 60 
o
C for 17.5 h under Argon. The reaction was stopped by cooling to 0 
o
C 
in an ice bath and exposed to air. The solution was precipitated in diethyl ether (500 mL) and 
filtered. The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-
dissolving and precipitating process were repeated twice. The yellow powder product was dried 
under high vacuum at room temperature for 24 h (yield = 72 %).  
 
Synthesis of block copolymer RAFT-PDMA-b-P(NIPAM-co-BA) (E) from P(NIPAM-co-BA) macro-
CTA. DMA (0.63 mL, 6.09 x 10
-3
 mol), P(NIPAM-co-BA) macro-CTA (D) (0.80 g, 6.09 x 10
-5
 
mol), and AIBN (1.00 mg, 6.09 x 10
-6 
mol) were dissolved in 8 mL of DMSO in a dry Schlenk tube 
equipped with a magnetic stirrer bar. The mixture was deoxygenated by purging with Argon for 30 
min and then heated to 60 
o
C for 16.5 h under Argon. The reaction was stopped by cooling to 0 
o
C 
in an ice bath and exposed to air. The solution was then diluted with dichloromethane (500 mL) and 
washed with brine (3x100 mL). The dichloromethane was then dried over anhydrous MgSO4, 
filtered and reduced in volume by rotary evaporation. The polymer was recovered by precipitation 
in diethyl ether (500 mL) and filtered. The polymer was re-dissolved in acetone and precipitated in 
diethyl ether. The re-dissolving and precipitating process were repeated twice. The yellow powder 
product was dried under high vacuum at room temperature for 48 h. (yield = 72 %). 
 
Synthesis of Boc-protected amine functional copolymer (F) by Michael addition of copolymer (E) 
with N-(t-BOC-aminopropyl) methacrylamide. Copolymer E (0.5 g, 2.20 x 10
-5
 mol), TCEP (63.15 
mg, 2.20 x 10
-4
 mol) were dissolved in 1.5 mL of DMF in a dry Schlenk tube equipped with a 
magnetic stirrer bar. The mixture was deoxygenated by purging with Argon for 30 min. At the same 
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time, TEA (31.3 μL, 2.20 x 10-4 mol), hexamine (31.4 μL, 2.20 x 10-4 mol) and 1.5 mL of DMF 
were added in another dry Schlenk tube and purged by Argon for 30 min. The mixture of TEA, 
hexamine, and DMF in the second tube was then transferred to the first tube by a deoxygenated 
syringe needle. The combined mixture was then kept stirring at room temperature under Argon flow 
for overnight and then dialysed against acetone for 1 day. The dialysed solution was concentrated to 
1mL and precipitated three times in Diethyl ether. The white powder product was then dried under 
high vacuum at room temperature for 24 hours (yield = 85 %). 
 
Synthesis of amine functional copolymer (G) by deprotection of copolymer (F) with TFA. 
Copolymer F (0.35 g, 1.54 x 10
-5
 mol), TFA (0.82 mL, 1.08 x 10
-2
 mol) were dissolved in 2 mL of 
DCM in a dry Schlenk tube equipped with a magnetic stirrer bar. The mixture was then stirred at 
room temperature for overnight. The DCM in the solution was then removed blown by under 
Nitrogen flow for 1 hour. The viscous solution was redissolved in 1.5 mL of DCM. The residue 
TFA in the solution was neutralized by 1 mL of TEA. The solution was then passed through a 0.45 
μm PTFE syringe filter, concentrated to 1mL by Nitrogen flow. The concentrated solution was then 
precipitated in Diethyl ether three times. The white powder product was then dried under high 
vacuum at room temperature for 24 hours (yield = 80 %). 
 
Synthesis of folic acid functional copolymer H.  Copolymer G (0.20 g, 8.81 x 10
-6
 mol), Folate 
(11.66 mg, 2.64 x 10
-5
 mol), EDC.HCl (10.13 mg, 5.29 x 10
-5
 mol), and NHS (3.04 mg, 2.64 x 10
-5
 
mol) were dissolved in 3.3 mL of DMSO/H2O (10/1 V/V) in a dry Schlenk tube equipped with a 
magnetic stirrer bar. The mixture was then stirred at room temperature for 24 h and dialysed against 
cold Milli Q water for 24 h. The yellow solid, folate, was removed by filtration. The filtrate was 
frozen and freeze-dried for 2.5 days to give the pale yellow fluffy powder (yield = 60 %). 
 
2.2.2.12 Cell uptaken assay. The osteosarcoma U-2OS cells were cultured in 24-well plate 
(1x10
5
/well) in completed DMEM medium. Folic acid functionalized copolymer H was mixed with 
copolymer B1, B2, C1 and C2, respectively, and dissolved in cold (ice-bath) nuclease-free water to 
give a copolymer solution with 15 mol % of folic acid (Scheme S3). A model siRNA, a 21nt oligo 
DNA conjugated with Cy3 (DNA-Cy3), was diluted and added to the polymers. The N/P ratio of 
polymer to siRNA was 50/1. The mixtures were incubated in ice-bath for 30 minutes to allow the 
complexation between positive charged polymer and negative charged siRNA, followed by 
incubation at 37
o
C (above the LCST for all the copolymers) for 10 minutes to allow the formation 
of polymer/siRNA nanoparticles. They were then added to the cells to reach the final concentration 
of the siRNA 50 nM for cell uptake.  The cells were then incubated for 10 hours before washing 
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with PBS buffer and fixation with 4% paraffinformaldehyde. The cell nuclei were stained with 
Hoechst 33341 and cell uptake was viewed under fluorescent microscope.  
 
2.2.3 Analytic methodologies 
1
H, 
1
D DOSY, and 
2
D DOSY Nuclear Magnetic Resonance (
1
H NMR). All NMR spectra were 
recorded on Bruker DRX 500 MHz using external locks (CDCl3 or D2O or DMSO-d6) and   
referenced to the residual non-deuterated solvent (CHCl3 or H2O or DMSO). After samples were 
well dissolved in CDCl3 or D2O or DMSO-d6, samples solutions were then transferred to NMR 
tubes. With samples in CDCl3, the spectrometer was set at 25 
o
C for determination of polymer 
structure. With samples in D2O, the spectrometer was set at different temperatures for determination 
of the polymer structure before and after degradation. With samples in DMSO-d6, a DOSY 
experiment was run at 25 
o
C to acquire spectra to suppress any small molecule or solvent signals by 
increasing the pulse gradient and increasing d (p30) from 1 ms to 3 ms. 
 
Size Exclusion Chromatography (SEC) and Triple Detection_ Size Exclusion Chromatography (TD-
SEC). Analysis of the molecular weight distributions of the polymers were determined using a 
Polymer Laboratories GPC50 Plus equipped with differential refractive index detector. Absolute 
molecular weights of polymers were determined using a Polymer Laboratories GPC50 Plus 
equipped with dual angle laser light scattering detector, viscometer, and differential refractive index 
detector. HPLC grade  N,N-dimethylacetamide (DMAc, containing 0.03 wt % LiCl) was used as the 
eluent at a flow rate of 1.0 mL/min. Separations were achieved using two PLGel Mixed B (7.8 x 
300 mm) SEC columns connected in series and held at a constant temperature of 50 
o
C. The triple 
detection system was calibrated using a 2 mg/mL PSTY standard (Polymer Laboratories: Mwt = 
110K, dn/dc = 0.16 mL/g and IV = 0.5809). Samples of known concentration were freshly prepared 
in DMAc + 0.03 wt % LiCl and passed through a 0.45 μm PTFE syringe filter prior to injection. 
The absolute molecular weights and dn/dc values were determined using Polymer Laboratories 
Multi Cirrus software based on the quantitative mass recovery technique.  
 
Dynamic Light Scattering (DLS). Dynamic light scattering measurements were performed using a 
Malvern Zetasizer Nano Series running DTS software and operating a 4 mW He-Ne laser at 633 
nm. Analysis was performed at an angle of 173° and a constant temperature of 25 °C. The sample 
refractive index (RI) was set at 1.59 for polystyrene. The dispersant viscosity and RI were set to 
0.89 Ns.m
-2
 and 1.33, respectively. The number-average hydrodynamic particle size and 
polydispersity index are reported. The polydispersity index (PDI) was used to describe the width of 
the particle size distribution. It was calculated from a Cumulants analysis of the DLS measured 
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intensity autocorrelation function and is related to the standard deviation of the hypothetical 
Gaussian distribution (i.e., PDIPSD = ζ
2
/ZD
2, where ζ is the standard deviation and ZD is the Z 
average mean size).  
 
2.3 Result and Discussion 
The diblock copolymer was designed (Scheme 2.1B) to have a first block that provides steric 
stabilization to the nanoparticles in water and a second block to be both thermoresponsive and able 
to undergo a self-catalyzed hydrolysis reaction in water. First, the stabilizing hydrophilic 
poly(dimethyl acrylamide),
26
 PDMA, was prepared using the Reversible addition−fragmentation 
chain transfer (RAFT) polymerization technique with a number-average molecular weight (Mn) of 
8200 and polydispersity index (PDI) of 1.14. This polymer was then blocked with PNIPAM and 
PDMAEA to form the random second block. PNIPAM has an LCST close to 32 °C;
27, 28
 at 
temperatures below its LCST, the PNIPAM is fully water-soluble, but when heated above its LCST, 
it becomes water insoluble.
29, 30
 We have studied the self-catalytic degradation behavior of the 
cationic PDMAEA, which transforms into the negatively charged poly(acrylic acid) (PAA) in water 
over time (see Scheme A2.1 in Appendix A).
24
  This polymer was shown to degrade at the same 
rate regardless of its molecular weight or pH (ranging from pH 5.5 to 10.1) and could bind and 
release negatively charged oligo DNA (a mimic of siRNA).
24, 31
The significant advantages of this 
polymer include its high binding to negative biomolecules, high transfection (or uptake) into cells, 
and full release of negatively charged biomolecules through ionic repulsion after degradation.
31
 The 
resulting nontoxic PAA eliminates the accumulation of highly toxic cationic polymers, especially 
when repeat doses are required. The polymer, P(DMA96-b (NIPAM87-co- DMAEA25)), with an Mn 
of 34500 and PDI of 1.23, was shown to have an LCST starting at 39 °C (see Table 2.1 and Figure 
A2.19), and when heated to 45 °C in water, it formed nanoparticles of 25 nm in diameter with a 
very narrow size distribution (0.095, where values <0.1 represents distributions that are narrow). 
These polymer particles changed from 25 to 19 nm in water over the first 5 h due to the intrabinding 
of negatively charged side groups with the positively charged ones (see Figure A2.20 in Appendix 
A). After 5 h, there was a sharp decrease in size over 1 h due to the disassembly to diblock unimers. 
Unfortunately, this polymer had an LCST well above 37 °C and would not be suitable as a drug 
delivery device for in vivo systems. We therefore modified the polymer to reduce the LCST well 
below 37 °C.  
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Table 2.1 Lower critical solution temperature (LCST), hydrodynamic diameter (Dh), 
Polydispersities (PDI) and degradation times for thermoresponsive block copolymers determined by 
dynamic light scattering (DLS). 
Polymer LCST (
o
C)
a
 
Dh (nm) 
(PDI)
b
 
tstart 
(tdegrade)
d
 
A: P(DMA96-b-(NIPAM87-co-DMAEA25)) 39.0 - 41.0 25.12 (0.095)
c
 5.5 (1)
c
 
B1: P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)) 25.0 - 29.0 27.02 (0.028) 21 (5.5) 
B2: P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)) 17.0 - 21.0 25.31 (0.047) 66 (5.75) 
C1: P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5)) 26.0 - 30.0 27.46 (0.024) 17 (5.44) 
C2: P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)) 15.0 - 19.0 19.99 (0.063) 47 (6.8) 
 
a
LCST determined by DLS (10 mg/mL). 
b
Hydrodynamic diameter (Dh) determined by DLS (5 
mg/mL) at 37 
o
C, 
c
Dh determined by DLS (5 mg/mL) at 45 
o
C. 
d
Disassembly time at 37 
o
C: tstart = 
time when the size starts to decrease; tdegrade = time from tstart to formation of unimers. 
 
One method for decreasing the LCST of polymers involves incorporating a hydrophobic monomer. 
The greater the weight fraction of a hydrophobic monomer in the copolymer the lower the LCST,
32, 
33
 conversely, the greater the amount of a hydrophilic monomer in the copolymer the higher the 
LCST.
34-36
 In this work, we incorporated either styrene (STY) or butyl acrylate (BA) with 
increasing mol % into the diblock copolymer (see Table A2.1 for Mn and PDI values) to lower the 
LCST to below 37 °C. Polymer B1 (5% mol fraction of BA in the second block, P(DMA96-b- 
(NIPAM88-co-DMAEA25-co-BA6))) gave an LCST between 25 and 29 °C, and when the soluble 
polymer in water was heated to 37 °C, nanoparticles of approximately 27 nm formed with a narrow 
size distribution (Table 2.1). Increasing the weight fraction of BA in the second block to 9.4 mol % 
(B2; P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12))) resulted in a marked decrease in the LCST, 
ranging from 17 to 21 °C. When this polymer was heated in water to 37 °C, we observed a narrow 
particle size distribution with an average size close to 25 nm. The incorporation of 4.5 mol % STY 
(C1; P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5))) resulted in the lowering of the LCST similar 
to that of 5 mol % BA (B1), in which the LCST ranged between 26 and 30 °C. This polymer 
produced a narrow size distribution of nanoparticles with an average size close to 27 nm when 
heated to 37 °C, which was again similar to the size produced from polymer B1. Increasing the 
amount of STY to 19 mol % (C2, P(DMA96-b-(NIPAM40-co-DMAEA15- co-BA13))) decreased the 
LCST down to a range between 15 and 19 °C, which was only 2 °C lower than for B2. The size of 
these polymer nanoparticles at 37 °C was 20 nm. The difference between B2 and C2 was due to the 
difference in the molecular weights and, in particular, the differences between the number of the 
comonomer units (see Table A2.1). The Appendix A provides all the LCST data for the five 
polymers synthesized in this work. The four polymers, B1 to C2, were then solubilized in water and 
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heated to 37 °C. The resulting polymer nanoparticles were stored at this temperature and the change 
in size measured over time by dynamic light scattering (DLS). Figure 2.1 showed the change in size 
for the four polymers over 100 h. Nanoparticles from polymer B1 decreased in size from 27 to 18 
nm after 8 h levelling off at this size until 21 h, after which time there was a rapid decrease in size 
to that consistent of diblock unimers (∼5 nm) after 26.5 h. The pH of the polymer solution was 
measured to be 7.6 before and after full degradation of the PDMAEA side groups. This pH is below 
the pKa for PDMAEA (8.3 for the monomer) 
37
 and above the pKa of PAA (4.3), suggesting that 
both cationic and anionic species will be ionized in water. These data are consistent with a three 
stage degradation process leading to disassembly: first, the small number of initially degraded side 
chains (now negatively charged) will bind with the positively charged side groups to decrease the 
size of the nanoparticles; second, a plateau region where no change in size is observed; and third, 
the nanoparticles disassemble to unimers over ∼5.5 h. A similar three stage size change was also 
observed for the other three polymers. Polymer B2 showed that the plateau time could be extended 
until 66 h, after which disassembly to unimers occurred over a 5.8 h period. When 4.5% mol 
fraction of STY was incorporated in the copolymer (i.e., C1), a similar three stage behavior similar 
to that of B1 was observed. Disassembly started after 17 h, and the polymer fully disassembled into 
unimers after a further 5.4 h. With a similar trend, polymer C2 (19 mol % STY in the second block) 
started to disassemble after 47 h, and was fully disassembled to unimers after a further 6.8 h. The 
data in Figure 2.1 clearly showed that the disassembly process for all polymers could be controlled, 
suggesting that we could control the time at which disassembly occurs by simply manipulating the 
hydrophobic monomer content in the second block. In addition, the time for disassembly for all 
polymers was approximately 6 h, suggesting the same release profile of the payload from the 
nanoparticles regardless of the time at the start of disassembly. 
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Figure 2.1 Degradation kinetics profiles for B1, B2, C1, and C2. The data were averaged from five 
measurements by DLS at polymer solution concentration of 5 mg/mL at 37 °C. 
 
The sharp disassembly profile observed in Figure 2.1 supports a change in the thermoresponsive 
nature of the polymers as the DMAEA side groups undergo a self-catalyzed hydrolysis. The LCST 
of the four polymers (B1 to C2) measured approximately 30 min after full disassembly to unimers 
(see Table 2.2 and Appendix A) showed that the LCST of polymers B1 to C2 were above 37 °C 
(ranging between 39 and 41 °C for B1 and C1, and 37−39 °C for B2 and C2). The data 
demonstrated that with the increase in the degradation of DMAEA side groups to carboxylic acids, 
the diblock copolymer‘s LCST increased, and when the LCST became greater than 37 °C, 
disassembly to water-soluble unimers occurred. This mechanism resulted in a sharp disassembly 
transition from spherical nanoparticles to water-soluble diblock copolymer unimers. When the 
polymers were allowed to be stored for one month at 37 °C, no LCST was observed even at 
temperatures as high as 70 °C.  
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Table 2.2 Lower critical solution temperature (LCST), hydrodynamic diameter (Dh), 
Polydispersities (PDI) for the block copolymers after being fully degraded (i.e., full conversion of 
DMAEA to acrylic acid (AA)). 
Polymer Time (h)
a
 LCST (
o
C)
b
 Dh (nm)
c
 
B1 27 39.0 - 41.0 16.67 ± 1.32 
B2 73 37.0 - 39.0 15.66 ± 1.42 
C1 26 39.0 - 41.0 15.39 ± 1.08 
C2 53 37.0 - 39.0 12.56 ± 0.15 
a
Time after which the LCST of the polymer was determined. 
b
 LCST determined by DLS (10 
mg/mL).  
c
Hydrodynamic diameter (Dh) determined by DLS (5 mg/mL) at a temperature just above the 
LCST. 
 
Polymer/DNA Binding, Release, and Cell Uptake. The efficient delivery of siRNA holds great 
promise in the cure for cancers and infectious diseases.
38-41
 For siRNA-based delivery carriers to 
reach their full potential, they must be protected from enzymatic degradation, efficiently be taken 
up by cells, and the siRNA released with controlled and reproducible pharmacokinetics.
42-44
 The 
main problems with positively charged polymers for siRNA delivery are (i) the difficulty to fully 
release the siRNA
45-47
 and (ii) their high toxicity, which becomes problematic after repeat doses due 
to accumulation in tissues.
27, 48
 We previously showed that PDMAEA can readily bind to oligo 
DNA (a 9−27 oligo DNA that is a close analog to siRNA) and once the side groups have degraded 
to negatively charged carboxylic acid groups release all the negatively charged oligo DNA.
24, 31
 
However, the homopolymer PDMAEA gave no control over the release profile. In this current 
work, we will use the well-proven model compound oligo DNA to determine whether the release 
profiles of the oligo DNA from four polymers (B1 to C2) were the same as the disassembly profiles, 
as shown in Figure 2.1.  
The oligo DNA and polymer were mixed in an ice bath at an N/P ratio of 10 (i.e., the ratio of 
nitrogen on the polymer to phosphorus on the oligo DNA) and allowed to stand for 30 min without 
stirring and then heated to 37 °C. This N/P ratio was chosen as it showed complete binding with the 
oligo DNA (see Figure A2.25 in Appendix A). It was found that there was no change in the size of 
the nanoparticles (between 20 to 30 nm in diameter) when measured at 37 °C (i.e., above the LCST 
of the polymers) in the absence or presence of oligo DNA, as shown in Table A2.2. To determine 
the ability of the oligo DNA to bind with the polymer nanoparticles, we performed agarose gel 
retardation assays. The oligo DNA cannot enter the gel when bound or complexed to the polymer 
nanoparticles. All four polymer nanoparticles strongly bound with oligo DNA at an N/P (nitrogen to 
phosphorus) ratio of 10 after incubation for 1 h (Figure 2.2). This assay also provided insight into 
the leakage of oligo DNA over time and the release of oligo DNA over time. There was no evidence 
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of leakage of any oligo DNA from polymer B after 20 h, and release of all oligo DNA was observed 
after 26 h. This release profile was consistent with the disassembly profile shown in Figure 2.1. 
Disassembly occurred after 21 h and full disassembly after a further 5.5 h, supporting the release of 
all oligo DNA after 26 h. Polymers B2, C1, and C2 also showed the same trends, with the release 
time of all oligo DNA consistent with the full disassembly time of the polymer nanoparticles (see 
Table 2.1). Importantly, there was no leakage of oligo DNA until disassembly commenced. These 
findings support the timed and controlled release of the oligo DNA by manipulating the LCST of 
the polymer above 37 °C as a function of the DMAEA degradation to PAA. 
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Figure 2.2 Agarose gel assay for binding and release of Oigo DNA 9-27 from the polymer/DNA 
complex nanoparticles at different times in Milli-Q water at N/P Ratio 10. Soluble copolymers in 
Milli-Q water were incubated with DNA (N/P ratio 10) at below their LCST for 30 min and then 
heated and kept at 37 
o
C for agarose gel retardation assay over different times. 
 
To test whether these timed-release nanoparticles could be taken up by cells prior to degradation to 
unimers, we mixed Cy3 oligo DNA with our polymers and added these complexes to osteosarcoma 
U2OS cells at 37 °C and were then incubated for 10 h. All polymers showed little or no uptake. 
Folic acid was then coupled to the end of a thermoresponsive polymer G (PDMA99-b-P(NIPAM97-
co-BA13)) to form polymer H (Figure 2.3A, and see Appendix A) as a binding agent to cancer cells. 
Polymer H (15 mol %) was coassembled with each of the polymers B1−C2 and complexed with 
Cy3-DNA in one pot. This represents a simple but effective method to surface functionalization 
such nanoparticles without changing the disassociation properties of polymer B1 to C2. The uptake 
(Figure 2.3B) of Cy3 oligo DNA with a representative polymers C2 and H was high (Figure 2.3B 
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(i)), while C2 and H polymers only (Figure 2.3B (ii)) and Cy3 oligo DNA (Figure 2.3B (iii)) 
showed no uptake. 
  
 
 
+ + +
+ + +
> LCST
< LCST
20-30 nm
= Folic acid
B1, B2, C1 or C2
H
(i) (ii) (iii)
C2+H+Cy3-DNA C2+H only Cy3-DNA  only
(A)
(B)
 
Figure 2.3 (A) Synthesis of folic acid functionalized timed-release nanoparticles. (B) Fluorescent 
microscopy photos of the osteosarcoma U2OS cells dosed with 50 nM Cy3 oligo DNA and 
copolymer polyplexes in completed DMEM medium. N/P ratio (i.e polymer to siRNA) was 50:1 in 
water at 37 
o
C. They were then added to the cells and were incubated for 10 hours before washing 
with PBS buffer and fixation with 4% paraffin formaldehyde. The cell nuclei were stained with 
Hoechst 33341 and cell uptake viewed under fluorescent microscope. Photos (i) copolymers 
C2+H+Cy3-DNA, (ii) C2+H and (iii) Cy3-DNA. 
 
2.4 Conclusion 
In conclusion, we have demonstrated the use of designer diblock copolymer nanoparticles to 
release, as a proof of concept, oligo DNA (a proven model compound for biological therapeutics) 
on-demand using a timed disassembly process. The release mechanism does not require activation 
from remote sources or biological or pH triggers. The polymers used in this study consisted of a 
hydrophilic block for stabilization and a second thermoresponsive block for self-assembly and 
disassembly. At temperatures below the second block‘s LCST (i.e., below 37 °C for in vitro 
assays), the diblock copolymer was fully water-soluble, and when heated to 37 °C, the polymer 
self-assembled into a narrow size distribution of nanoparticles with an average diameter of 
approximately 25 nm. The thermoresponsive nature of the second block could be manipulated in 
situ by the self-catalyzed degradation of cationic DMAEA units to negatively charged acrylic acid 
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groups, and when the amount of acids groups was sufficiently high to increase the LCST of the 
second block above 37 °C, the nanoparticles disassembled to unimers over approximately 5−6 h. 
The disassembly time of 5−6 h was similar regardless of the time when the nanoparticles started to 
disassemble, and the polymers showed excellent binding to oligo DNA without any leakage until 
full disassembly to unimers. These naked nanoparticles could only be taken up by osteosarcoma 
cells when coated with a transfection agent, folic acid. We used a coassembly method using the 
polymers B1−C2 and a folic acid functionalized thermoresponsive polymer to produce 
nanoparticles with folic acid on the surface and without changing the disassembly profiles of the 
B1−C2 polymers. The well-defined and controlled release profiles observed in this work represent a 
significant step toward controlled release in the absence of an external trigger and, with our 
coassembly method, allows for other functional molecules to be decorated on the nanoparticle 
surface. This new nanoparticle technology could enable sophisticated combination therapies. For 
example, one or more therapeutic agents encapsulated in different timed-release nanoparticles, in 
which this particle mixture could be used in a one dosing regimen for tailored release of the agents 
when required. They could be programmed to release certain therapeutics at the time after 
administration when optimal biodistribution of the particles has occurred and when the agents will 
have maximal pharmacodynamic effect, and then slowly and consistently over time. One key 
application we are exploring is in improved methods for delivery of antitumor agents, leading to an 
optimized therapeutic index for cancer therapy. 
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Chapter 3 
Fine Tuning the Disassembly Time of Thermoresponsive Polymer 
Nanoparticles 
 
 
Macro-CTA
(PDMA96-CTA)
Series A: P(DMA96-b-(NIPAM94-co-DMAEA25-co-BAx)
X= 6, 8, 10, 12, 14, 16, 18, 20
Series B: P(DMA96-b-(NIPAM88-co-DMAEA42-co-BAx)
X = 6, 8, 10, 12, 14, 16, 20
AIBN
DMSO, 
60 oC
AIBN
dioxane, 
60 oC
DMA
RAFT agent
NIPAM
DMAEA
BA
Acrylic acid (AA)
T > LCSTT < LCST
Disassembly
LCSTnew > T
 
Timed-released disassembly of nanoparticles without a remote trigger or environmental cues is 
demonstrated in this work. The Reversible addition−fragmentation chain transfer (RAFT) 
polymerization allowed the fine-tuning of the chemical composition in the diblock copolymers, in 
which the first block consisted of a hydrophilic monomer (DMA) and the second random block 
consisted of three different monomers: (a) the thermoresponsive NIPAM, (b) the self-catalyzed 
hydrolyzable DMAEA, and (c) the hydrophobic BA. These diblock copolymers were solubilized in 
water below the lower critical solution temperature (LCST) of the thermoresponsive second block, 
and heated to 37 °C (i.e., >LCST) to form small micelle nanoparticles with a narrow particle size 
distribution. As DMAEA hydrolyzed to acrylic acid groups, the LCST of the diblock increased, and 
the time at the start of micelle disassembly (tstart) corresponded to the point where the LCST was 
equal to the solution temperature (i.e., 37 °C). The high water content in the PNIPAM core allowed 
an even degradation of the core over time. The copolymer composition allowed fine control over 
tstart, as this time was linearly dependent upon the BA units in the second block. These nanoparticles 
could also be designed to be stable (i.e., not disassemble) over a wide pH range or disassemble 
below a pH of 7.3. Additionally, the time from the start of disassembly to full unimer formation 
(tdegrade) could be controlled by the amount of DMAEA units in the second block. A longer tdegrade 
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(∼5.5 h) was found when the number of DMAEA units was 42 compared to tdegrade of 1.1 h for 25 
units. The nanoparticles designed in this work, through fine control of the polymer chemical 
composition, have the potential for drug delivery purposes for timed-release of drugs and prodrugs 
and other wide-ranging applications where timed-release would be beneficial. 
 
3.1 Introduction 
The ―on-demand‖ triggered disassembly of polymer nanoparticles has attracted attention for use in 
many applications, ranging from drug delivery, to fragrance release, to nanoreactors. 
1-8
 The most 
utilized methods for disassembly are via pH change,
9-11
 acid or base degradation of polymer side 
groups,
12
 light,
13-16
 enzymatic cleavage of chemical linkers,
17-19
 and electrical or magnetic 
stimulation.
20-22
 Diblock copolymers, consisting of a permanent hydrophilic first block and a 
thermoresponsive polymer (e.g., poly(N-isopropylacrylamide), PNIPAM) and other trigger-
susceptible monomer units in a second random block, self-assemble into micelles above the LCST 
(lower critical solution temperature) of the thermoresponsive polymer.
5, 6, 23
These micelles can 
disassemble using one of the external triggers described above.
24, 25
 Environmental triggers (such as 
pH, enzymatic activity, temperature) may be difficult to control in practice and will have significant 
variability depending upon the application; an aspect that becomes important in biological and other 
applications. Developing new self-triggered disassembly methods would represent an advance in 
―smart‖ materials overcoming the variability and enabling applications, where external sources are 
not viable. Recently, we found that the cationic poly(2- (dimethylamino)ethyl acrylate (PDMAEA) 
could self-catalyze into the negatively charged poly(acrylic acid) (PAA).
26
 The rate of PDMAEA 
degradation in water was found to be independent of the studied pH range (i.e., 5.5 to 10.1) and 
independent of the molecular weight. The cationic nature of PDMAEA allowed strong binding of 
an oligo DNA (a model compound for siRNA) and its release after 24 h due to the DMAEAs 
hydrolysis to the nontoxic PAA.
27
 The degradation to the nontoxic PAA has the potential for 
multidose applications, especially important in drug delivery. The PDMAEA/oligo DNA complex 
was rapidly taken up by 80% of cells in less than 4 h, providing sufficient time for release of the 
oligo DNA in the cytosol. We utilized the self-degradation mechanism of PDMAEA in polymer 
nanoparticles to deliver and release siRNA to knockdown biochemical pathways in cells.
3
 The 
diblock copolymer consisted of a first PDMAEA block joined to a random second block of P(N-(3-
(1Himidazol-1-yl)propyl)acrylamide (PImPAA) and poly(butylacrylate) (PBA).
3
 The first 
PDMAEA block bound to siRNA transfected the cells and released siRNA after 17 h, while the 
second block (P(ImPAA-co-BA)) was designed to induce fusion with the endosome membrane and 
allowed the siRNA/polymer complex to escape into the cytosol. The in vitro results showed 
selective and potent knockdown of two very different cell lines at approximately 80% at an N/P 
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(nitrogen on the polymer to phosphorus on the oligonucleotide) ratio of only 10,
3
 and at N/P ratios 
greater than 10 we observed near complete knocked down of cells.
2
 Controlling the release time of 
oligo DNA or siRNA from the polymer complex could be achieved using a thermoresponsive 
diblock copolymer that formed micelles (∼25 nm) above the LCST of the thermoresponsive 
block.
28
 The first block consisted of the permanent hydrophilic poly(dimethyl acrylamide) (PDMA), 
and the second block consisted of a random block of the thermoresponsive NIPAM, DMAEA, BA, 
and styrene (STY) units. Using various ratios of monomer units in the second block, we could 
control the micelle disassembly time from 20 to 70 h (denoted as tstart) with four polymer variants. 
By increasing the hydrophobic units of either BA or STY, the disassembly time could be increased, 
representing the first nontriggered disassembly method independent of pH. Interestingly, the time 
from the start of disassembly to full unimer formation for all polymers was ∼5 h (denoted as 
tdegrade), and allowed release of oligo DNA after time t (=tstart + tdegrade).  
 
3.1.1 Aim of the Chapter 
The goal of this chapter is not only to control the disassembly time (tstart), with great precision but 
also control time from the start of disassembly to full unimer formation (tdegrade) by systematically 
dialing in the number of DMAEA and BA units in the second block. We synthesized two series of 
diblock thermoresponsive copolymers PDMA-b-P(NIPAM-co-DMAEA-co-BA) by Reversible 
addition− fragmentation chain transfer (RAFT) polymerization (see Scheme 3.1). In this work, we 
varied the number of self-degradable DMAEA unit and hydrophobic BA unit in order to investigate 
the influence of these change in polymer composition on the tstart and tdegrade of the self-assembled 
polymer nanoparticles. Moreover, the mechanism of the disassembly was also studied. The effect of 
the pH medium on the self-assembly of the polymer nanoparticles was also evaluated.   
 
3.2 Experimental 
3.2.2 Materials 
Dioxane (Aldrich, 99%), carbondisulfide (Aldrich, 99%), 1-butanethiol (Aldrich, 99%), methyl 
bromopropionate (Aldrich, 98%), dimethyl sulfoxide (DMSO, Aldrich >99.9%), dichloromethane 
(DCM: Labscan, AR grade), buffer concentrate at pH = 7 (Fluka –Sigma Aldrich), and 10X 
Phosphate buffered Saline (Gibco-Life Technology) were used as received. The following 
monomers were purified by passing through a basic alumina (activity I) column to remove inhibitor: 
styrene (STY, Aldrich, 99 %), dimethylacrylamide (DMA, Aldrich, 99 %), N,N-(dimethylamino) 
ethyl acrylate (DMAEA, Sigma-Aldrich, 98%), and butyl acrylate (BA, Aldrich, 99%). N-
Isopropylacrylamide (NIPAM, Aldrich, 97 %) was purified by recrystallization from hexane. 
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Azobisisobutyronitrile (AIBN) was also recrystallized twice from methanol prior to use. Milli-Q 
Water (18.2 MΩcm-1) was generated using a Millipore Milli-Q academic water purification system. 
All other chemicals and solvents used were of at least analytical grade and used as received. The 
chain transfer agent (CTA), methyl 2-(butylthiocarbonothioylthio)propanoate (MCEBTTC) was 
synthesized according to the literature procedure,
5
 and found to have a low toxicity.
4
 
 
3.2.2 Synthetic procedures 
3.2.2.1 Synthesis of Poly(N, N-diethylacrylamide) Macro Chain Transfer Agent (PDMA96 Macro-
CTA).DMA (25.99 mL, 0.25mol), MCEBTTC (636.6 mg, 2.50 x 10
-3
 mol), and AIBN (33.10 mg, 
2.02 x 10
-4
 mol) were dissolved in 50 mL DMSO in a 100 mL dry Schlenk flask equipped with a 
magnetic stirrer bar. The mixture was deoxygenated by purging with argon for 1 h and then heated 
to 60 
o
C for 3 h. The reaction was stopped by cooling to 0 
o
C in an ice bath and exposed to the air. 
The solution was then diluted with dichloromethane (500 mL) and washed with brine (3x100 mL). 
The DCM fraction was then dried over anhydrous MgSO4, filtered and reduced in volume by rotary 
evaporation. The polymer was recovered by precipitation into large excess of diethyl ether (1 L), 
and isolated by filtration. The polymer was re-dissolved in acetone and precipitated in diethyl ether. 
The re-dissolving and precipitation process was repeated two times. The polymer was filtered and 
then dried under high vacuum for 24 h at room temperature to give a yellow powder product (yield 
= 81%): Mn = 9700, PDI =1.03 (SEC-Triple Detection using PSTY Standards in DMAc solution 
containing 0.03 wt% of LiCl, dn/dc = 0.081); Mn = 9770 (
1
H NMR). 
1
H NMR (500 MHz, CDCl3): δ 
0.87 (CH3CH2CH2-), 1.09 (CH3-(CH-COO)-), 2.84-3.05 ((CH3)2-N-), 3.29 (-CH2-S-(C=S)-S-), 3.60 
(CH3O-(C=O)-), 5.14 (-(C=S)-S-CH-). 
 
3.2.2.2 Synthesis of block copolymers of NIPAM, DMAEA, and BA from PDMA96 Macro-CTA 
(A1 to A8). In a typical reaction, NIPAM (1.00 g, 8.85 x 10
-3
 mol), DMAEA (0.34 mL, 2.21 x 10
-3
 
mol), BA in different amounts (see Table A3.1), PDMA96 macro-CTA (725.66 mg, 7.43 x 10
-5
 mol) 
and AIBN (1.45 mg, 8.85 x 10
-6 
mol) were dissolved in 6 mL of dioxane in a 20 mL dry Schlenk 
flask equipped with a magnetic stirring bar. The mixture was deoxygenated by purging with argon 
for 30 min and then heated to 60 
o
C under argon. The reaction time of the reactions (A1 to A8) is 
listed in Table 3.1. The reaction was stopped by cooling to 0 
o
C in an ice bath and exposed to air. 
The solution was precipitated in diethyl ether (500 mL) and filtered. The polymer was re-dissolved 
in acetone and precipitated in diethyl ether. The re-dissolving and precipitating steps were repeated 
twice. The yellow powder product was dried under high vacuum at room temperature for 48 h.  
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3.2.2.3 Synthesis of block copolymers of NIPAM, DMAEA, and BA from PDMA96 Macro-CTA 
(B1to B7). In a typical reaction, NIPAM (1.00 g, 8.85 x 10
-3
 mol), DMAEA (0.62 mL, 3.98 x 10
-3
 
mol), BA with different amounts (see Table A3.2), PDMA macro-CTA (725.66 mg, 7.43 x 10
-5
 
mol) and AIBN (1.45 mg, 8.85 x 10
-6 
mol) were dissolved in 6 mL of dioxane in a 20 mL dry 
Schlenk flask equipped with a magnetic stirring bar. The mixture was deoxygenated by purging 
with argon for 30 min and then heated to 60 
o
C under argon. The reaction time of the reactions 
(B1to B7) is listed in Table 3.2. The reaction was stopped by cooling to 0 
o
C in an ice bath and 
exposed to air. The solution was precipitated in diethyl ether (500 mL) and filtered. The polymer 
was re-dissolved in acetone and precipitated in diethyl ether. The re-dissolving and precipitating 
steps were repeated twice. The yellow powder product was dried under high vacuum at room 
temperature for 48 h.  
 
3.2.2.4 Preparation of buffer solution 
(i) pH 5.5. Sodium acetate (540.0 mg, 6.6 mmol), and acetic acid (54.0 mg, 0.9 mmol) were 
dissolved in 50 mL of Milli-Q water. The pH was checked by a pH meter.   (ii) pH 6.5. Sodium 
dihydrogen phosphate (68.5 mL, 0.2 M) was mixed with disodium hydrogen phosphate (31.5 mL, 
0.2 M). The total solution was made up to 200 mL with Milli-Q water. The pH was checked by a 
pH meter.   (iii) pH 8. Potassium dihydrogen phosphate (50 mL, 0.2M) was mixed with sodium 
hydroxide (46.8 mL, 0.2M). The total solution was made up to 200 mL with Milli-Q water. The pH 
was checked by a pH meter.    (iv) pH pH 7.0 and 7.4. The buffer solutions with pH at 7.0 and 7.4 
were directly diluted from the 10X stock solution (pH 7.0, Fluka–Sigma Alrich; pH 7.4, Gibco-Life 
Technology)   
 
3.2.2.5 Lower Critical Solution Temperature (LCST) of the block copolymer as determined by 
DLS. Polymer samples were weighed in vials and dissolved in cold Milli-Q water or buffer solution 
at different pH values and at a concentration of 10 mg/mL. These solutions were immediately 
placed in an ice bath, and then filtered directly into DLS cuvettes using 0.45 μm cellulose syringe 
filter. For measurement of the LCST, the polymer solutions were cooled to 5 or 10 
o
C in a DLS 
machine, and the measurements were carried out by slowly increasing the temperature in the DLS 
machine from 5 or 10 
o
C to 60 
o
C using the Standard operating procedures (SOP) software.  
 
3.2.2.6 Lower Critical Solution Temperature (LCST) of the block copolymer after hydrolysis at 
different times as determined by DLS. Polymer samples were weighed in vials and dissolved in cold 
Milli-Q water at a concentration 10 mg/mL. These solutions were immediately placed in an ice 
bath, and then filtered directly into DLS cuvettes using 0.45 μm cellulose syringe filter. These 
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cuvettes were then kept in a water bath at 37 
o
C. The LCST of the hydrolysed samples at different 
times were then measured by the DLS. The measurements were carried out by slowly increasing the 
DLS temperature from 10 to 60 
o
C using SOP software over 3 h.   
 
3.2.2.7 Disassembly kinetics of block copolymer nanoparticles at 37 oC by DLS. The number-
average particle diameter was measured for each sample to determine the disassembly time of the 
nanoparticles. Polymer samples were weighed in vials and dissolved in cold Milli-Q water at the 
concentration of 5 mg/mL. These solutions were immediately placed in an ice bath, and then 
directly filtered into DLS cuvettes using 0.45 μm cellulose syringe filter. The samples were kept at 
37 
o
C water bath and the particle size at different time intervals was measured in DLS machine set 
at 37 
o
C. The particles size and polydispersity index (PDIDLS) were averaged from five 
measurements.  
 
3.2.2.8 Disassembly Kinetics of block copolymer nanoparticles in different buffer solutions at 37 
o
C by DLS. The number-average particle diameter was measured for each sample to determine the 
disassembly time of the nanoparticles. Polymer samples were weighed in vials and dissolved in cold 
Milli-Q water at the concentration 5.55 mg/mL. These solutions were immediately placed in an ice 
bath, and 1 mL of the solution was filtered directly into DLS cuvettes using 0.45 μm cellulose 
syringe filter. The particle size was measured in DLS set at 37 
o
C. At the same time, 45 mL of the 
polymer solution (5.55 mg/mL) was transferred in a 50 mL centrifuge tube, and then placed in a 37 
o
C water bath for 5 min.  5 mL of a 10X or 1M buffer solution of a known pH value was mixed 
with the polymer solution in the tube to obtain the final solution concentration of 5 mg/mL. The pH 
value of the final solution was checked by a pH meter. This solution was then directly filtered into 
DLS cuvettes using a 0.45 μm cellulose syringe filter and measured the particle size at different 
time intervals in DLS set at 37 
o
C 
 
3.2.3 Analytic methodologies 
1
H Nuclear Magnetic Resonance (NMR). All NMR spectra were recorded on Bruker DRX 500 
MHz using external locks (CDCl3) and referenced to the residual non-deuterated solvent (CHCl3). 
 
Size Exclusion Chromatography (SEC) and Triple Detection Size Exclusion Chromatography (TD-
SEC). The molecular weight distributions (MWDs) of the polymers were determined using a 
Polymer Laboratories GPC50 Plus equipped with differential refractive index detector and the 
absolute MWDs of polymers were determined using a Polymer Laboratories GPC50 Plus equipped 
with dual angle laser light scattering detector, viscometer, and differential refractive index detector. 
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HPLC grade  N,N-dimethylacetamide (DMAc, containing 0.03 wt % LiCl) was used as the eluent at 
a flow rate of 1.0 mL/min. Separations were achieved using two PLGel Mixed B (7.8 x 300 mm) 
SEC columns connected in series and held at a constant temperature of 50 
o
C. The triple detection 
system was calibrated using a 2 mg/mL PSTY standard (Polymer Laboratories: Mwt = 110K, dn/dc 
= 0.16 mL/g and IV = 0.5809). Samples of known concentration were freshly prepared in DMAc + 
0.03 wt % LiCl and passed through a 0.45 μm PTFE syringe filter prior to injection. The absolute 
molecular weights and dn/dc values were determined using Polymer Laboratories Multi Cirrus 
software based on the quantitative mass recovery technique.  
 
Dynamic Light Scattering (DLS). Dynamic light scattering measurements were performed using a 
Malvern Zetasizer Nano Series running DTS software and operating a 4 mW He-Ne laser at 633 
nm. Analysis was performed at an angle of 173°. The sample refractive index (RI) was set at 1.59 
for polystyrene. The dispersant viscosity and RI were set to 0.89 Ns.m
-2
 and 1.33, respectively. The 
number-average hydrodynamic particle size and polydispersity index are reported. The 
polydispersity index (PDI) was used to describe the width of the particle size distribution. It was 
calculated from a Cumulants analysis of the DLS measured intensity autocorrelation function and is 
related to the standard deviation of the hypothetical Gaussian distribution (i.e., PDIPSD = ζ
2
/ZD
2
, 
where ζ is the standard deviation and ZD is the Z average mean size).  
 
pH meter. pH of the buffer solution was checked by using a HORIBA pH meter calibrated by 
standard buffer solution pH 7.0, pH 4.0, and pH 10.0. 
 
3.3 Result and Discussion 
Preparation of the thermoresponsive diblock copolymers with near precise control over the number 
of units of each monomer (i.e., DMA, NIPAM, DMAEA, and BA) can be achieved using ―living‖ 
radical polymerization. Reversible addition−fragmentation chain transfer (RAFT) polymerization 
allows the incorporation of various monomers to build the desired homo or block copolymers with 
narrow molecular weight distributions and thus with fine control over the copolymer chemical 
composition.
29-34
 In this work, we first used RAFT to form the permanent hydrophilic polymer 
(PDMA) Macro-CTA with a number-average molecular weight (Mn) of 9700 (which is close to that 
found by 
1
H NMR of 9770 giving 96 units of DMA by accounting for the molecular weight of the 
RAFT agent) and polydispersity index (PDISEC) of 1.03, as measured by triple detection SEC. This 
low PDISEC value should be regarded as a slight underestimation of the true value due to the lower 
scattering at very low molecular weights. This Macro-CTA was then combined with blocks of 
NIPAM, DMAEA, and BA in various molar ratios to produce two series of diblock copolymers (see 
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Tables A3.1 and A3.2 in Appendix B). The SEC traces in Figure A3.1 showed that most of Macro 
CTA was converted to diblock copolymer, suggesting excellent block efficiency. The Mnvalues for 
all polymers determined by triple detection SEC were close to those found by 
1
H NMR (see Tables 
3.1 and 3.2), and the polydispersity index by triple detection SEC for both series of polymers was 
less than 1.07, which was found to be a slight underestimation when compared to the PDISEC of 
approximately 1.22 determined by RI-SEC (data not shown). 
The conversion of all monomers determined by 
1
H NMR for Series A was restricted to between 76 
and 80% to minimize the variation in the number of units for NIPAM (∼94) and DMAEA (∼25) in 
Series A (i.e., A1−8), as shown in Tables 3.1 and A3.1. Series B polymerizations gave conversions 
close to 74% with even less variation between the NIPAM (∼87) and DMAEA (∼ 42) units from 
B1 to B7 (Tables 3.2 and A3.2). The number of BA units was systematically increased from 6 to 20 
for both Series A and B, allowing the fine-tuning not only of the polymer chemical composition but 
of the disassembly time as will be described below.  
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Table 3.1 Reaction time, conversion, Molecular weights, Polydispersities (PDISEC), 
1
H NMR, 
Lower Critical Solution Temperature (LCST), Hydrodynamic Diameter (Dh), Polydispersities 
(PDIDLS) describing the width of the particle size distribution, and degradation times for 
thermoresponsive block copolymers (A1−8). 
 
a
Total conversion of the polymer  (Total conv.) was calculated by: Total conv. =[[(conv. NIPAM x 
119) + (conv. DMAEA x 30) + (conv.BA x [BA])] / (119+30+ [BA])] x 100, where the monomer 
feeding ratios and conversions of each monomers were given in Table A3.1.  
b
Triple detection SEC in DMAc (with 0.03 wt % LiCl)with PSTY as standards. Calculations were 
based on the dn/dc and polymer concentration.  
c
Molecular weight determined by 
1
H NMR were calculated based on the repeating units of NIPAM 
(NNIPAM), BA (NBA), DMAEA (NDMAEA), PDMA96-Macro CTA, and  molecular weight of 
MCEBTTC (252.42): Mn = (NNIPAM x 113) + (NBA x 128.2) + (NDMAEA x 143) + [(96 x 99.131) + 
252.42)].  
d
LCST determined by DLS (10 mg/mL). 
e
Hydrodynamic diameter (Dh) and PDI determined by DLS (5 mg/mL) at 37 
o
C.  
f
Disassembly time at 37 
o
C measured by DLS: tstart = time when the size starts to decrease; tdegrade = 
time from tstart to formation of unimers. 
 
 
 
 
Polymer 
Polym
. time 
(h) 
Total 
conv. 
(%)
a
 
SEC-Triple 
detection
b
 
1
H 
NMR
c
 
LCST 
(
o
C)
d
 
Dh (nm) 
(PDI)
e
 
tstart 
(tdegrade)
f
 
Mn PDI Mn 
A1 
P(DMA96-b-(NIPAM88-
co-DMAEA24-co-BA6)) 
8 76 27800 1.05 23900 25-29 27.02 (0.028) 21 (5.5) 
A2 
P(DMA96-b-(NIPAM94-
co-DMAEA25-co-BA8)) 
8 78 28300 1.04 25000 23-29 29.93 (0.053) 35.5 (5.4) 
A3 
P(DMA96-b-(NIPAM94-
co-DMAEA25-co-BA10)) 
8.5 78 28100 1.05 25200 21-29 29.55 (0.018) 47.5 (5.6) 
A4 
P(DMA96-b-(NIPAM91-
co-DMAEA25-co-BA12)) 
9 77 24100 1.04 25100 17-21 25.31 (0.047) 66 (5.75) 
A5 
P(DMA96-b-(NIPAM93-
co-DMAEA25-co-BA14)) 
11 78 28700 1.05 25600 15-19 25.85 (0.056) 73.5 (5.8) 
A6 
P(DMA96-b-(NIPAM93-
co-DMAEA25-co-BA16)) 
11 78 28100 1.05 25800 13-17 25.19 (0.040) 79.9 (5.7) 
A7 
P(DMA96-b-(NIPAM93-
co-DMAEA25-co-BA18)) 
15.5 78 28400 1.06 26100 11-15 25.07 (0.024) 85.9 (5.5) 
A8 
P(DMA96-b-(NIPAM97-
co-DMAEA25-co-BA20)) 
15.5 80 30700 1.04 26800 10-15 24.93 (0.045) 93.5 (5.6) 
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Table 3.2 Reaction time, conversion, Molecular weights, Polydispersities (PDISEC), 
1
H NMR, 
Lower Critical Solution Temperature (LCST), Hydrodynamic Diameter (Dh), Polydispersities 
(PDIDLS) describing the width of the particle size distribution, and degradation times for 
thermoresponsive block copolymers (B1−7). 
 
a
 Total conversion of the polymer  (Total conv.) was calculated by: Total conv. =[[(conv. NIPAM x 
119) + (conv. DMAEA x 30) + (conv.BA x [BA])] / (119+30+ [BA])] x 100, where the monomer 
feeding ratios and conversions of each monomers were given in Table A3.2.  
b
 Triple detection SEC in DMAc (with 0.03 wt % LiCl)with PSTY as standards. Calculations were 
based on the dn/dc and polymer concentration.  
c 
Molecular weight determined by 
1
H NMR were calculated based on the repeating units of NIPAM 
(NNIPAM), BA (NBA), DMAEA (NDMAEA), PDMA96-Macro CTA, and  molecular weight of 
MCEBTTC (252.42): Mn = (NNIPAM x 113) + (NBA x 128.2) + (NDMAEA x 143) + [(96 x 99.131) + 
252.42)].  
d 
LCST determined by DLS (10 mg/mL).  
e 
Hydrodynamic diameter (Dh) and PDI determined by DLS (5 mg/mL) at 37 
o
C.  
f
 Disassembly time at 37 
o
C measured by DLS: tstart = time when the size starts to decrease; tdegrade = 
time from tstart to formation of unimers. 
 
 
Polymer 
Polym
. time 
(h) 
Total 
conv. 
(%)
a
 
SEC-Triple 
detection
b
 
1
H 
NMR
c
 
LCST 
(
o
C)
d
 
Dh (nm) (PDI)
e
 
tstart 
(tdegrade)
f
 
Mn PDI Mn 
B1 
P(DMA96-b-(NIPAM87-
co-DMAEA42-co-BA6)) 
14 73 28400 1.05 26300 27-37 30.02 (0.032) 10.3 (1.1) 
B2 
P(DMA96-b-(NIPAM88-
co-DMAEA41-co-BA8)) 
14 74 29200 1.04 26600 25-35 29.21 (0.025) 12.9 (1.1) 
B3 
P(DMA96-b-(NIPAM87-
co-DMAEA43-co-BA10)) 
14 74 29000 1.05 27000 23-33 27.98 (0.028) 14.9 (1.1) 
B4 
P(DMA96-b-(NIPAM85-
co-DMAEA42-co-BA12)) 
15 73 29400 1.07 26900 21-31 26.81 (0.041) 17.4 (1.1) 
B5 
P(DMA96-b-(NIPAM85-
co-DMAEA42-co-BA14)) 
15 73 29200 1.05 27100 19-29 26.49 (0.046) 22.4 (1.1) 
B6 
P(DMA96-b-(NIPAM88-
co-DMAEA42-co-BA16)) 
15 74 30200 1.04 27700 17-25 26.48 (0.020) 25.7 (0.9) 
B7 
P(DMA96-b-(NIPAM87-
co-DMAEA43-co-BA20)) 
15.5 74 30500 1.05 28300 13-25 25.58 (0.013) 34.3 (1.0) 
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The potential use of timed-release polymer nanoparticles in drug delivery applications requires that 
the LCST of the thermoresponsive hydrophobic block must be below 37 °C (i.e., below body 
temperature) in order to form nanoparticles.The diblock copolymer, P(DMA96-b-(NIPAM87-co- 
DMAEA25), did not form nanoparticles at 37 °C due to its higher LCST (39 to 41 °C).
28
 However, 
the LCST of PNIPAM can be modulated through its chain-end functionality
35
 and through 
manipulating the amount of hydrophilic or hydrophobic monomer units incorporated within the 
thermoresponsive block.
36, 37
 Incorporation of hydrophilic monomer units will increase the LCST 
and hydrophobic monomer units will decrease the LCST. In our system, the incorporation of 
hydrophilic DMAEA units in the second random block should increase the LCST, while 
incorporating hydrophobic BA units will counterbalance this effect, allowing us to produce a 
polymer with an LCST below 37 °C. Tables 3.1 and 3.2 showed that the LCST can be finely tuned 
by varying the BA content for Series A and B, respectively. In this work, the LCST is defined as a 
temperature range observed from the initial increase in hydrodynamic diameter (Dh) to where Dh 
initially reaches its upper value. We define the LCST as this small temperature range due to slight 
variations in the Dh temperature profiles between samples, and in many cases the micelle formation 
transition is not sharp and well-defined. For example, A1 showed an initial increase in Dh at 25 °C 
and reached its initial upper Dh at 29 °C (i.e., the start of the plateau region), a temperature range of 
4 °C (see Figure A3.5 in Appendix B); in which the LCST was denoted in Table 3.1 ranging 
between 25 and 29 °C. With an increase in the number of BA units from 6 to 20, the initial change 
in Dh (i.e., lower value of the LCST range in Tables 3.1 and 3.2) decreased from 25 to 10 °C for 
Series A and from 27 to 13 °C for Series B; a trend also observed for the upper LCST value. 
 
For these nanoparticles to have great efficacy in cancer therapy applications, they must be small to 
diffuse and penetrate deep into the center of the tumor where the most aggressive tumor cells 
reside.
38
 Recent work has demonstrated that the size of the nanoparticles plays an important role in 
this respect: small particles close to 10 nm can diffuse and penetrate into the tumor two or three 
times further than particles of 60 and 120 nm.
39
 The micelle sizes for the two series of polymers 
was small, ranging from 25 to 30 nm, and importantly with a very narrow particle size distributions 
(PSD) determined from their low PDIDLS values of below 0.06 from DLS (see Tables 3.1 and 3.2). 
It should be noted that PDIDLS value of less than 0.1 represents a narrow PSD. The slight decrease 
in Dh from approximately 30 to 25 nm with an increase in the number of BA units for both polymer 
series was presumably due to the greater hydrophobic content. Series A polymer when mixed with 
water and incubated (i.e., heated to and maintained) at 37 °C formed micelles with a solution pH of 
7.6. The disassembly properties as monitored by DLS were shown in Figure 3.1A. There was a 
small decrease in size after the first few hours of incubation due to the ionic binding between the 
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newly formed negatively charged acrylic acid side groups (from self-catalysis of DMAEA) and 
non-degraded cationic DMAEA units. The Dh remained relatively constant until a sharp transition 
due to the micelle disassembly. The time to disassemble was dependent upon the BA (Table 3.1), 
and with greater BA content the time to disassemble (denoted tstart) increased. There was a linear 
relationship between the number of the BA units in the copolymer and tstart, providing a predictive 
means to select tstart for the desired application. The time (i.e., tdegrade) from tstart to full micelle 
disassembly to unimers, observed when Dh was approximately 5−7 nm, for Series A was 
consistently ∼5.5 h. Series B polymers were nearly identical to Series A but the number of 
DMAEA units was increased from 25 to 42. This change in DMAEA units as shown in Figure 3.1B 
gave much shorter tstart values. For example, for 20 units of BA in the copolymer, tstart reduced from 
93.5 h (A8) to 34.3 h (B7).There was also a linear relationship for Series B between tstart and the 
number of BA units. Interestingly, the time to full micelle disassembly (tdegrade) was also much 
shorter and consistent at ∼1.1 h for the B series. Taken together, Series A and B polymers showed 
that both tstart and tdegrade could be controlled independently.  
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(A)
(B)
 
Figure 3.1 Degradation kinetics profiles for polymers A1 to A8 (A) and polymers B1 to B7 (B) in 
Milli-Q water at 37 °C. The data were averaged from five measurements by DLS at polymer 
solution concentration of 5 mg/mL. 
 
The sharp disassembly time of either 5.5 or 1.1 h was directly related to the self-catalyzed 
hydrolysis of the DMAEA units changing the LCST behavior of the thermoresponsive second 
block. We measured the LCST of A1, A8, B1, and B7 as a function of time at 37 °C with the clear 
observation that the LCST of all four polymers increased over time (Figure A3.6 in Appendix B). 
The data demonstrated that with the increase in the degradation of DMAEA side groups to 
carboxylic acids, the diblock copolymer‘s LCST increased, and when the LCST became greater 
than 37 °C, disassembly to water-soluble unimers occurred. Figure 3.2 showed the rate of change of 
the LCST changed with time for these four polymers. Both A1 and B1 (i.e., with 6 BA units) had an 
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initial LCST of 27 °C that reached 38 °C in 21 and 10 h, respectively, corresponding to tstart (in 
Tables 3.1 and 3.2). The rate of LCST change over time was similar for A1, B1, and B7, while A8 
showed a two-step LCST profile. When the polymers were allowed to be stored in water for one 
month at 37 °C, no LCST was observed even at temperatures as high as 70 °C.  
 
Figure 3.2 The rate of change in the LCST of polymer A1:  P(DMA96-b-(NIPAM88-co-DMAEA24-
co-BA6)); A8: P(DMA96-b-(NIPAM97-co-DMAEA25-co-BA20)); B1: P(DMA96-b-(NIPAM87-co-
DMAEA42-co-BA6)); B7: P(DMA96-b-(NIPAM87-co-DMAEA43-co-BA20)) in Milli-Q water after 
incubation in water bath at 37 
o
C at different time points. The data were averaged from five 
measurements by DLS at polymer solution concentration 10 mg/mL. 
 
The coil to globule transition (i.e., > LCST) for PNIPAM results in precipitation of PNIPAM out of 
water. Dehydration of PNIPAM chains at temperatures above the LCST drives the coils to collapse 
due to hydrophobic interactions between the isopropyl groups and intra hydrogen bonding between 
the amide groups.
40
 This has been interpreted as resulting in a hydrophobic PNIPAM environment 
above the LCST. The level of dehydration from the coil required for collapse is actually rather 
small, suggesting that the percentage of bound water within the globule is still high, ranging from 
50 to 80%.
41-43
 This data suggests that although there are hydrophobic pockets within our polymer 
micelles, there remains high water content for the self-catalyzed hydrolysis of the DMAEA units, 
allowing a linear rate of LCST change for A1, B1, and B7. The high BA to DMAEA content in A8 
suggests some restriction of water to the hydrophobic pockets within the micelle, thus retarding 
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hydrolysis of the DMAEA units in these regions. If water was fully restricted from a hydrophobic 
micelle core, one would expect a slow surface degradation process, resulting in shorter (tstart) and 
significantly longer (tdegrade) disassembly times. 
In the treatment of tumors, the nanoparticle delivery device should accumulate at the tumor site by 
utilizing the EPR effect.
44
 It is now well established that the extracellular environment around the 
tumor cells is acidic between 6.5 to 6.9 due to cell secretion of lactate and H
+
 to the extracellular 
space.
45, 46
 The question we wanted to answer was how our nanoparticles behaved in different pH 
environments since the DMAEA units would be protonated at lower pH values (pKa of PDMAEA = 
7.1). Selected polymers from Series A and B (i.e., A1, A3, B5, and B7) were self-assembled in 
solutions with pH ranging from 6.5 to 8 at 37 °C. The size of the nanoparticles at a pH of 8 was 
small (∼26 nm) with a narrow PSD for all polymers (see Table 3.3). Decreasing the pH showed 
little or no change in the size for A3 and B7 over the pH range studied (Figure 3.3). However, for 
A1 and B5, there was a sharp and rapid disassembly to form unimers below a pH of 7.3. It was 
found that the LCST of the four polymers increased with a decrease in pH (Table 3.3 and Figures 
A3.7A to A3.10A in Appendix B). This trend was due to the greater ionization of the DMAEA 
units in the second block. For A1 and B5, the LCST at a pH below 7.3 was well above the mixture 
temperature of 37 °C. In the case of A3 and B7, the additional BA units maintained the LCST 
below the mixture temperature, resulting in little change in particle size. It was found that at a pH of 
5.5, all four polymers had an LCST greater than 83 °C (as determined from the change in turbidity), 
and thus did not form nanoparticles at 37 °C. The disassembly time (tstart) also decreased linearly 
with a decrease in pH as shown in Table 3.3 (and Figures A3.7B to A3.10B). For example, tstart for 
A3 decreased from 53.8 to 38.3 h with a decrease in pH from 8 to 6.5. Interestingly, tdegrade did not 
alter remaining relatively constant at 5.5 h for the A polymers and 1.1 h for the B polymers. The 
data demonstrated that our nanoparticles (e.g., A1 and B5) can be designed to disassemble in a low 
pH environment, similar to that of the extracellular environment of a tumor,
46
 or be designed to be 
stable in a low pH environment and disassemble after a designated time (e.g., A3 and B7). 
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A3
B7
A1
B5
 
Figure 3.3 Hydrodynamic diameter (Dh) for the polymer particles from polymer A1: P(DMA96-b-
(NIPAM88-co-DMAEA24-co-BA6)), A3: P(DMA96-b-(NIPAM94-co-DMAEA25-co-BA10)), 
B5:P(DMA96-b-(NIPAM85-co-DMAEA42-co-BA14)) and B7: P(DMA96-b-(NIPAM87-co-
DMAEA43-co-BA20)) in different buffer solutions  at 37 
o
C. The data were averaged from five 
measurements by DLS at polymer solution concentration 5 mg/mL. 
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Table 3.3 Lower Critical Solution Temperature (LCST), Hydrodynamic Diameter (Dh), Polydispersities (PDIDLS), and degradation times for 
thermoresponsive block copolymers. 
Polymer 
LCST (
o
C)
a 
in buffer solutions Dh (nm) (PDI)
c
 at 37 
o
C tstart (tdegrade)
d
 at 37 
o
C 
pH 5.5 pH 6.5 pH 7 pH 7.4 pH 8 pH 6.5 pH 7 pH 7.4 pH 8 pH 6.5 pH 7 pH 7.4 pH 8 
A1 87b 39-55 37-55 27-41 23-41 
5.87 
(0.216) 
5.80 
(0.277) 
24.35 
(0.031) 
26.36 
(0.025) 
DNM e DNM e 
17.9 
(5.29) 
25.3 
(5.41) 
A3 85b 35-50 33-45 21-33 19-31 
20.49 
(0.126) 
22.57 
(0.128) 
26.18 
(0.076) 
27.12 
(0.048) 
38.3 
(5.3) 
40.1 
(5.6) 
43.7 
(5.8) 
53.8 
(5.7) 
B5 90b 41-57 39-55 23-37 21-35 
4.44 
(0.234) 
6.09 
(0.231) 
22.31 
(0.050) 
26.68 
(0.029) 
DNM e DNM e 
19.06 
(1.15) 
25.82 
(1.56) 
B7 83b 33-50 31-45 15-27 17-29 
21.64 
(0.042) 
19.65 
(0.102) 
25.48 
(0.037) 
26.41 
(0.046) 
26.5 
(1.10) 
29.3 
(1.33) 
33.5 
(1.10) 
37.2 
(1.08) 
 
a
 LCST measured by DLS (10 mg/mL).
  
b
 LCST was determined by measuring the turbid point of the polymer solution.  
c
 Hydrodynamic diameter (Dh) determined by DLS (5 mg/mL) at 37 
o
C.  
d
 Disassembly time at 37 
o
C: tstart = time when the size starts to decrease, tdegrade = time from tstart to formation of unimers.  
e
 DNM: 'did not micellize'. 
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3.4 Conclusion 
In conclusion, we have demonstrated the utilization of RAFT mediated polymerization to fine-tune 
the number and types of monomer units in a diblock copolymer. This fine control over polymer 
chemical composition allowed a study of the micelle disassembly times for two series of 
thermoresponsive diblock copolymers. The self-hydrolysis of the DMAEA units in water to acrylic 
acid side groups resulted in an increase in the LCST, and once the LCST increased above the 
polymer/water solution temperature (in our case, 37 °C) the micelles disassembled to unimers. The 
time to disassembly (tstart) increased linearly with an increase in the number of BA units in the 
second block. By controlling the second block‘s composition, tstart could be predicted, allowing the 
use of such timed-release nanoparticles for a wide range of applications. Additionally, the time from 
the start of disassembly to full unimer formation (tdegrade) could be controlled by the amount of 
DMAEA units in the second block. A shorter tdegrade (∼1.1 h) was found when the number of 
DMAEA units was 42 compared to tdegrade of 5.5 h for 25 units. The mechanism of degradation of 
the DMAEA units within the core of the micelle results from the high water content bound to 
PNIPAM. This allows DMAEA to hydrolyze evenly throughout the core, resulting in sharp 
disassembly transitions. The polymer micelles with a low number of BA units disassembled at a pH 
less than 7.3, while incorporating a higher number of BA units increased stability (i.e., no 
disassembly observed until a pH of 5.5). It could be envisaged that combinations of nanoparticles 
(e.g., A1 and A3) could release their payload at the site of the tumor (where the extracellular pH is 
less than 7.3) and further penetrate to inside the tumor for an effective therapeutic effect. The 
formation of small and uniform polymer nanoparticles has great potential in drug delivery where 
drugs or prodrugs could be released after desired times, or delivery to tumors where due to their 
small size they could penetrate deep into the tumor. These nanoparticles could also be designed to 
be pH sensitive and act to release at both the extracellular environment of the tumor and also deep 
inside. These nanoparticles will also have potential for applications where timed-release is 
beneficial. 
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Chapter 4 
Large timed-release polymer nanoparticles stabilized by SDS 
 
T>LCST
T<LCST
disassembly
8-100 h
20-500 nm
PNIPAM PDMAEA PBA or PSTY PAA
(A)
(B)
SDS
 
 
The self-assembly, stabilization and self-disassembly of thermoresponsive nanoparticles from the 
random copolymer of thermoresponsive PNIPAM, hydrophobic PBA or PSTY and self-catalyzed 
hydrolysis poly(N, N-dimethylaminoethyl acrylate) (PDMAEA) were investigated in the presence 
of sodium dodecyl sulphate (SDS) surfactant. The polymers could self-assemble into large SDS 
stabilized nanoparticles with a very narrow size distribution. The polymer particle size can be tuned 
by changing the SDS concentration, and these nanoparticles were stable upon dilution. Increasing 
the amount of SDS resulted in higher LCST of the copolymers due to a greater amount of bound 
SDS molecules to the PNIPAM backbone. Furthermore, the presence of SDS did not influence the 
self-degradation process of DMAEA. The polymer nanoparticles self-disassembled into unimers in 
a precisely time-controlled manner. 
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4.1 Introduction 
Stimulus-responsive polymers that are able to change their physicochemical properties in response 
to stimuli such as temperature,
1, 2
 pH,
3-5
 light,
6-9
 magnetic field,
10-13
 ultrasonication,
14-16
 oxidation-
reduction,
17-21
 and enzyme activity
22-24
 have attracted significant attention in wide range of areas 
including those related to microfluidic,
25
 textile,
26
 and sensors.
27
 Thermoresponsive polymers, e.g., 
Poly(N-isopropyl acrylamide) (PNIPAM), are the most extensively exploited stimuli in the field of 
responsive polymers.
28
 PNIPAM exhibits a typical lower critical solution temperature (i.e., LCST) 
of about 32 
o
C. When the polymer chains are hydrated, they expanded to a hydrophilic water 
swollen state below the LCST while when they are dehydrated, they collapsed to a hydrophilic 
globular state above the LCST.
29-34
  Amphiphilic copolymers of PNIPAM can self-assemble into 
various nanostructures including nanoparticles upon heating in polymer aqueous solution above the 
LCST.
28, 35-38
  
In chapter 1 and 2, we have designed thermoresponsive copolymers with an adjustable LCST that 
can self-assemble into small polymer nanoparticles and then disassemble into unimers at a precise 
time.
39, 40
 We have reported the synthesis of thermoresponsive block copolymers in which the first 
block consisted of the hydrophilic poly(dimethyl acrylamide) (PDMA), and the second blocks 
consisted of the random polymers of thermoresponsive PNIPAM, hydrophobic PBA or PSTY and 
self-catalyzed poly(N, N-dimethylaminoethyl acrylate) (PDMAEA).  The block copolymers, 
PDMA-b-P(NIPAM-co-DMAEA-co-BA) and PDMA-b-P(NIPAM-co-DMAEA-co-STY), are able 
to form nanoparticles when the solution is heated above its LCST (i.e., > 37 
o
C) producing 
nanoparticles with a small hydrodynamic diameter (Dh) of 25 nm and a size distribution less than 
0.063 (where values less than 0.1 represent a narrow distribution). The self-catalyzed hydrolysis of 
DMAEA side groups to carboxylic acid increases over time,
41
 resulting in the increase in the LCST 
of the diblock copolymers, and when the LCST raises above 37 
o
C, a sharp disassembly of the 
polymer particles to unimers occurs.
39
 By varying the composition (i.e., hydrophobic and 
hydrophilic units), we then are able to tune the LCST of the copolymers and therefore create a 
series of block copolymer nanoparticles which are stable in water from 10 to 95 h.
40
 However, 
nanoparticle sizes of the diblock copolymer were unchanged when changing polymer composition. 
Sodium dodecyl sulphate (SDS), a widely used anionic surfactant, has been found to increase the 
LCST of PNIPAM through hydrophobic interaction between the dodecyl tail of SDS and the 
isopropyl side groups of PNIPAM. 
42-47
 The interaction of PNIPAM and SDS has been studied for 
many decades to explore this binding process.  For example, Binkert and coworkers conducted a 
series of work on SDS/PNIPAM systems by time-resolved fluorescence and dynamic light 
scattering (i.e., DLS) techniques.
42, 43
 They suggested that at the temperature below the LCST of 
PNIPAM there are polymer-bound SDS micelles attached along the PNIPAM chain that results in 
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the increase of the LCST. Above the LCST, PNIPAM globules are stabilized from precipitation 
through the bound SDS.
43
 This effect is called intermolecular solubilization.
42
 However, in most of 
these SDS/PNIPAM interaction studies, the maximum SDS concentration used is about the critical 
micelle concentration (i.e., CMC) of SDS and the concentration of PNIPAM is below 0.1 wt%.
42, 44, 
45, 47
 The interaction on nanoparticle formation at much higher concentrations of both SDS and 
PNIPAM has not been investigated. 
 
4.1.1 Aim of the Chapter 
In this chapter, we investigated the self-assembly, stabilization and self-catalyzed disassembly of 
large thermoresponsive particles the random copolymers P(NIPAM-co-DMAEA-co-BA) and 
P(NIPAM-co-DMAEA-co-STY) stabilized by SDS (see Scheme 4.1). We demonstrated that even at 
a high weight fractions of polymer (2.5 wt%) and high SDS concentration (26.4 mM), large and 
stable polymer nanoparticles (e.g., up to 500 nm) could be formed above the LCST (e.g., 37 
o
C). 
Moreover, the particle size could be tuned by changing the SDS concentration. The particles could 
disassemble into unimers by decreasing the temperature to below the LCST, but when heated back 
above the LCST produce particles with the same size, representing a reversible 
assembly/disassembly process. The particles could also be diluted by approximately ten times 
without a change in size until the critical aggregation concentration was reached. It was also found 
that the self-catalysed hydrolysis property of PDMAEA was not affected by SDS, and as such the 
time required for disassembly of the polymer nanoparticles could be precisely controlled. 
 
4.2 Experimental 
4.2.1 Materials 
Dioxane (99%) was used as received from Sigma-Aldrich. Styrene (STY, 99 %, Aldrich), 2-
(dimethylamino) ethyl acrylate (DMAEA, 98%, Sigma-Aldrich), and butyl acrylate (BA, 99%, 
Aldrich) were passed through a column of basic alumina (activity I) to remove inhibitor. N-
isopropylacrylamide (NIPAM, Aldrich, 97 %) was recrystallized from hexane.  
Azobisisobutyronitrile (AIBN) was also recrystallized twice from methanol prior to use. Sodium 
dodecyl sulphate (SDS: Aldrich, 99 %), Potassium chloride (KCl, Alrich). Milli-Q Water (18.2 
MΩcm-1) was generated using a Millipore Milli-Q academic water purification system. All other 
chemicals and solvents used were of at least analytical grade and used as received. The Chain 
Transfer Agent (CTA), Methyl 2-(butylthiocarbonothioylthio) propanoate (MCEBTTC) was 
synthesized according to the literature procedure.
48 
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4.2.2 Synthetic procedures 
4.2.2.1 Synthesis of random copolymers of P(NIPAM-co-DMAEA) (A). NIPAM (4.00 g, 3.54 x 10-
2
 mol), DMAEA (1.37 mL, 8.85 x 10
-3
 mol), MCEBTTC (44.6 mg, 1.77 x 10
-4
 mol) and AIBN (5.8 
mg, 3.54 x 10
-5
 mol) were dissolved in 20 mL of dioxane in a 50 mL dry Schlenk flask equipped 
with magnetic stirrer bar. The mixture was deoxygenated by purging with argon for 30 min and 
then heated to 60 
o
C for 15 h under argon. The reaction was stopped by cooling to 0 
o
C by an ice 
bath and exposed to air. The solution was precipitated in diethyl ether (500 mL) and filtered. The 
polymer was redissolved in acetone and precipitated in diethyl ether. The re-dissolving and 
precipitating process were repeated twice. The yellow powder product was dried under high 
vacuum at room temperature for 48 h (yield = 92%). 
 
4.2.2.2 Synthesis of random copolymers of P(NIPAM-co-DMAEA-co-BA) (B1, B2). Typically, 
NIPAM (4.00 g, 3.54 x 10
-2
 mol), DMAEA (1.37 mL, 8.85 x 10
-3
 mol), BA (0.33 mL, 2.30 x 10
-3
 
mol for B1 or 0.71 mL, 4.96 x 10
-3
 mol for B2), MCEBTTC (44.6 mg, 1.77 x 10
-4
 mol) and AIBN 
(5.8 mg, 3.54 x 10
-5 
mol) were dissolved in 20 mL of dioxane in a 50 mL dry Schlenk flask 
equipped with magnetic stirrer bar. The mixture was deoxygenated by purging with Argon for 30 
min and then heated to 60 
o
C for 16 h under argon. The reaction was stopped by cooling to 0 
o
C by 
an ice bath and exposed to air. The solution was precipitated in diethyl ether (500 mL) and filtered. 
The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-dissolving and 
precipitating process were repeated twice. The yellow powder product was dried under high 
vacuum at room temperature for 48 h (yield = 87.6% for B1 and 87.8% for B2). 
 
4.2.2.3 Synthesis of random copolymers of P(NIPAM-co-DMAEA-co-STY) (C1, C2). Typically, 
NIPAM (4.00 g, 3.54 x 10
-2
 mol), DMAEA (1.37 mL, 8.85 x 10
-3
 mol), STY (0.27 mL, 2.30 x 10
-3
 
mol for C1 and 0.57 mL, 4.96 x 10
-3
 mol for C2), MCEBTTC (44.6 mg, 1.77 x 10
-4
 mol) and AIBN 
(5.8 mg, 3.54 x 10
-5 
mol) were dissolved in 20 mL of dioxane in a 50 mL dry Schlenk flask 
equipped with magnetic stirrer bar. The mixture was deoxygenated by purging with argon for 30 
min and then heated to 60 
o
C for 48 h (C1) or 72 h (C2) under argon. The reaction was stopped by 
cooling to 0 
o
C by an ice bath and exposed to air. The solution was precipitated in diethyl ether (500 
mL) and filtered. The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-
dissolving and precipitating process were repeated twice. The yellow powder product was dried 
under high vacuum at room temperature for 48 h (yield = 89.2% for C1 and 80.2% for C2). 
 
4.2.2.4 Diameter of polymer nanoparticles of the random copolymers in differently concentrated 
SDS solutions determined by DLS. SDS was dissolved in Milli-Q water to obtain differently 
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concentrated SDS solutions (8.2, 12.3, 16.4, 20.5, and 24.6 mM) Polymer samples were weighed in 
vials.  The prepared SDS solutions were then added to the polymers to give polymer solutions with 
concentration 2.5 wt%. These solutions were immediately placed in an ice bath to facilitate the 
dissolution.  The polymer solutions were then filtered directly into DLS cuvettes using 0.45 μm 
cellulose syringe filter. In a typical measurement, the polymer nanoparticle diameter (Dh) and 
polydispersity index (PDI) was measured in DLS machine set at 37 
o
C. The present data were 
averaged from five measurements. 
 
4.2.2.5 Lower Critical Solution Temperature (LCST) of the random copolymers in differently 
concentrated SDS solutions determined by DLS. SDS was dissolved in Milli-Q water to obtain 
differently concentrated SDS solutions (8.2, 12.3, 16.4, 20.5, and 24.6 mM). Polymer samples were 
weighed in vials. The prepared SDS solutions were then added to the polymers to give polymer 
solutions with concentration 2.5 wt%. These polymer solutions were immediately placed in an ice 
bath to facilitate the dissolution. The polymer solution was then filtered directly into DLS cuvettes 
using 0.45 μm cellulose syringe filter. In a typical measurement of the LCST, the polymer solution 
was cooled to 5 
o
C in a DLS machine, and the measurement of polymer nanoparticle diameter (Dh) 
was carried out by gradually increasing the temperature in the DLS machine from 5 
o
C to 60 
o
C at 2 
o
C intervals using the Standard operating procedures (SOP) software.  
 
4.2.2.6 Diameter of polymer nanoparticles (Dh) of the random copolymers in 24.6 mM SDS 
solutions slowly diluted with pre-warmed 10 mM KCl solution determined by DLS. SDS was 
dissolved in Milli-Q water to obtain 24.6 mM solution. Polymer samples were weighed in vials.  
The prepared SDS solutions were then added to the polymers to give polymer solutions with 
concentration 2.5 wt%. These solutions were immediately placed in an ice bath to facilitate the 
dissolution.  The polymer solutions were then filtered directly into DLS cuvettes using 0.45 μm 
cellulose syringe filter. Polymer solutions in the cuvettes were heated up to 37 
o
C in DLS 
afterwards. These solutions were then slowly diluted from 2.5 wt% to 0.1 wt% with 37 
o
C 10mM 
KCl solution. The polymer nanoparticle diameter and polydispersity index (PDI) were measured at 
37 
o
C by DLS. The present data were averaged from five measurements.  
 
4.2.2.7 Thermal history of random copolymers in 24.6 mM SDS solutions. SDS was dissolved in 
Milli-Q water to obtain 24.6 mM solution. Polymer samples were weighed in vials. The prepared 
SDS solutions were then added to the polymers to give polymer solutions with concentration 2.5 
wt%. These polymer solutions were immediately placed in an ice bath to facilitate the dissolution. 
The polymer solution was then filtered directly into DLS cuvettes using 0.45 μm cellulose syringe 
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filter. The polymer nanoparticle diameter (Dh) was measured in DLS with a cycle of gradual 
decrease/increase temperature from 37 
o
C to 20 
o
C and then from 20 
o
C to 50 
o
C using the SOP 
software.  
 
4.2.2.8 Disassembly kinetics of the random copolymers nanoparticles in differently concentrated 
SDS solutions determined by DLS. The nanoparticle diameter was measured over time to determine 
the disassembly time of the nanoparticles. SDS was dissolved in Milli-Q water to obtain differently 
concentrated SDS solutions (8.2, 12.3, 16.4, 20.5, and 24.6 mM). Polymer samples were weighed in 
vials.  The prepared SDS solutions were then added to the polymers to give polymer solutions with 
concentration 2.5 wt%. These solutions were immediately placed in an ice bath to facilitate the 
dissolution. The polymer solution was then filtered directly into DLS cuvettes using 0.45 μm 
cellulose syringe filter. In a typical measurement, the polymer nanoparticle diameter (Dh) was 
measured in DLS machine set at 37 
o
C over time.  
 
4.2.2.9 Lower Critical Solution Temperature (LCST) of the random copolymers in 12.3 mM SDS 
solution after hydrolysis at different times determined by DLS. SDS solution was prepared by 
dissolving SDS in Milli-Q water to concentration 12.3 mM. Polymer samples were weighed in 
vials. The prepared SDS solution was then added to the polymers to give polymer solutions with 
concentration 2.5 wt%. These polymer solutions were immediately placed in an ice bath to facilitate 
the dissolution. The polymer solution was then filtered directly into DLS cuvettes using 0.45 μm 
cellulose syringe filter. These cuvettes were then kept in a water bath at 37 
o
C to obtain hydrolysed 
samples. The LCST of the hydrolysed samples at different times were then measured by the DLS. 
The measurements were carried out by measuring nanoparticle diameter of the polymer (Dh) while 
gradually increasing the DLS temperature from 15 to 60 
o
C using SOP software over 3 h.   
 
4.2.3 Analytic methodologies 
1
H Nuclear Magnetic Resonance (
1
H NMR). All 
1
H NMR spectra were recorded on Bruker DRX 
500 MHz using external locks (CDCl3 or D2O) and   referenced to the residual non-deuterated 
solvent (CHCl3 or H2O). After samples were well dissolved in CDCl3 or D2O, samples solutions 
were then transferred to NMR tubes. With samples in CDCl3, the spectrometer was set at 25 
o
C for 
determination of polymer structure. With samples in D2O, the spectrometer was set at different 
temperatures for determination of the polymer structure before and after degradation.  
 
Size Exclusion Chromatography (SEC). Analysis of the molecular weight (Mn) and molecular 
weight distribution (PDI) of the polymers was accomplished using a Waters 2695 separations 
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module, fitted with a Waters 410 refractive index detector maintained at 35 
o
C, a Waters 996 
photodiode array detector, and two Ultrastyragel linear columns (7.8 x 300 mm) arranged in series. 
These columns were maintained at 40 
o
C for all analyses and are capable of separating polymers in 
the molecular weight range of 500-4 million g/mol with high resolution. The dried polymer was 
dissolved in tetrahydrofuran (THF) to a concentration of 1 mg/mL and then filtered through a 0.45 
μm PTFE syringe filter. All samples were eluted at a flow rate of 1.0 mL/min. Calibration was 
performed using narrow molecular weight PSTY standards (PDI ≤ 1.1) ranging from 500 to 2 
million g/mol. Data acquisition was performed using Empower software, and molecular weights 
were calculated relative to polystyrene standards.  
 
Dynamic Light Scattering (DLS). Measurements were performed using a Malvern Zetasizer Nano 
Series running DTS software and operating a 4 mW He-Ne laser at 633 nm. Analysis was 
performed at an angle of 173
o
. The sample refractive index (RI) was set at 1.59 for polystyrene. The 
dispersant viscosity and RI were set to 0.89 Ns.m
-2
 and 1.33, respectively. The number-average 
hydrodynamic particle size and polydispersity index are reported. The polydispersity index (PDIPDS) 
was used to describe the width of the particle size distribution. It was calculated from a Cumulants 
analysis of the DLS measured intensity autocorrelation function and is related to the standard 
deviation of the hypothetical Gaussian distribution (i.e., PDIPSD = ζ
2
/ZD
2, where ζ is the standard 
deviation and ZD is the Z average mean size).  
 
4.3 Result and Discussion 
Polymer synthesis. Reversible addition-fragmentation chain transfer (RAFT) polymerization is a 
technique that allows control over the molecular weight of a wide range of monomers, including 
acrylates and acrylamides, to produce homo or block copolymers with narrow molecular weight 
distributions and controlled copolymer chemical composition.
49, 50
 In this work, we synthesized a 
series of thermoresponsive random copolymers by RAFT polymerization in which MCEBTTC was 
employed as the chain transfer agent (CTA). Table 4.1 summarizes the polymerization conditions 
and resultant copolymer characterization by 
1
H NMR and size exclusion chromatography (SEC). 
Addition of BA allowed the polymerization to reach a greater conversion. On the other hand, the 
addition of STY monomer (C1 and C2) required a longer polymerization time than those with only 
acrylate and acrylamide monomers (A, B1 and B2) to reach a similar conversion. This is due to the 
low propagation rate constant (kp) of STY compared to the acrylates or acrylamides.  We found that 
regardless of the polymerizatrion times, all polymers were obtained with narrow molecular weight 
distributions ranging  with PDISEC values from 1.12 to 1.18 (Table 4.1, Figure A4.1 in Appendix C), 
indicating a well-controlled ―living‖ radical polymerization. The 1H NMR spectra (Figure A4.2) 
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showed the presence of protons at 3.63 ppm and 3.30 ppm assigned to R (l) and Z (b) of the RAFT 
agent, respectively. The 
1
H NMR spectra was also used to calculate the repeating units of each 
monomer and the molecular weight of polymers (Table A4.1). The results showed that the 
molecular weight of polymers obtained from 
1
H NMR were quite similar to those determined from 
SEC (Table 4.1, Table A4.1 and Figure A4.2).  
 
Table 4.1 Reaction time, molecular weights, polydispersities (PDI), and 
1
H NMR data of RAFT 
polymerization of thermoresponsive random copolymers at 60 
o
C in dioxane 
a
  
 Polymer 
code  
Reaction 
time (h)  
SEC 
 
1
H NMR 
M
n
 PDI 
Monomer conversion (%) Total 
conversion 
(%) 
M
n
 
Percentage 
of BA or 
STY (%) 
NIPAM DMAEA BA STY 
A 15 9600 1.14  31.5 34.0 - - 32.0 9800 - 
B1 16 12800 1.13  49.0 34.0 53.0 - 46.4 14800 5.70 
B2 16 14900 1.12  60.0 44.0 64.0 - 57.6 19270 11.25 
C1 48 9500 1.14  38.0 34.0 - 54.0 38.0 12000 7.00 
C2 72 10200 1.18  32.0 32.0 - 50.0 33.8 11230 14.90 
 
a
All repeating units and detailed calculation were presented in Table A4.1. 
 
Self-assembly and disassembly of nanoparticles. In Chapters 2 and 3, we used the hydrophilic 
PDMA as the first block of the copolymer PDMA-b-P(NIPAM-co-DMAEA-co-BA) and PDMA-b-
P(NIPAM-co-DMAEA-co-STY) to act as the steric stabilizer for the polymer nanoparticles, 
producing particles with a narrow particle size distribution.
39, 40
 The random copolymer made in this 
chapter will precipitate upon heating above the LCST. The addition of surfactant could provide 
such stabilization above the LCST. It has been reported that the SDS can bind to the backbone of 
PNIPAM and stabilize the resultant nanoparticles from precipitation above the LCST.
43
 Therefore, 
we studied the influence of SDS on stabilizing the random copolymers particles at high polymer 
concentration (2.5 wt%) above the LCST.
44-47
 This weight fraction of polymer was significantly 
higher than previous studies. Each polymer solution (2.5 wt%) was mixed with different SDS 
concentrations (8.2, 12.3, 16.4, 20.5, and 24.6 mM) and then directly heated to 37 
o
C. The 
temperature of 37 
o
C was chosen for this study in order to compare this system with nanoparticles 
reported from our previous work (i.e., Chapters 2 and 3).
39, 40
 The results in Table 4.2 and Figure 
A4.5 showed that all polymer self-assembled into nanoparticles at 37 
o
C with the exception of 
polymer A, which remained as unimers (data not shown). The reason was due to polymer A having 
an LCST greater than 37 
o
C. Importantly, the size distribution of the polymer particles of B1, B2, 
C1 and C2 was very narrow (PDIDLS < 0.1, in which a value less than 0.1 represents narrow 
distribution by DLS). This was confirmed by the similar Dh values (Number mean, Volume means, 
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Intensity means, and Z-average) of the polymer nanoparticles in each SDS concentration by DLS. 
Interestingly, this particle size distribution was in agreement with the results achieved from the 
polymer particles stabilized by PDMA in our previous works,
39, 40
 demonstrating that the SDS 
provided adequate stability.  
The particle size of all four polymers (B1-C2) could be tuned by changing the SDS concentration 
while maintaining a narrow particle size distribution. When the SDS concentration was increased, 
the particle size was also found to increase. For example, the number mean value of polymer B1 
(5.7 mol% of BA) was 64.83 nm in 8.2 mM SDS solution, increased to 195.58 nm in a 16.4 mM 
SDS solution, and further increased to 502.56 nm in a 24.6 mM SDS solution. Similarly, the 
polymer C1 (7 mol% fraction of STY) formed a particle size of 78.76 nm in a 8.2 mM SDS solution 
and increased to 140.82 nm and 233.36 nm when the concentration of SDS increased to 16.4 mM 
and 24.6 mM, respectively. A similar trend of particle size as a function of SDS concentration was 
also observed for the polymer B2 and C2. In nearly all cases, the polydispersity of the distribution 
was below 0.1, demonstrating that the polymer particles could be increased to larger sizes while still 
maintaining anarrow distribution. The increase in the particle size with higher SDS concentration 
above the LCST of polymers was consistent with the work reported by Binkert,
42, 43
 who found that 
through the strong hydrophobic interactions between the SDS tails and the isopropyl groups of 
PNIPAM the particle size increased due to ionic repulsion of the neighboring negatively charged 
SDS head groups. They proposed that the morphology would consist of an open internal 
morphology similar to that of a vesicle. Elucidation of the internal morphological of our polymer by 
TEM or Cryo-TEM was challenging because sample preparation was below the LCST (e.g., at 25 
o
C for TEM or < 0 
o
C for Cryo-TEM).  
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Table 4.2 Dh and Polydispersities (PDIDLS) copolymers determined at 37 
o
C by Dynamic Light Scattering (DLS). The polymer concentration 
was 2.5 wt% in five different sodium dodecyl sulfate (SDS) solution concentrations at 8.2, 12.3, 16.4, 20.5, and 24.6 mM. 
SDS 
concentration 
(mol/L) 
Dh at 37 
o
C 
B1: P(NIPAM98-co-DMAEA18-co-BA7)  B2: P(NIPAM120-co-DMAEA22-co-
BA18) 
 C1: P(NIPAM76-co-DMAEA17-co-
STY7) 
 C2: P(NIPAM64-co-DMAEA16-co-
STY14) 
PDI 
(DLS) 
Number 
mean 
Intensity 
mean 
Volume 
mean 
Z-
Average 
PDI 
(DLS) 
Number 
mean 
Intensity 
mean 
Volume 
mean 
Z-
Average 
PDI 
(DLS) 
Number 
mean 
Intensity 
mean 
Volume 
mean 
Z-
Average 
PDI 
(DLS) 
Number 
mean 
Intensity 
mean 
Volume 
mean 
Z-
Average 
8.2 0.188 64.83 197.72 152.20 159.28  0.043 43.39 60.42 50.64 56.74  0.043 78.76 106.90 93.59 100.56  0.080 20.58 31.34 24.63 28.64 
12.3 0.013 153.42 181.54 179.98 174.72 0.045 46.91 64.23 54.36 60.43 0.044 119.02 153.48 145.70 144.40 0.062 25.22 37.13 29.94 34.41 
16.4 0.018 198.58 230.64 232.84 220.00 0.023 49.19 65.15 56.27 61.95 0.042 140.82 171.60 168.18 164.16 0.047 27.06 37.66 31.36 35.33 
20.5 0.089 268.22 339.82 362.98 310.62 0.050 57.15 78.48 66.78 73.66 0.042 187.24 210.24 211.46 203.64 0.048 31.59 44.96 36.94 41.96 
24.6 0.057 502.56 564.74 646.94 524.92 0.026 72.79 95.15 83.92 90.44 0.083 233.36 298.62 311.98 271.86 0.049 35.98 49.76 41.70 46.66 
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To determine the temperature that the polymer can form particles (i.e., LCST of the polymers), the 
five polymers (2.5 wt%) in 12.3 mM SDS solution were heated from 5 
o
C to 60 
o
C at 2 
o
C intervals 
until the formation of stable polymer particles. The results in Figure 4.1 and Table 4.3 showed that 
all polymer particles (B1, B2, C1 and C2) formed at 37 
o
C (i.e the polymer's LCSTs were below 37 
o
C); the only exception was polymer A whose LCST was 38 
o
C. At 37 
o
C polymer A remains as a 
unimer. The higher LCST of copolymer A compared to the other copolymers at the same SDS 
concentration (i.e., 12.3 mM) was a result of its higher hydrophilicity contributed from the 
hydrophilic DMAEA. It has been demonstrated that increasing the hydrophilicity of the 
thermoresponsive polymer, an increase in the PNIPAM‘s LCST will be observed and an increase in 
the hydrophobicity of the polymer will decrease the LCST.
51
 Upon heating this polymer solution to 
45 
o
C, polymer A self-assembled into polymer nanoparticle with 794.1 nm in diameter. When the 
hydrophobic component such as BA or STY was incorporated in the polymer, the LCST of the 
polymer decreased, consistent with our previously reported results.
39, 40
 Polymer B1 (P(NIPAM98-
co-DMAEA18-co-BA7)) that contained 5.7 % mol fraction of BA gave an LCST of 30 
o
C in 12.3 
mM SDS solution, and when polymer solution was heated to 37 
o
C, the polymer self-assembled into 
polymer nanoparticle with a diameter of 245.94 nm and PDIDLS of 0.094 (Table 4.3). This particle 
size was slightly different with the value reported in Table 4.2 (153.42 nm) which may be due to the 
differences in the methods of heating the polymer solutions (directly heating versus slow gradual 
heating to 37 
o
C; the latter used to measure the LCST).  Increasing the amount of BA to 11.25 % 
mol in polymer B2, the LCST of the polymer B2 (P (NIPAM120-co-DMAEA22-co-BA18)) lowered 
to 24 
o
C, resulting in a smaller size of 120.34 nm at 37 
o
C. Similarly, when adding 7% and 14.90 % 
mol fraction of STY to polymer C1 (P(NIPAM76-co-DMAEA17-co-STY7)) and C2 (P(NIPAM64-co-
DMAEA16-co-STY14)), respectively, the LCST of the polymers dropped down to 28 
o
C for C1 and 
19 
o
C for C2. Particle sizes of C1 and C2 were 141.26 nm and 32.63 nm at 37 
o
C, respectively.  
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Figure 4.1 Dh vs temperature of polymer (A) P(NIPAM63-co-DMAEA17), (B1) P(NIPAM98-co-
DMAEA18-co-BA7), (B2) P(NIPAM120-co-DMAEA22-co-BA18), (C1) P(NIPAM76-co-DMAEA17-
co-STY7), and (C2) P(NIPAM64-co-DMAEA16-co-STY14) 12.3 mM SDS solution. The data were 
reported as average numbers from five measurements on DLS machine. Polymer concentration was 
2.5 wt%. Inset: LCST vs polymer. 
 
Table 4.3 Lower Critical Solution Temperature (LCST), Hydrodynamic Diameter (Dh), 
Polydispersities (PDIDLS) and disassembly times for thermoresponsive random copolymers 
determined by Dynamic Light Scattering (DLS). The polymer concentration was 2.5 wt% in 12.3 
mM SDS solution 
 
Polymer 
LCST 
(
o
C)  
Dh (nm)
  
(PDIDLS)  
a
 
Disassembly 
time 
 tstart (tdegrade) (h) 
c
 
A  P(NIPAM63-co-DMAEA17) 38 794.10 (0.451)
b
 3.60 (4.1)
b
 
B1  P(NIPAM98-co-DMAEA18-co-BA7) 30 245.94 (0.094) 11.30 (6.0) 
B2 P(NIPAM120-co-DMAEA22-co-BA18) 24 120.34 (0.056) 40.00 (6.2) 
C1 P(NIPAM76-co-DMAEA17-co-STY7) 28 231.26 (0.044) 17.80 (6.2) 
C2 P(NIPAM64-co-DMAEA16-co-STY14) 19 52.42 (0.028) 95.00 (6.0) 
 
a 
Data were measured by slowly heating polymer solutions from 5 
o
C to 60 
o
C (LCST 
determination) in DLS. The values were averaged from five measurements at 37 
o
C.
b
 Reported 
value at 45 
o
C.
c
 Disassembly time tstart = time when the size starts to decrease; tdegrade = time from 
tstart to formation of unimers. 
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The LCST of the polymers (e.g., B1 and C1) were further investigated over a wide range of SDS 
concentrations. The data showed the LCST of polymer also increased linearly with an increase in 
SDS concentration (Figure 4.2, A4.6, A4.7 and Table A4.2). At higher SDS concentrations, more 
SDS molecules can bind to PNIPAM resulting in a greater hydrophilicity and thus higher LCST, 
which was consistent with the previous studies.
45, 46, 52
  
 
 
Figure 4.2 LCST vs SDS concentrations of polymer (B1) P(NIPAM98-co-DMAEA18-co-BA7 and 
(C1) P(NIPAM76-co-DMAEA17-co-STY7) when the polymers were dissolved in five different 
Sodium dodecyl sulfate (SDS) solution concentrations: 8.2, 12.3, 16.4, 20.5, and 24.6 mM. The data 
were reported as average numbers from five measurements on DLS machine. Polymer 
concentration was 2.5 wt%. 
 
To test the stability of the polymer nanoparticles in SDS, the particles (e.g., B1, C1) underwent 
heating/cooling cycles and even a significant dilution. The polymers B1 and C1 were dissolved in a 
solution of 24.6 mM of SDS with a weight fraction of 2.5 wt %. The solution was heated to 37 
o
C to 
form stable particles with size of 550 nm for B1 and 264 nm for C1. The solution was gradually 
cooled to 20 
o
C in the DLS machine using the Standard operating procedures (SOP) program. A 
sharp decrease of the size was observed at 35 
o
C and the solution was then heated gradually to 55 
o
C. The size profile of heating cycle perfectly overlaid the cooling cycle, indicating reversibility and 
temperature stablity of the particles as shown in Figure 4.3A. Polymer C1 showed a similar result as 
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depicted in Figure 4.3B. Further experiments were carried out by diluting the polymer particles by 
adding 10 mM pre-heated KCl solution from 2.5 wt % down to 0.05 wt % and monitoring the size 
change at 37 
o
C. Figure 4.3C and 4.3D showed the size dependence on the weight fraction of 
polymer B1 and C1, respectively. Surprisingly, upon the dilution, the size of particles made from 
B1 and C1 was kept relatively constant with narrow distribution (PSDDLS<0.1).  A dramatic 
decrease of the particles size took place when the concentration of polymer dropped to below 0.3 
wt% for B1 and 0.1 wt% for C1. When the polymer B1 solution reached approximately 10-fold 
dilution corresponding with a solution of 0.25 wt% polymer and 2.46 mM SDS (i.e., well below the 
CMC of the SDS, which is close to 8.2 mM), the polymer particles were no longer stabilized and 
rapidly changed in size from approximately 500 to 110 nm (Figure 4.3C). A similar process was 
also found for the polymer C1 solution, which underwent almost 25-folder dilution (Figure 4.3D). 
The sharp decrease in size can be considered as the weight fraction below which the particles 
disassemble and can be considered as the critical aggregation concentration (CAC). 
 
A B
C D
 
Figure 4.3 Polymer/SDS particles from polymer (A) B1 and (B) C1 over cooling and heating 
cycles, and Dh and PDIDLS of the particles from polymer (C) B1 and (D) C1 upon dilution with 10 
mM pre-warmed KCl solution at 37 
o
C (initial polymer concentration was 2.5 wt%, SDS 24.6 mM). 
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 We then investigated the influence of SDS on disassembly profiles of the polymer nanoparticles by 
measuring the decrease in the particle size over time using dynamic light scattering (DLS). Due to 
the high LCST of the polymer A, well above 37 
o
C, the degradation kinetic of the polymer A was 
conducted at 45 
o
C. In 12.3 mM SDS solution, the polymer self-assembled into particles with 
diameter 276.23 nm. The size increase slowly over 3.6 h, and then fully dissociated to unimers after 
7.7 h (Figure A4.8). For the other four polymers (B1 to C2), the degradation profiles were studied at 
37 
o
C in order to compare with the degradation profile of the thermoresponsive block copolymers 
found in our previous work.
39, 40
 The four polymers were solubilized in water at 2.5 wt% in a 
solution of SDS at a concentration of 12.3 mM, and directly heated to 37 
o
C. The polymer 
nanoparticles were then kept at 37 
o
C, and the nanoparticle size of the four polymers was measured 
over 120 h.  The nanoparticle B1 (5.7 % mol BA) was produced with initial average size of about 
191.62 nm, which was almost identical with the result presented in Table 4.2. This size then 
increased to about 220 nm after approximately 11 h and rapidly disassembled to unimers after 17.3 
h (Figure 4.4A and Table 4.3). The increase in particle size may result from electrostatic repulsion 
between the negatively charged carboxylic acid groups formed through the hydrolysis of PDMAEA 
side groups and negatively charged SDS molecules. The additional negative charge on the polymer 
will result in an increase in size, similar to the observation by Walter et al.
42, 43
 A similar 
observation was also found for the other polymers. Increasing BA to 11.25 % mol fraction, a 
smaller nanoparticle size was observed with diameter approximately 60.76 nm which then slowly 
increased to 100 nm at 40 h before dropping to 5 nm after a further 6.2 h. Similarly, the size of the 
polymer nanoparticle C1 which contained 7% mol fraction of STY started at around 141.26 nm in 
diameter and increased to about 180 nm in first 17.8 h and then quickly dissociated to unimers after 
24 h. Incorporation of 14 mol % of STY in C2, produced an elevation in the size of C2 polymer 
nanoparticle from 32.63 nm to around 100 nm in 95 h before disassembling to unimers at 
approximately 101 h (Figure 4.4A in Appendix C). Furthermore, the time to disassemble (tstart) of 
the polymers with higher hydrophobic BA or STY (B2, C2) was longer, but the time (i.e., tdegrade), 
determined from tstart to full micelle disassembly to unimers (Dh ~5nm), was almost identical at ~6 h 
for the four polymers having similar units of DMAEA (~ 18 units) (see Table 4.3). This result 
exhibited that tstart was controlled by the LCST while tdegrade was dependent on the DMAEA units, 
which is consistent with our previous work.
39, 40
 The data suggested that the disassembly time (tstart, t 
degrade) of the polymer nanoparticles can be independently controlled by simply changing the 
composition of the copolymers. 
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Figure 4.4 Degradation kinetic profile (A) and the rate of change in the LCST (B) of polymer (B1) 
P(NIPAM98-co-DMAEA18-co-BA7) incubated at 37 
o
C, determined by dynamic light scattering 
(DLS). The polymer concentration was 2.5wt% in 12.3 mM SDS solution. 
 
The polymer solutions were also kept at 37 
o
C for different times before measuring their LCST to 
investigate the rate of change in the LCST over time. Figure 4.4B showed that the LCST of the 
polymers shifted to a higher value over time. We observed that the change in the LCST of the 
polymers was quite consistent with the degradation profile of the polymers in Figure 4.4A.  The 
LCST of the polymer B1 increased to 42 
o
C, after which time the polymer became unimers. An 
increase in LCST was also observed for polymer B2. After the polymer nanoparticle disassembled 
at 37 
o
C, the LCST of the polymer reached 39 
o
C. For both polymer C1 and C2, the LCST of the 
two polymers were 39 
o
C after the disassembly of the polymer nanoparticles to unimers occurred 
(Table A4.3, Figure A4.9-A4.12).  The data demonstrated that the rate of LCST change 
corresponded with the increase in the degradation of PDMAEA to the more hydrophilic polyacrylic 
acid (PAA) resulting in the increase in LCST of the copolymers. When the formation of PAA was 
sufficient to shift LCST of the polymer to above 37 °C, rapid disassembly to water-soluble unimers 
occurred. The shift of LCST over 37 
o
C was the reason for the sharp disassembly of the polymer 
particles shown in Figure 4.4A. This result demonstrated that the degradation of PDMAEA was not 
affected by the addition of SDS, consistent with the self-catalysed hydrolysis characteristic of the 
PDMAEA. Furthermore, the disassembly of the polymer particle was mainly caused by the increase 
in LCST due to the degradation of PDMAEA. The disassembly profiles of the four polymers (B1-
C2) were also studied in 24.6 mM SDS solution. Similar to 12.3 mM SDS solution, we found that 
the polymers possessing higher mol fraction of BA or STY provided longer degradation times 
(Figure A4.13 and Table A4.4). The disassembly time for the polymer nanoparticles increased from 
8.17 h for B1 to 15.82 h for B2. Similarly, polymer nanoparticles C1 and C2 dissociated after 10.12 
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h and 37.77 h, respectively. The disassembly profiles of these four polymers suggested that the 
disassembly time can be precisely controlled by simply manipulating not only the polymer 
composition but also the SDS concentration. 
To understand more about the influence of SDS concentration on the disassembly time of the 
polymer nanoparticles at 37 
o
C, the disassembly profiles of polymer B1 and C1 was investigated at 
four different SDS concentrations 12.3, 16.4, 20.5, and 24.6 mM (Figure A4.14 and Table A4.2). 
The summarized data in Figure 4.5 clearly showed that a greater SDS concentration led to a shorter 
disassembly time, consistent with the change in the LCST of the polymers as a function of the SDS 
concentrations reported in Figure 4.2. This data once again confirmed that higher SDS 
concentration results in greater LCST of the polymers contributing to the shorter disassembly time 
of the polymer particles.  
 
 
Figure 4.5 Disassembly time of B1: P(NIPAM98-co-DMAEA18-co-BA7) and C1: P(NIPAM76-co-
DMAEA17-co-STY7) (B) as a function of SDS concentration determined at 37 
o
C by DLS. The 
polymer concentration was 2.5 wt% in different SDS solution concentrations: 12.3, 16.4, 20.5, and 
24.6 mM. 
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4.4 Conclusion 
In conclusion, we synthesized a series of well-defined random copolymers by one-pot Reversible 
addition-fragmentation chain transfer (RAFT) polymerization of monomers NIPAM, DMAEA and 
BA or STY. Above the LCST (i.e., 37 
o
C), these polymers could self-assemble into nanoparticles at 
high polymer weight fraction (2.5 wt%) and high SDS concentration (ranging from 8.2 mM up to 
24.6 mM). Interestingly, the self-assembled polymer nanoparticles with large particle size (e.g., up 
to ~500nm) could be stabilized by SDS and demonstrated a very narrow size distribution. 
Furthermore, polymer particle size could be tuned, which was dependent on SDS concentration 
(e.g., higher SDS concentration resulted in larger particle size). Moreover, the particles size could 
be reversed through heating/cooling cycles, and dilution of the particles did not alter the size or 
change its narrow size distribution. The SDS concentration also influenced the LCST of the 
polymer as proved by higher polymer LCST in higher SDS concentration. Moreover, the hydrolysis 
of the side group of PDMAEA was not affected by SDS.  The hydrolysis of PDMAEA side groups 
to carboxylic acid groups caused an increase in the LCST of the polymer over time, and when the 
LCST of the polymer increased above 37 
o
C, rapid disassembly of the polymer nanoparticles to 
unimers occurred. By controlling the SDS concentration (i.e., control in the LCST of the polymer) 
and the polymer composition, the disassembly time of the polymer nanoparticles can be precisely 
controlled. 
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Chapter 5 
Non-triggered degradable thermoresponsive hydrogel for controlled 
release of gold nanoparticles 
 
> Tgel
< Tgel
Sol Gel
A
B
 
 
Polymeric hydrogels as carriers have attracted a lot of attention for applications in drug and gene 
delivery systems. In this chapter, a novel self-degradable release hydrogel system was designed. 
The hydrogels were prepared based on a series of random copolymers synthesized from NIPAM, 
self-catalysed hydrolysis DMAEA, hydrophilic PEGMEA, and hydrophobic BA (P(NIPAM-co-
DMAEA-co-PEGMEA-co-BA)) via Reversible addition−fragmentation chain transfer (RAFT) 
polymerization. The thermoresponsive copolymers formed a stable gel at temperature higher than 
the gelation point and then self-degraded into sol state over time without the need of any triggers. 
Moreover, the gelation temperature and degradation time increased with increase in the DMAEA 
units. Gold nanoparticles coated with PDMA were encapsulated in the hydrogel and subsequently 
released at different rates through the degradation of the hydrogel. 
 
Non-triggerred degradable hydrogel 
96 
 
5.1 Introduction 
Thermoresponsive polymers and their copolymers have attracted significant attention for 
biomedical applications such as drug delivery, cell immobilization, in-situ gelling implantation and 
tissue engineering.
1-3
  Based on the particular properties of the thermoresponsive PNIPAM,
4-13
 it 
has been employed in the synthesis and development of injectable hydrogels because gelation can 
be obtained by simply altering the temperature above the LCST of the polymer without any 
chemical/photo cross-linking which may cause cytotoxicity issues.
7, 14-18
 It has been reported that 
the sol-gel transition of the polymer solution is the result of chain entanglement as well as the 
physical junction, which forms from hydrophobic interaction between collapsed polymer globules 
and the expanding polymer coils.
19
 However, these hydrogels are non-degradable which may cause 
chronic inflammatory response and thus limits the application of such hydrogels in vivo.
20
  
Various efforts have been made to create thermoresponsive degradable hydrogels. For example, 
biodegradable PNIPAM-based hydrogels can be achieved by the incorporation of PNIPAM with 
degradable polymers or crosslinkers.
21-24
 The presence of crosslinkers can limit the hydrogel‘s 
injectability, and the degradation of such hydrogel systems requires the existence of triggers (e.g., 
enzymes). Another limitation is that the variations in environmentally triggered stimuli between cell 
lines and even within the same tissue or organ may result in different rates of degradation and 
inconsistent data between in vitro and in vivo experiments. Therefore the application of 
thermoresponsive degradable hydrogels as delivery systems can sometimes be limited. 
25, 26
  
To address the issue of biodegradation, PNIPAM based copolymers that possess different gelation 
temperatures before and after degradation have been developed.  In these degradable hydrogel 
systems, PNIPAM was copolymerized with hydrolysable side groups containing polymers. Polymer 
solutions exhibited sol state at below 37 
o
C, this allows the polymer solution to be injectable before 
gelation. Increase in temperature to 37 
o
C results in the polymer solution transitioning to a gel state. 
After degradation of the side groups, the hydrogel returns to sol state, which allows the degradation 
products to dissolve into the bodily fluids and to be eliminated from the body.
20, 27-30
 However, the 
degradation rates of these hydrogels are not able to be controlled.
27, 29, 30
 
In previous chapters, we have reported a type of polymer micelles with well-controlled disassembly 
time that was formed by self-assembly of thermoresponsive diblock copolymer PDMA-b-
P(NIPAM-co-DMAEA-co-BA).
12, 13
 PDMAEA can self-hydrolyse to poly acrylic acid (PAA) 
independent of molecular weight or pH environment.
31, 32
 The degradation product, PAA, increased 
the LCST of the polymer resulting in the disassembly of the polymer nanoparticle at a precisely 
controlled time without the need of a trigger.
12, 13 
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5.1.1 Aim of the Chapter 
The goal of this chapter is to synthesize a novel non-triggered degradable hydrogel system based on 
a series of hydrolyzable random copolymers of thermoresponsive PNIPAM, self-catalyzed 
hydrolysis PDMAEA, hydrophilic PEGMEA, and hydrophobic PBA (P(NIPAM-co-DMAEA-co-
PEGMEA-co-BA)). The Reversible addition-fragmentation chain transfer (RAFT) was employed to 
synthesize these random thermoresponsive copolymers. The gelation temperature of polymer 
solutions was investigated by both DSC and vial inverting method. Moreover, the water content and 
the degradation of the hydrogels were studied. In addition, PDMA functionalized gold nanoparticles 
(PDMA-AuNPs) were employed as a model drug to be encapsulated into the hydrogels. The 
releases of PDMA-AuNPs from the hydrogels were then monitored over time by UV-vis 
spectroscopy.  
 
5.2 Experimental 
5.2.1 Materials 
Dioxane (Alrich, 99%), carbondisulfide (Alrich, 99%), 1-butanethiol (Alrich, 99%), methyl 
bromopropionate (Alrich, 98%), and dimethyl sulfoxide (DMSO, Alrich >99.9%), dichloromethane 
(DCM: Labscan, AR grade), Styrene (STY, Aldrich, 99 %), 2-(dimethylamino) ethyl acrylate 
(DMAEA, Sigma-Aldrich, 98%), Poly(ethylene glycol) methyl ether acrylate (PEGMEA, Sigma-
Aldrich) and butyl acrylate (BA, Aldrich, 99%) were passed through a column of basic alumina 
(activity I) to remove inhibitor. N-isopropylacrylamide (NIPAM, Aldrich, 97 %) was recrystallized 
from hexane. Azobisisobutyronitrile (AIBN) was also recrystallized twice from methanol prior to 
use. Hydrogen tetrachloroaurate (III) hydrate (HAuCl4 · 3H2O; Aldrich, 99.9%), trisodium citrate 
dehydrate (Na3Ct; Aldrich, 99%). Milli-Q Water (18.2 MΩcm-1) was generated using a Millipore 
Milli-Q academic water purification system. All other chemicals and solvents used were of at least 
analytical grade and used as received. 
 
5.2.2 Synthetic procedures 
5.2.2.1 Synthesis of the Chain Transfer Agent (CTA), Methyl 2-(butylthiocarbonothioylthio) 
propanoate (MCEBTTC). The synthesized MCEBTTC was carried out according to the literature 
procedure
33
. Carbondisulfide (3.1 mL, 0.051 mol) in dichloromethane (50 mL) was added dropwise 
to a stirred solution of 1-butanethiol (5 mL, 0.047 mol) and triethylamine (7.2 mL, 0.051 mol) in 
dichloromethane (25 mL) over 30 min at 0 
o
C under an argon atmosphere. The solution gradually 
turned yellow during the addition. After complete addition, the solution was stirred at room 
temperature for 30 min. Methyl bromopropionate (5.7 mL, 0.051 mol) in dichloromethane (25 mL) 
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was then added dropwise over 30 min and the solution stirred for 2 h. The dichloromethane was 
removed under nitrogen and the residue dissolved in diethylether. The solution was then washed 
with cold 10% HCl solution (3 x 50 mL) and Milli-Q water (3 x 50 mL) and dried over anhydrous 
MgSO4. The ether was removed under vacuum, and the residual yellow oil was purified by column 
chromatography (19:1 petroleum ether/ethyl acetate on silica, second band). 
1
H NMR (CDCl3) δ 
0.90 (t, J = 7.5 Hz, 3H, CH3), 1.40 (m, J = 7.5 Hz, 2H, CH2), 1.57 (d, J = 7.5 Hz, 3H, CH3), 1.66 (q, 
J = 7.5 Hz, 2H, CH2), 3.34 (t, J = 7.5 Hz, 2H, CH2), 3.73 (s, 3H, CH3), 4.80 (q, J = 7.5 Hz, 1H, 
CH). 
 
5.2.2.2 Synthesis of random copolymers. P(NIPAM198-co-DMAEA12-co-BA8-co-PEGMEA14) (A). 
NIPAM (2.00 g, 1.77 x 10
-2
 mol), DMAEA (0.205 mL, 1.33 x 10
-3
 mol), PEGMEA (0.58 mL, 1.33 
x 10
-3
 mol), BA (0.127 mL, 8.85 x 10
-4 
mol), CTA (22.3 mg, 8.85 x 10
-5
 mol) and AIBN (2.90 mg, 
1.77 x 10
-5 
mol) were dissolved in 12 mL of dioxane in a dry Schlenk flask equipped with a 
magnetic stirrer bar. The mixture was deoxygenated by purging with Argon for 40 min and then 
heated to 60 
o
C for 24 h under Argon atmosphere. The reaction was stopped by cooling to 0 
o
C in 
an ice bath and exposed to air. The solution was precipitated in diethyl ether (500 mL) and filtered. 
The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-dissolving and 
precipitating process were repeated twice. The light yellow powder product was dried under high 
vacuum at room temperature for 48 h (yield = 70%). 
 
5.2.2.3 Synthesis of random copolymers. P(NIPAM196-co-DMAEA9-co-BA8-co-PEGMEA13) (B). 
NIPAM (2.00 g, 1.77 x 10
-2
 mol), DMAEA (0.137 mL, 8.85 x 10
-4
 mol), PEGMEA (0.58 mL, 1.33 
x 10
-3
 mol), BA (0.127 mL, 8.85 x 10
-4 
mol), CTA (22.3 mg, 8.85 x 10
-5
 mol) and AIBN (2.90 mg, 
1.77 x 10
-5 
mol) were dissolved in 12 mL of dioxane in a dry Schlenk flask equipped with a 
magnetic stirrer bar. The mixture was deoxygenated by purging with Argon for 40 min and then 
heated to 60 
o
C for 24 h under Argon atmosphere. The reaction was stopped by cooling to 0 
o
C in 
an ice bath and exposed to air. The solution was precipitated in diethyl ether (500 mL) and filtered. 
The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-dissolving and 
precipitating process were repeated twice. The light yellow powder product was dried under high 
vacuum at room temperature for 48 h (yield = 78%).  
 
5.2.2.4 Synthesis of random copolymers. P(NIPAM196-co-DMAEA4-co-BA8-co-PEGMEA14) (C). 
NIPAM (2.00 g, 1.77 x 10
-2
 mol), DMAEA (0.068 mL, 4.42 x 10
-4
 mol), PEGMEA (0.58 mL, 1.33 
x 10
-3
 mol), BA (0.127 mL, 8.85 x 10
-4 
mol), CTA (22.3 mg, 8.85 x 10
-5
 mol) and AIBN (2.90 mg, 
1.77 x 10
-5 
mol) were dissolved in 12 mL of dioxane in a dry Schlenk flask equipped with a 
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magnetic stirrer bar. The mixture was deoxygenated by purging with Argon for 40 min and then 
heated to 60 
o
C for 24 h under Argon atmosphere. The reaction was stopped by cooling to 0 
o
C in 
an ice bath and exposed to air. The solution was precipitated in diethyl ether (500 mL) and filtered. 
The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-dissolving and 
precipitating process were repeated twice. The light yellow powder product was dried under high 
vacuum at room temperature for 48 h (yield = 81%).  
 
5.2.2.5 Synthesis of 10 nm gold nanoparticles (AuNPs).100 mL of Milli-Q water and 6 mL of 1% 
sodium citrate solution were added in a 250 mL Erlenmeyer flask, and the solution was heated to 
boil for 5 min on a hot plate with vigorous stirring. 1 mL of 1% HAuCl4 solution was then added 
rapidly, and the solution boiled for another 15 min while stirring. The colour of solution turned to a 
wine red. The AuNPs synthesized from this method give a size in the range of 10-13 nm as 
confirmed by both DLS and TEM. The solution mixture contained 5 mg of AuNP in 100 mL. 
 
5.2.2.6 Synthesis of RAFT functionalized poly (N, N-diethylacrylamide) (PDMA). RAFT (0.64 g, 
2.52 x 10
-3
 mol), AIBN (33.1 mg, 2.02 x 10
-4
 mol), DMA (25.0 g, 2.52 x 10
-1
 mol) were dissolved 
in DMSO in a 50 mL dry Schlenk flask equipped with a magnetic stirrer bar. The mixture was 
deoxygenated by purging with Argon for 30 min and then heated to 60 
o
C for 1.5 h. The reaction 
was stopped by cooling to 0 
o
C in an ice bath and exposed to the air. The solution was then diluted 
with dichloromethane (500 mL) and washed with brine (3x100 mL). The dichloromethane (DCM) 
was then dried over anhydrous MgSO4, filtered and reduced in volume by rotary evaporation. The 
polymer was recovered by precipitation into large excess of diethyl ether (1 L), and isolated by 
filtration. The polymer was re-dissolved in acetone and precipitated in diethyl ether. The re-
dissolving and precipitation process was repeated twice. The polymer was filtered and then dried 
under high vacuum for 24 h at room temperature to give a yellow powder product (yield = 71%). 
Mn = 7300, PDI = 1.14 (SEC-RI calibrated using PSTY Standards in DMAc solution containing 
0.03 wt% of LiCl), Mn = 7900 (SEC-Triple Detection, dn/dc = 0.081); Mn = 7900 (
1
H NMR). 
1
H 
NMR (500 MHz, CDCl3): δ 0.87 (CH3CH2CH2-), 1.09 (CH3-(CH-COO)-), 2.84-3.05 ((CH3)2-N-), 
3.29 (-CH2-S-(C=S)-S-), 3.60 (CH3O-(C=O)-), 5.14 (-(C=S)-S-CH-). 
 
5.2.2.7 Coating of RAFT functionalized PDMA on the gold nanoparticles. Poly (N, N-
diethylacrylamide)  (PDMA) (15.88 mg, 1.99 x 10
-6
 mol) was dissolved in 3 mL of cold Milli-Q 
water and added dropwise to 100 mL of gold solution under vigorous stir.  The final red-wine 
solution was then kept stirring for 16 hours. The polymer grafted AuNPs were purified by three 
cycles of centrifugation (40000g ) /washing/redispersing to remove unbound polymers to remove 
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excessive amount of polymers. The PDMA coated AuNPs (PDMA-AuNPs) size was determined by 
both DLS and TEM. The resulting solution was then freeze dried to get the powder-like PDMA 
coated AuNPs (PDMA-AuNPs).  
 
5.2.2.8 Hydrogel preparation. Polymers were added in cold Milli-Q water and placed in an ice 
bath to form 30 wt% solutions in a glass vial. These polymer solutions were then gradually heated 
at 1 
o
C interval in a temperature controlled water bath to temperature that the polymer solution 
transitioned to non-transparent gel (Tgel) without flowing when inverting the vial. The gels still 
maintain upon heating to 37
o
 C. 
 
5.2.2.9 Water content. Polymers were added in cold Milli-Q water and placed in an ice bath to 
form 30 wt% solutions. These polymer solutions (30 wt%) were placed in a 37
o
 C water bath for 
gelation. The formed gels were maintained at 37
o
 C for 2 h. Water expelled (supernatant) during the 
gelation and incubation was not observed, otherwise removed by cotton to give wet mass (w1), and 
the gel was then freeze-dried for 5 days to give dry mass (w2). Water content was defined as the 
difference between the wet mass (w1) and dry mass (w2) of the hydrogel.  
Water content = (w1-w2)/w1 x 100% 
The water content of each hydrogel was averaged from three repetitive experiments. 
 
5.2.2.10 Gelation temperature (oC) of polymer solution (30 wt%) determined by DSC. Polymers 
were added in cold Milli-Q water and placed in an ice bath to form 30 wt% solutions. These 
polymer solutions were loaded onto a DSC aluminium crucible cell (40 μL, Mettler Toledo 
International Inc.) and heated under nitrogen at a constant heating rate of 2 °C /min from 10° C up 
to 60° C. The transition temperature is the mid-point of inflection of the obtained DSC curves.  
 
5.2.2.11 Hydrogel degradation. Measurement the degradation of hydrogel was designed according 
to the method developed by Guan and co-workers.
27
 Polymers were added in cold Milli-Q water 
and placed in an ice bath to form 30 wt% solutions. 1.0 g of polymer solutions was transferred into 
glass vial. The vial was then placed in 37
o
 C water bath for gelation. The formed gels were 
maintained at 37
o
 C for 5 h, and 2.5 mL of 37 
o
C water was then loaded to the top of the hydrogels. 
The degradation time is the time that the hydrogels transitioned from non-transparent gel to 
transparent solutions. The degradation time of each hydrogel was averaged from three repetitive 
experiments. 
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5.2.2.12 Lower critical solution temperature (LCST) of the polymer solution (5 wt%) determined 
by observing cloud point over time. Polymers were added in cold Milli-Q water and placed in an ice 
bath to form 5 wt% solutions. These polymer solutions (5 wt%) were gradually heated in a 
temperature controlled water bath until the polymer solution became turbid (i.e., cloud point). This 
temperature was determined as the LCST of polymer. The polymer solutions were then incubated at 
37 
o
C until they became transparent solutions (i.e., polymers were degraded at 37 
o
C). The degraded 
polymer solutions were gradually heated to higher temperature to determine the LCST of the 
degraded polymer solutions. A temperature showed a later turbid point was chosen as LCST of the 
degraded polymer solution. The polymer solutions were further incubated to approximately 240 
hours to make sure the polymers were fully degraded demonstrated by a constant LCST over 
measuring times.  
 
5.2.2.13 Weight loss percentage of PDMA grafted gold nanoparticles (PDMA-AuNPs) determined 
by TGA. PDMA grafted gold nanoparticles were heated from 30 to 750 °C in TGA at a rate of 10 
°C/min. The surface density of polymer (chains/nm
2
) can be estimated by TGA according to the 
following equation.  
 
where, Wpolymer is the percent weight loss corresponding to the decomposition of polymer,  is the 
density of gold (19.32 g/cm
3
), Vparticle is the volume of gold nanoparticle calculated from the radius 
measured by DLS, NA is Avogadro‘s number, Mpolymer is the molecular weight of polymer, and 
Sparticle is the surface area of gold nanoparticle. 
 
5.2.2.14 Loading and release PDMA grafted AuNPs (PDMA-AuNPs) from thermoresponsive 
hydrogels. 0.24 mg PDMA-grafted AuNPs was mixed with 0.3 g copolymer and 0.7 g of cold Milli 
Q water in glass vial and placed in an ice bath to form 30 wt. % polymer solutions. The mixture was 
then transferred to plastic cuvette, heated up to 37 
o
C to form hydrogel and then kept at 37 
o
C for 30 
min. 2.5 mL of 37 
o
C Milli-Q water was then added to the top of the gel and the cuvette was then 
kept at 37 
o
C water bath. Triplicate samples were done for each polymer. The Absorbance (Abs) of 
PDMA grafted AuNPs diffused up to the aqueous phase on top of the hydrogel was measured by 
UV-vis at λmax= 527 nm. The Abs values at each time point was the average of three repetitive 
experiments. 
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5.2.3 Analytic methodologies 
1
H Nuclear Magnetic Resonance (NMR). All NMR spectra were recorded on Bruker DRX 500 
MHz and 300 MHz using external locks (CDCl3) and   referenced to the residual non-deuterated 
solvent (CHCl3). 
 
Size Exclusion Chromatography (SEC) and Triple Detection_ Size Exclusion Chromatography (TD-
SEC). Analysis of the molecular weight distributions of the polymers were determined using a 
Polymer Laboratories GPC50 Plus equipped with differential refractive index detector. Absolute 
molecular weights of polymers were determined using a Polymer Laboratories GPC50 Plus 
equipped with dual angle laser light scattering detector, viscometer, and differential refractive index 
detector. HPLC grade  N,N-dimethylacetamide (DMAc, containing 0.03 wt % LiCl) was used as the 
eluent at a flow rate of 1.0 mL/min. Separations were achieved using two PLGel Mixed B (7.8 x 
300 mm) SEC columns connected in series and held at a constant temperature of 50 
o
C. The triple 
detection system was calibrated using a 2 mg/mL PSTY standard (Polymer Laboratories: Mwt = 
110K, dn/dc = 0.16 mL/g and IV = 0.5809). Samples of known concentration were freshly prepared 
in DMAc + 0.03 wt % LiCl and passed through a 0.45 μm PTFE syringe filter prior to injection. 
The absolute molecular weights and dn/dc values were determined using Polymer Laboratories 
Multi Cirrus software based on the quantitative mass recovery technique.  
 
Dynamic light scattering (DLS). Measurements were performed using a Malvern Zetasizer Nano 
Series running DTS software and operating a 4 mW He-Ne laser at 633 nm. Analysis was 
performed at an angle of 173
o
. The sample refractive index (RI) was set at 1.59 for polystyrene. The 
dispersant viscosity and RI were set to 0.89 Ns.m
-2
 and 1.33, respectively. The number-average 
hydrodynamic particle size and polydispersity index are reported. The polydispersity index (PDIPDS) 
was used to describe the width of the particle size distribution. It was calculated from a Cumulants 
analysis of the DLS measured intensity autocorrelation function and is related to the standard 
deviation of the hypothetical Gaussian distribution (i.e., PDIPSD = ζ
2
/ZD
2, where ζ is the standard 
deviation and ZD is the Z average mean size). 
 
Thermogravimetric Analysis (TGA). TGA was carried out using a Mettler Toledo STARe 
instrument. Samples were heated from 30 to 750 °C at a rate of 10 °C/min.  
 
Differential scanning calorimetry (DSC). DSC was carried out on a Mettler Toledo DSC1 STARe 
System calorimeter.  
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Ultraviolet Visible Absorption (UV-vis). UVvis absorption spectra were recorded using a Cary 500 
Scan UV-vis/NIR spectrophotometer at 37 
o
C using a 1 cm plastic cuvette. 
 
Fourier Transform Infrared Spectroscopy (FTIR). FTIR spectra were recorded using a Nicolet 6700 
FTIR spectrometer 
 
Transmission Electron Microscopy (TEM). The nanostructure appearance of the polymer lattices 
was analyzed using a JEOL 1010 transmission electron microscope utilizing an accelerating voltage 
of 100 kV with spot size 6 at ambient temperature. A typical TEM grid preparation was as follows: 
A formvar precoated copper TEM grid (Proscitech) was dipped into the nanoparticle solution, the 
excess aliquot was blotted and then allowed to air dry prior imaging on TEM. 
 
5.3 Result and Discussion 
Polymer synthesis. The copolymer was synthesized by random copolymerization of four monomers 
NIPAM, DMAEA, PEGMEA, and BA. PNIPAM provides the thermoresponsive property, 
PDMAEA acts as self-degradable component, PEGMEA improves water retention, and BA 
employed to control the LCST of the copolymers. Polymerizations were conducted using the 
Reversible addition-fragmentation chain transfer (RAFT) technique (Scheme 5.1A) which allows 
control over molecular weight distributions (MWD) for a wide range of functional polymers.
34-39
 
The molecular weight of the three polymers at the peak maximum determined by RI-SEC showed 
number-average molecular weight ranging from 51000 to 55000 (Table 5.1). The slight differences 
in the molecular weights of the polymers may be due to the difference in the content of PDMAEA 
which was well consistent with difference in the mol ratios of monomer added to the reactions. In 
addition, the SEC traces in Figure 5.1 showed unimodal MWD, and the polydispersities (PDISEC-RI) 
of the three polymers were below 1.4, demonstrating that polymerization was well controlled even 
though the copolymer comprised of four monomers. The Mn values determined by triple detection 
SEC were approximately 34000 to 35000 and the polydispersity index by triple detection SEC 
(PDISEC-TP) for all three polymers was less than 1.05, which was found to be a slight 
underestimation when compared to the PDISEC-RI (see Table 5.1).   
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Table 5.1 Molecular weights, polydispersities index (PDISEC), and 
1
H NMR data of RAFT 
polymerization of thermoresponsive random copolymers at 60 
o
C in dioxane. 
NIPAM]:[DMAEA]:[BA]: 
[PEGMEA]:[CTA]:[AIBN]
a
 
SECb 1H NMR 
 
RI 
Triple 
detectionc 
Repeating units 
Mn
h 
Percentage 
of 
DMAEA 
(mol %) 
Mn PDI Mn PDI 
NIPAM 
d 
DMA
EAg 
BAe 
PEG
MEA f  
A 200:15:10:15:1:0.2 54700 1.34 35200 1.04 198 12 8 14 32000 5.17 
B 200:10:10:15:1:0.2 54100 1.32 34500 1.03 196 9 8 13 31100 3.98 
C 200:5:10:15:1:0.2 51000 1.34 34200 1.03 196 4 8 14 30600 1.80 
 
a 
CTA concentration was 8.85 x 10
-5
 mol. 
b 
SEC data measured in DMAc solution with 0.03 wt% of LiCl and using PSTY standards for 
calibration. 
c 
Triple detection data measured based on the dn/dc calculated from the polymers‘ concentration. 
d 
Repeating units of NIPAM (NNIPAM) determined by 
1
H NMR were calculated based on the 
conversion of NIPAM. The conversion of NIPAM was calculated based on the 
1
HNMR spectra in 
Figure A5.3 with integral area of the peak at 1.08 ppm (I1.08) and the peak a 5.57 ppm (I5.57)  using 
the following equation: 1- (6 x I5.57/I1.08). Repeating units of NIPAM (NNIPAM) = mol feeding ratio 
of NIPAM x conversion of NIPAM = 200 x [1- (6 x I5.57/I1.08)] 
e 
Repeating units of BA (NBA) determined by 
1
H NMR were calculated based on the repeating unit  
of NIPAM (NNIPAM) and the integral area of the peak at 1.08 ppm (I1.08) and the peak at 0.88 ppm 
(I0.88) using the following equation: NBA = [2 x NNIPAM x (I0.88-3)] / I1.08 
f 
Repeating units of PEGMEA (NPEGMEA) determined by 
1
H NMR were calculated based on the 
repeating unit  of NIPAM (NNIPAM) and the integral area of the peak at 1.08 ppm (I1.08)  and the 
peak at 3.34 ppm (I3.34) using the following equation: NPEGMEA = [2 x NNIPAM x (I3.34 -2)]/I1.08 
g 
Repeating units of DMAEA (NDMAEA) determined by 
1
H NMR were calculated based on the 
NNIPAM , NBA, NPEGMEA and the integral area of the peak at 1.08 ppm (I1.08) and the peak in the range 
3.95-4.30 ppm (I3.95-4.30) using the following equation: NDMAEA =[3 x NNIPAM x (I3.95-4.30 – (NNIPAM 
+2 x NBA+ 2 x NPEGMEA))]/I1.08 
h 
Molecular weight determined by 
1
H NMR were calculated based on the repeating units of NNIPAM, 
NDMAEA, NBA, NPEGMEA and the molecular weight of CTA: Mn = (NNIPAM x 113) + (NDMAEA x 143) + 
(NBA x 128.2) + (NPEGMEA x 480) + 252. 
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Figure 5.1 Size Exclusion Chromatography (SEC) traces, A: P(NIPAM198-co-DMAEA12-co-BA8-
co-PEGMEA14), B: P(NIPAM196-co-DMAEA9-co-BA8-co-PEGMEA13), C: P(NIPAM196-co-
DMAEA4-co-BA8-co-PEGMEA14). The data were measured by DMAc SEC. The intensity for 
different distribution curves was normalized. 
 
The three polymers were also characterized by 
1
H NMR to confirm the structure as well as the 
composition of the copolymers. Acrylate protons are usually used in the calculation of the polymers 
conversion. In this work, due to the overlap of most peaks assigned for acrylate protons of the 
monomers, the conversion of DMAEA, PEGMEA, and BA monomers were not able to be directly 
determined from  
1
H NMR of unpurified samples. Only conversion of the NIPAM was able to be 
calculated by this method. The conversion of PNIPAM, approximately 98.9%, was determined 
based on the isolated peaks at 5.54 ppm and 1.12 ppm, which were respectively assigned for the 
acrylamide proton of NIPAM monomer (b) and methyl groups (d, g) for both the NIPAM monomer 
and the polymer (Figure A5.1 in Appendix D). 
1
H NMR spectra of purified and dried polymer 
samples were then used to calculate the repeating units of the segments in the copolymers. The 
1
H 
NMR spectra showed that most of the peaks assigned for the RAFT agent, which are usually used 
as a calibration value in calculating the repeating units of polymer synthesized by RAFT, were 
overlapped with the polymers peaks (Figure 5.2). The repeating unit of PNIPAM, obtained from the 
conversion of NIPAM was thus used as calibration in determination of the repeating units of the 
other segments in the copolymers (see Table 5.1). The results show that the content of NIPAM, 
PEGMEA, and BA was similar for the three polymers while the content of DMAEA steadily 
decreased with 5.17, 3.98, and 1.80 mol % for polymer A, B, and C, respectively. This 
demonstrates that the composition of the polymers was well controlled. The Mn values for all 
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polymers determined by 
1
H NMR were relatively close to those found by triple detection SEC. This 
data further confirms that the chain lengths of three polymers were almost identical and that small 
variations in the polymer chain lengths resulted from the differences in the content of PDMAEA 
among the three polymers. 
 
A B
C
 
Figure 5.2 
1
H NMR spectrum of A: P(NIPAM198-co-DMAEA12-co-BA8-co-PEGMEA14), B: 
P(NIPAM196-co-DMAEA9-co-BA8-co-PEGMEA13), and C: P(NIPAM196-co-DMAEA4-co-BA8-co-
PEGMEA14) in CDCl3.  
 
Hydrogel preparation and thermal properties. Hydrogels were prepared by dissolving copolymers 
in Milli-Q water in an ice bath to obtain 30 wt% copolymer solutions in glass vials and gradually 
heated in a temperature controlled water bath to the temperature that the transparent polymer 
solution transitioned to a non-transparent gel (Scheme 5.1B). The gelation temperature (denoted as 
Tgel) is determined when the vial is inverted and the gel shows no flow for 1 min.
40, 41
 The gelation 
temperatures (Tgel) of the three polymers were 34, 33, and 32 
o
C for polymer A, B and C, 
respectively (see Table 5.2).  
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Table 5.2 Thermo transition temperature of polymer solutions (30 wt%) and water content, and 
degradation time of hydrogels at 37 
o
C.  
Polymer 
code 
Tgel (
o
C) 
determined by 
vial invert 
a
  
Tgel (
o
C) 
determined by 
DSC 
Water content 
(%) 
b
 
Degradation time 
(h) 
c
 
A 34 33 70.13±0.13 86.0±2.0 
B 33 32.5 69.37±0.17 108.6±2.3 
C 32 32 68.55±1.35 158.66±3.06 
 
a
Tgel was determined by observing the formation of gel without flowing while inverting the glass 
vial. 
b
The water content of each hydrogel was an average of three repetitive water content 
experimentscalculated by using the equation showed in the experimental.
 c
The degradation time is 
the time that the all hydrogel completely become solution. The result was averaged from three 
repetitive experiments. 
 
The gel state of the three polymers still maintained upon heating to 37 
o
C. Furthermore, the formed 
gel can reversely change to the sol state upon cooling below Tgel (Scheme 5.1B) showing typical 
reversible characteristic of thermoresponsive hydrogels. It is reported that the formation of 
thermoresponsive hydrogels is the result of chain entanglement and hydrophobic interactions, which 
form as junctions of collapsed copolymer globules at above LCST.
19
 A lower polymer 
concentration 25 wt% was also prepared to test hydrogel formation. However, the solution only 
became turbid and flowed when inverting the vials at 37 
o
C indicating that the concentration of 
polymer may not sufficient to induce gelation. Therefore, 30 wt% is the minimum concentration 
required of these copolymers to be able to form stable gels 
The sol to gel transition temperature of the polymer solutions was further determined by DSC. The 
DSC data in Figure 5.3 showed that the gelation temperature of all three polymer solutions were 
below body temperature, decreased from 33 
o
C (for polymer A) to 32.5 
o
C (for polymer B), and 32 
o
C (for polymer C) corresponding with decrease of hydrophilic DMAEA percentage in the 
copolymers from 5.17 to 3.98, and 1.8 mol %, respectively. This data matched quite well with the 
gelation temperature obtained from the vial inverting method that was determined by visible 
observation (see Table 5.2).  
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Figure 5.3 Thermo transition temperature (
o
C) of the hydrogel (polymer weight fraction 30 wt%) 
measured by DSC (heating rate of 2 
o
C min
-1
). The transition temperature is the middle point of the 
DSC curve. 
 
Water content. It has been found that the Tgel of the polymer was affected by the composition of the 
hydrogel.
30, 42-44 
The more hydrophobic components in the copolymer results in the lower Tgel while 
greater hydrophilicity in the copolymer leads to higher Tgel.
 
In our work, because the composition of 
NIPAM, PEGMEA, and BA were similar for the three polymers, the small change in Tgel of the 
three polymer solutions mainly resulted from the little difference in the amount of hydrophilic 
PDMAEA in the three polymers. Increasing the DMAEA content resulted in the increase of the Tgel 
due to the higher amount of hydrophilic components. 
 
Hydrogel degradation. The degradation time of the hydrogel was investigated after loading pre-
warm Milli-Q water on the top of 1.0 g of freshly formed hydrogels at 37 
o
C. The hydrogel 
periphery layer that was in contact with water gradually degraded until the total gel completely 
changed to the solution state. This process can be named as a surface-to-core degradation.
27 
Basically, the DMAEA units in the copolymers on the gel surface which is in contact with the large 
amount of free water started to degrade and the gel became solution. The process took place from 
the gel surface to the core and finally became solution at 37 
o
C, which coincides with previous 
reported gel degradation profiles.
27
 It is worth to note that the similar copolymer systems (e.g., 
diblock or star copolymers of poly(ethylene glycol) (PEG) and PNIPAM) which did not contain 
DMAEA units can also form hydrogels but are not able to degrade over time.
17
 The complete 
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degradation time of the three hydrogels increased with the decrease of mol% of DMAEA. The 
degradation time for polymer A (5.17 mol%) was 86 h, polymer B (3.98 mol%)108 h, and polymer 
C (1.80 mol%) 158 h (Table 5.2). It is expected that the formation of carboxylic acid groups after 
the self-catalysed hydrolysis of PDMAEA side groups increases the LCST of the copolymers, thus 
increases the gelation temperature of the polymers. When the amount of carboxylic groups 
increases sufficiently to shift the gelation temperature above 37 
o
C, the polymers become soluble 
and diffuse into water.
9, 11-13, 20, 27, 30, 43, 45, 46
 The evidence of increase in the gelation temperature of 
the polymers was supported by the change in the LCST (i.e., cloud point) of 5wt% polymer 
solutions over time (Figure A5.2).    
 
Gold nanoparticles synthesis and functionalization. In order to study the loading and release 
properties of the novel hydrogels, polymer-coated gold nanoparticles were synthesized. Gold 
nanoparticles (AuNPs) with a diameter of ~ 10 nm were synthesized by adding HAuCl4 solution to 
a boiling solution of trisodium citrate (Na3Ct) under vigorous stirring.
47
 Gold nanoparticles obtained 
were covered by citrate ions which adsorbed onto the naked AuNPs surface during synthesis. The 
size and the uniformity of the gold nanoparticles were determined by both TEM and DLS. The 
results from DLS showed that the AuNPs was successfully prepared with a particle size of about 
11.27 nm. The polydispersity index (PDIDLS) of the gold nanoparticles was 0.096 suggesting that 
the particle size distribution was narrow (values <0.1 represents distributions that are narrow) (see 
Table 5.3). TEM showed that the spherical AuNPs had a diamerter of approximately 12.40 nm 
supporting for the results obtained from DLS (Figure 5.4A).  
 
Table 5.3 Diameter (Dh) and polydispersities index (PDIDLS), weight loss and surface density of 
gold nanoparticles (AuNPs) before and after functionalization with PDMA (PDMA-AuNPs). 
Material 
DLS
a
 
TEM (nm) 
TGA 
Dh (nm) PDIDLS 
Weight loss 
(%) 
b
 
Surface 
density of 
PDMA-AuNPs 
(chains/nm
2
)
c
 
Bare AuNPs 11.27 ± 0.53 0.096 12.40 - - 
PDMA-AuNPs 26.55 ± 0.97 0.070 20.00 24.51 0.898 
 
a
The Dh and PDIDLS were averaged from five measurement on DLS. 
b
Weight loss was determined 
from TGA. 
c
Surface density of the polymer on AuNPs was calculated based  weight loss, molecular 
weight of polymer, and diameter of AuNPs.  
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To increase the compatibility  as well as stability of the AuNPs,  polymer-functionalized AuNPs 
was synthesized by ―grafting to‖ approach  in which the thiol groups araised from polymer can 
strongly affinity bind  to gold via chemisorption.
47-54
 RAFT functionalized PDMA was employed 
for this purpose because PDMA not only is high soluble to effectively stabilize the AuNPs but also 
contains trithiocarbonate end- group (from RAFT agent) that can be converted to thiol groups to 
bind to AuNPs (Scheme 5.2).  
 
Scheme 5.2 PDMA functionalized gold nanoparticles AuNPs (PDMA-AuNPs). 
 
AuNP AuNP
Self-assembly
 
 
RAFT-PDMA was synthesized with a number-average molecular weight (Mn) of 7900 (RI-SEC) 
which was close to that measured by 
1
H NMR (
1
H NMR, Mn=7900 giving 78 units of DMA by 
accounting for the molecular weight of the RAFT agent), and polydispersity index (PDIRI-SEC) was 
1.14. In 
1H NMR spectrum of PDMA, the two protons associated with the RAFT agent‘s R (e) and 
Z (a) groups were observed at 3.60 and 0.87 ppm, respectively, which demonstrated that most of the 
polymer chains were functionalized by RAFT (Figure A5.3). 
To coat the PDMA on the AuNPs surface, the polymer was dissolved in water and added dropwise 
into the AuNPs solution under stirring for 16 h. The PDMA-AuNPs solution then underwent three 
cycles of centrifugation/washing/redispersing to remove unbound polymers. The purified PDMA-
AuNPs were collected and resuspended in water to measure DLS and TEM. The DLS data showed 
that the diameter of AuNPs (PDMA-AuNPs) increased to approximately 26.5 nm with a very 
narrow size distribution (PDIDLS =0.07) suggesting that the PDMA was grafted onto AuNPs and 
provided steric stabilization to AuNPs (see Table 5.3).  TEM images in Figure 5.4B also showed 
that the spherical shape of AuNPs was preserved with no aggregation after grafting with PDMA. 
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Figure 5.4 TEM of bare gold nanopartciles (AuNPs) (A) and PDMA grafted gold nanopartciles 
(PDMA-AuNPs) (B).  
 
The purified PDMA-AuNPs solution was also freeze-dried to obtain the powder-like PDMA-
AuNPs. The PDMA-AuNPs product was then characterized by ATR-FTIR. The appearance of the 
C=O stretching vibration at approximately 1700 cm
-1
, and N-H stretching vibration at about 3400 
cm
-1
 on the spectrum of PDMA-grafted AuNP supported that the PDMA was grafted onto the 
AuNPs. (Figure 5.5).   
C=O
C-O
 
Figure 5.5 ATR-FTIR of pure PDMA and PDMA grafted AuNPs. 
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TGA was employed to determine the number of polymer chains bound to one AuNP (chains/nm
2
) 
(Figure A5.4). Approximately 24.5 wt% of grafted polymer was decomposed at 380 
o
C resulting in 
a relatively high graft density at 0.898 chains/nm
2
 which was calculated based on the following 
equation: surface density of polymer (chain/nm
2
) =  
 
where, Wpolymer is the percent weight loss corresponding to the decomposition of polymer,  ρ is the 
density of gold (19.32 g/cm
3
), Vparticle is the volume of gold nanoparticle calculated from the radius 
measured by TEM, NA is Avogadro‘s number, Mpolymer is the molecular weight of polymer, and 
Sparticle is the surface area of gold nanoparticle. This high grafting density provided further evidence 
that the AuNPs were successfully coated with PDMA. 
 
Loading and release of PDMA functionalized gold nanoparticles (PDMA-AuNPs) from hydrogel. 
These PDMA-AuNPs were encapsulated in 1.0 g of the hydrogel by mixing PDMA-AuNPs at 2 
o
C 
and then heating up to 37 
o
C.  Pre-warmed water was loaded onto the top of the gel and incubated at 
37 
o
C. During the process of the polymer hydrolysing at 37 
o
C as well as the hydrogel degrading, 
the PDMA-AuNPs were able to be released from the hydrogel. The release experiment was carried 
out in a 4 mL cuvette that allowed the UV-vis beam passing through the middle of the cuvette 
where the water phase occupied. The percentage of released AuNPs was determined by measuring 
the absorbance (Abs) of AuNP in water phase at λ527nm.  
 
Chapter 5 
 
113 
 
 
Figure 5.6 Released profile of PDMA-grafted gold nanoparticles (PDMA-AuNPs) from the 
hydrogels. 
 
Figure 5.6 showed that, under same condition, the release rates of PDMA-AuNPs from gels A, B 
and C were different. The more DMAEA units resulted in the faster release rates of AuNPs. This 
result suggests that the release rate of AuNPs can be regulated by the amount of DMAEA 
component. The time taken to completely release the AuNPs from hydrogels A, B, and C were 72 h, 
115 h, and 163 h, respectively (Table 5.4). The release time relatively correlated with the 
degradation time of hydrogels (without loading PDMA-AuNPs) presented in Table 5.2. This result 
confirms that the polymer is fully degraded and is completely in solution. 
 
Table 5.4 The release time of PDMA-grafted gold NPs from the hydrogels. 
Polymer code Release time of PDMA-AuNPs (h)
a
 
A 72 
B 115 
C 163 
 
a
The release of PDMA-AuNPs from hydrogels was determined by UV-vis for three repetitive 
samples.  
 
The release profiles once again proved that the erosion of the hydrogels initially occurred on the top 
layer and then gradually invaded to the successive layers. When the polymer layer at the interphase 
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of hydrogel and water were hydrolysed leading to elevation in the LCST over 37 
o
C, the polymer 
became soluble, allowing the PDMA-AuNPs to diffuse out of the gel. However, the release profiles 
may be different when thin film hydrogels or microgels are produced from these copolymers. 
 
5.4 Conclusion 
 We have developed a hydrogel system from injectable thermoresponsive random copolymer 
P(NIPAM-co-DMAEA-co-PEGMEA-co-BA) with a non-triggerred release characteristic. The 
copolymer solutions transitioned from sol state at below 37 
o
C to opaque gel state at 37 
o
C. The 
hydrogels were formed without syneresis. The hydrogels degraded over time due to self-catalysed 
hydrolysis of the PDMAEA side chains. Furthermore, the degradation time of the hydrogel can be 
controlled by varying the number of DMAEA units. The gelation temperature of the copolymers 
increased with higher DMAEA content resulting in shorter degradation times of the gels. PDMA 
functionalized gold nanoparticles (PDMA-AuNPs) were employed as a model drug to investigate 
drug loading and release from the hydrogels. The release of PDMA-AuNPs from the hydrogels was 
quite effective. Furthermore, the release profile indicates that the hydrogels were able to load and 
gradually release the gold nanoparticles at different rates through their different degradation times. 
Further investigation into copolymer compositions and types of gels may provide a better 
understanding of the mechanisms involved in the gels degradation and control over the release of 
the encapsulated materials.  
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Chapter 6 
Summary 
The main objective of the work described in this thesis was to synthesize and study novel timed-
release polymeric micelles and hydrogels based on thermoresponsive PNIPAM and self-degradable 
PDMAEA. In particular, the efforts was put towards the understanding of the self-assembly and 
self-disassembly characteristic of thermoresponsive PNIPAM in the presence of self-degradable 
components and other factors such as hydrophilic and hydrophobic contents as well as surfactants. 
Such understanding established some general design principles to serve as guidelines for developing 
the next generation of nanocarriers with controllable timed-release characteristics. 
 
6.1 Novel timed-release polymer nanoparticles with controllable disassembly time. 
The first step towards meeting the overall goals of the project, thermoresponsive PNIPAM and self-
degradable  PDMAEA were combined with hydrophobic polymers to regulate the LCST and 
disassembly time of thermoresponsive PNIPAM, and thus control the release time of oligo DNA 
(i.e., a mimic of siRNA) from the polymer complex. Reversible addition-fragmentation chain 
transfer (RAFT) polymerization was employed to synthesize the diblock thermoresponsive 
copolymers which consisted of a hydrophilic block (e.g., PDMA) for stabilization and a second 
thermoresponsive block with three components (e.g., NIPAM, DMAEA, and BA or Styrene) for 
self-assembly and disassembly. The copolymers were fully water-soluble below LCST and self-
assembled into approximately 25-nm nanoparticles with very narrow particle size distribution, 
measured by Dynamic Light Scattering (DLS), above the LCST (e.g., 37 
o
C). The polymer 
nanoparticles can sharply disassembled to unimers ~5 nm (i.e., the core of the copolymer became 
water soluble) when the amount of negatively charged poly (acrylic acid) (PAA) that transformed 
from the self-catalytic degradation of cationic PDMAEA was sufficiently high to increase the LCST 
of the copolymers above 37 °C. These nanoparticles excellently bound to oligo DNA through ionic 
interactions without any leakage and released through the ionic repulsion after full degradation of 
the polymers or sharp disassembly of the nanoparticles. Interestingly, the disassembly time of the 
nanoparticles and consequently the release time of oligo DNA could be precisely controlled. These 
particles could be easily modified with folic acid to enhance cellular uptake by osteosarcoma cells. 
 
6.2 The effect of copolymers components and surfactants on timed-release nanoparticles 
The next step is to understand the effect of hydrophilic and self-hydrolysis DMAEA components as 
well as hydrophobic components on the timed-release nanoparticles. The disassembly time (tstart) 
and time from the start of disassembly to full unimer formation (tdegrade) of the polymer 
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nanoparticles could be controlled by manipulating the number of self-degradable DMAEA units and 
hydrophobic BA units in the copolymer. Increasing BA units resulted in longer tstart while adding 
more DMAEA units made the tdegrade shorter. The self-catalysed hydrolysis of the PDMAEA side 
groups to acrylic acid groups increased the LCST of the polymer to over 37 
o
C over time and was 
postulated as the mechanism of degradation of PDMAEA. In addition, the polymer could be 
designed to self-assemble into nanoparticles over a wide range of pHs and disassemble to unimers 
below a pH of 7.3. The polymer nanoparticles have potential for application in drug and gene 
delivery where one or more therapeutic agents can be released at desired times. 
The stabilization and self-disassembly of large thermoresponsive particles self-assembled from the 
random copolymer of thermoresponsive PNIPAM, hydrophobic PBA or PSTY and self-catalytic 
degradation PDMAEA were further investigated in the presence of surfactant. The random 
copolymers (P(NIPAM-co-DMAEA-co-BA) and P(NIPAM-co-DMAEA-co-STY)) were 
synthesized via one-pot RAFT polymerization. The polymers could self-assemble into large 
nanoparticles with very narrow size distribution demonstrated a well stabilization as provided by 
SDS. Interestingly, the polymer particle size increased with the increase in SDS concentration, and 
these nanoparticles were stable upon intensive dilution. Moreover, the LCST of the polymers were 
controlled by not only the polymers composition (i.e., lower hydrophobic segment in the 
copolymers resulted in higher LCST) but also the concentration of the SDS. An increase in the 
amount of SDS resulted in higher number of hydrophobic interactions between the SDS and 
PNIPAM molecules, and hence the LCST of copolymers were also raised. Additionally, the self-
degradation of DMAEA as well as the self-disassembly characteristic of the polymer nanoparticles 
were not influenced by the SDS. The polymer nanoparticles sharply disassembled to unimers when 
the LCST of the polymer elevated to above the conducting temperature (e.g., 37 
o
C).  
 
6.3 Novel self-degradable hydrogel 
In the final step of this thesis, self-degradable polymeric hydrogel from random copolymers of 
thermoresponsive PNIPAM self-catalytic degradation PDMAEA, hydrophilic PEGMEA, and 
hydrophobic PBA were designed based on the understanding of controllably timed-release polymer 
nanoparticles. The three copolymers were also synthesized via RAFT polymerization with varying 
the initial concentration of monomer DMAEA in the reactions and keeping the concentration of the 
other reactants (i.e., NIPAM, PEGMEA, and BA) constant. The compositions of obtained 
copolymers were also controllable in which the units of NIPAM, PEGMEA, and BA were similar 
for the three copolymers, and the variation in the units of DMAEA for the three polymers was 
consistent with that in the initial composition added to the three polymerizations.  The 
thermoresponsive copolymers could form stable gel at the temperatures higher than the gelation 
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point (e.g., 37 
o
C) and then self-degraded into sol state after different times without the need of any 
triggers. Moreover, there was a dependence of gelation temperature as well as degradation time on 
the number of DMAEA units. Higher DMAEA units in the copolymer resulted in higher gelation 
temperature and faster degradation time. To test the encapsulation and release ability of the 
hydrogels, the gold nanoparticles coated with PDMA (PDMA-AuNPs) were chosen as a model.  
The encapsulated PDMA-AuNPs gradually released at different rates through the degradation of the 
hydrogels. These results suggest that this novel non-triggered release hydrogel has promising 
potential in applications where controlled-release is beneficial. 
Appendix A 
122 
 
Appendix A 
 
Scheme A2.1. Self-catalyzed hydrolysis of Poly(2-dimethylaminoethyl acrylate).  
 
 
 
Scheme A2.2 Synthesis of folic acid functional copolymer E
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Table A2.1 Molecular weights, polydispersities (PDI), and 
1
H NMR data of RAFT polymerization of thermo responsive block copolymers at 60 
o
C in 
Dioxane. 
Polymer code 
a 
 
SEC
b
 
1
H NMR 
RI Triple detection
c
 Repeating units 
Mn
i
 
Percentage of 
BA or STY (%)
k
 Mn PDI Mn Mw NIPAM
d
 DMAEA BA
e
 STY
f
 
A P(DMA96-b-(NIPAM87-co-DMAEA25)) 34500 1.23 23800 24000 87 25
g
 - - 23175 - 
B1 P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)) 36200 1.24 28500 28900 88 25
h
 6 - 24057 5.04 
B2 P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)) 36700 1.26 24000 24300 91 25
h
 12 - 25165 9.38 
C1 P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5)) 34300 1.32 24800 25700 84 22
g
 - 5 22927 4.50 
C2 P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)) 24700 1.27 24100 24900 40 15
g
 - 13 17786 19.11 
 
a 
PDMA (Macro-CTA) with repeating unit = 96; Mn = 9769 calculated from
1
H NMR. 
b
 SEC data measured in DMAc solution with 0.03 wt% of LiCl and using PSTY standards for 
calibration.
c Triple detection data measured based on the dn/dc calculated from the polymers‘ concentration.d Repeating units of NIPAM (NNIPAM) determined by 
1
H NMR were 
calculated based on 96 repeating unit of Macro-CTA by the integral area of a peak at 1.08 ppm (I1.08) and a peak in the range 2.85-3.07 ppm (I2.85-3.07) using the following equation: 
NNIPAM = 96 x I1.08  /I2.85-3.07 .
e
 Repeating units of BA (NBA) determined by 
1
H NMR were calculated based on 96 repeating unit of Macro-CTA by the integral area of a peak at 0.88 
ppm (I1.08) and a peak in the range 2.85-3.07 ppm (I2.85-3.07) using the following equation: NBA = (96 x 2 x I0.88 / I2.85-3.07) – 1.
f 
Repeating units of STY (NSTY) determined by 
1
H NMR 
were calculated based on 96 repeating unit of Macro-CTA  and the NNIPAM by the integral area of the peak in the range 6.20-7.18 ppm (I6.20-7.18) and the peak in the range 2.85-3.07 
ppm (I2.85-3.07) using the following equation: NSTY =[( 96 x 6 x I6.20-7.18)/I2.85-3.07 - NNIPAM]/5.
g
 Repeating units of DMAEA (NDMAEA) determined by 
1
H NMR were calculated based on 
96 repeating unit of Macro-CTA and the NNIPAM by the integral area of the peak in the range 2.85-3.07 ppm (I2.85-3.07) and the peak in the range 3.95-4.30 ppm (I3.95-4.30) using the 
following equation: NDMAEA = [(96 x 6 x I3.95-4.30 / I2.85-3.07) – NNIPAM]/2.
h
 Repeating units of DMAEA (NDMAEA) determined by 
1
H NMR were calculated based on 96 repeating unit of 
Macro-CTA, and the NNIPAM and NBA by the integral area of the peak in the range 2.85-3.07 ppm (I2.85-3.07) and the peak in the range 3.95 - 4.30 ppm (I3.95-4.30) using the following 
equation:  NDMAEA = [(96 x 6 x I3.95-4.30/I2.85-3.07) – (NNIPAM + 2 NBA)]/2 
i 
Molecular weight determined by 
1
H NMR were calculated based on the repeating units of NNIPAM, NBA or NSTY ,NDMAEA, and the molecular weight of macro-CTA: Mn = (NNIPAM x 
113) + (NBA x 128.2) or (NSTY x 104) + (NDMAEA x 143) + 9769.
k 
Percentages of BA or STY were calculated  based on NDMAEA ,NNIPAM ,NBA or NSTY: Percentage of BA = 
NBA/(NDMAEA + NNIPAM + NBA) and percentage of STY = NSTY/(NDMAEA + NNIPAM + NSTY). 
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Table A2.2 Hydrodynamic diameter (Dh), Polydispersities (PDIs) of thermoresponsive block copolymers / Oligo DNA 9-27 complexes in Milli-Q 
water at N/P Ratio 0.5, 1, 2, 5, and 10 with 1 μg DNA. Measurements were carried out on DLS machine. 
N/P ratio 
Complexed polymers 
B1/oligo DNA at 37 
o
C  
Complexed polymers B2/oligo 
DNA at 37 
o
C  
Complexed polymers C1/oligo 
DNA at 37 
o
C  
Complexed polymers C2/oligo 
DNA at 37 
o
C  
Dh (nm) PDI Dh (nm) PDI Dh (nm) PDI Dh (nm) PDI 
0.5 30.33 ± 6.58 0.413 27.16 ± 2.14 0.356 11.10 ± 1.01 0.453 17.20 ± 4.29 0.389 
1 29.49 ± 3.44 0.337 27.35 ± 1.23 0.218 24.03 ± 1.07 0.400 24.53 ± 0.86 0.243 
2 14.75 ± 4.24 0.450 24.21 ± 0.24 0.240 9.021 ± 2.40 0.430 24.20 ± 1.33 0.361 
5 17.72 ± 8.74 0.488 25.56 ± 0.70 0.168 8.872 ± 2.74 0.560 23.75 ± 0.58 0.214 
10 27.21 ± 0.20 0.048 29.12 ± 1.02 0.071 29.27 ± 0.69 0.080 20.76 ± 0.54 0.110 
 
B1: P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)), B2: P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)), C1: P(DMA96-b-(NIPAM84-co-DMAEA22-
co-STY5)), C2: P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)). Data were reported as soluble polymers in Milli-Q water were incubated with DNA 
at N/P Ratio 0.5, 1, 2, 5, and 10 at below their LCST for 30 min prior to be measured at 37 
o
C on DLS machines. Data were reported as an average of 
five measurements. The mean standard of deviation of polymer particle sizes was calculated from five measurements.  
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Table A2.3 Molecular weights, polydispersities (PDI), and 
1
H NMR data of RAFT polymerization of thermo responsive random/block copolymers at 
60 
o
C.  
Polymer code 
SEC
a 1H NMR 
RI Triple detectionb Repeating units 
Mn 
Mn PDI Mn Mw NIPAM
c BAd DMA
e
 
D P(NIPAM97-co-BA13) 28700 1.16 15900 16100 97 13 - 12880
f 
E P(DMA99-b-(NIPAM97-co- BA13)) 38500 1.19 26900 27200 - - 99 22694
g 
 
a
 SEC data measured in DMAc solution with 0.03 wt% of LiCl and using PSTY standards for calibration. 
b Triple detection data measured based on the dn/dc calculated from the polymers‘ concentration. 
c
 Repeating units of NIPAM (NNIPAM) determined by 
1
H NMR were calculated by the integral area of a peak at 1.12 ppm (I1.12) and a peak at 3.64 ppm 
(I3.64) using the following equation: NNIPAM = I1.12  /(2 x I3.64)  
d
 Repeating units of BA (NBA) determined by 
1
H NMR were calculated by the integral area of a peak at 0.89 ppm (I0.89) and a peak at 3.64 ppm (I3.64) 
using the following equation: NBA = (I0.89 / I3.64) – 1 
e 
Repeating units of DMA (NDMA) determined by 
1
H NMR were calculated based on NBA by the integral area of the peak in the range 2.86-3.07 ppm 
(I2.86-3.07) and the peak at  0.89 ppm (I0.89) using the following equation: NDMA =[((NBA + 3) x I2.86-3.07)/(I0.89  x 6)] 
f 
Molecular weight determined by 
1
H NMR were calculated based on the repeating units of NNIPAM, NBA and the molecular weight of MCEBTTC: Mn = 
(NNIPAM x 113) + (NBA x 128.2) + 252.42 
g 
Molecular weight determined by 
1
H NMR were calculated based on the repeating units of NDMA and the molecular weight of macro-CTA: Mn = 
(NDMA x 99.131) + 12880. 
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Table A2.4 Lower critical solution temperature (LCST), hydrodynamic diameter (Dh), 
Polydispersities (PDI) for thermoresponsive block copolymers (E) and conjugation of 
(aminopropyl)methacrylamide-click-PDMA-b-P(NIPAM-co-BA) and folic acid (H) determined by 
dynamic light scattering (DLS). 
 
 
 
a
LCST determined by DLS (10 mg/mL) 
b
Hydrodynamic diameter (Dh) and Polydispersity (PDI) determined by DLS (10 mg/mL) at 37 
o
C.  
Polymer code DLS 
LCST (
o
C)
a
 Dh (nm)
b
 PDI
b
 
E 13 – 15 33.83 ± 0.65 0.017 
H 15 – 19 31.66 ± 0.98 0.089 
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Figure A2.1 Size Exclusion Chromatography (SEC) traces of  macro CTA; PDMA96, A; P(DMA96-
b-(NIPAM87-co-DMAEA25)), B1; P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)), B2; P(DMA96-
b-(NIPAM91-co-DMAEA25-co-BA12)), C1; P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5)), C2; 
P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)). The data were measured by DMAc SEC. The 
intensity for different distribution curves was normalized. 
 
Figure A2.2 
1
H NMR spectrum of Macro-CTA: PDMA96 in CDCl3. 
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Figure A2.3 
1
H NMR spectrum of A: P(DMA96-b-(NIPAM87-co-DMAEA25)) in CDCl3. 
 
Figure A2.4 
1
H NMR spectrum of B1: P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)) in CDCl3. 
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Figure A2.5 
1
H NMR spectrum of B2: P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)) in CDCl3. 
 
Figure A2.6 
1
H NMR spectrum of C1: P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5)) in CDCl3. 
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Figure A2.7 
1
H NMR spectrum of C2: P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)) in CDCl3. 
 
Figure A2.8 
1
H NMR spectrum of A: P(DMA96-b-(NIPAM87-co-DMAEA25)) after being dissolved 
in D2O and immediately measured at 25 
o
C. 
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Figure A2.9 
1
H NMR spectrum of A; P(DMA96-b-(NIPAM87-co-DMAEA25)) after being dissolved 
and kept in D2O for 80 h. The spectrum was measured at 25 
o
C. 
 
Figure A2.10 
1
H NMR spectrum of B1: P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)) after being 
dissolved in D2O and immediately measured at 25 
o
C. 
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Figure A2.11 
1
H NMR spectrum of B1: P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)) after being 
dissolved and kept in D2O for 80 h. The spectrum was measured at 25 
o
C. 
 
Figure A2.12 
1
H NMR spectrum of B2: P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)) after 
being dissolved in D2O and immediately measured at 15 
o
C. 
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Figure A2.13 
1
H NMR spectrum of B2: P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)) after 
being dissolved and kept in D2O for 80 h. The spectrum was measured at 25 
o
C. 
 
Figure A2.14 
1
H NMR spectrum of C1: P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5)) after 
being dissolved in D2O and immediately measured at 25 
o
C. 
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Figure A2.15 
1
H NMR spectrum of C1: P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5 after being 
dissolved and kept in D2O for 80 h. The spectrum was measured at 25 
o
C. 
 
Figure A2.16 
1
H NMR spectrum of C2: P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)) after 
being dissolved in D2O and immediately measured at 15 
o
C. 
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Figure A2.17 
1
H NMR spectrum of C2: P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)) after 
being dissolved and kept in D2O for 80 h. The spectrum was measured at 25 
o
C. 
 
Figure A2.18 DOSY NMR spectrum of C1: P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5)) after 
being dissolved in D2O for 80h. The spectrum was measured at 25 
o
C. 
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Figure A2.19 Degradation kinetic of A: P(DMA96-b-(NIPAM87-co-DMAEA25)). The data were 
averaged from five measurements on DLS machine at polymer solution concentration 5 mg/mL at 
45 
o
C. 
 
Figure A2.20 LCST of A: P(DMA96-b-(NIPAM87-co-DMAEA25)). The data were reported as 
average numbers from five measurements on DLS machine at concentration 10 mg/mL. 
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Figure A2.21 LCST of B1: P(DMA96-b-(NIPAM88-co-DMAEA25-co-BA6)) at different times after 
the polymer was dissolved in water. The data were reported as average numbers from five 
measurements on DLS machine at concentration 10 mg/mL. 
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Figure A2.22 LCST of B2: P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)) at different times after 
the polymer was dissolved in water. The data were reported as average numbers from five 
measurements on DLS machine at concentration 10 mg/mL. 
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Figure A2.23 LCST of C1: P(DMA96-b-(NIPAM84-co-DMAEA22-co-STY5 at different times after 
the polymer was dissolved in water. The data were reported as average numbers from five 
measurements on DLS machine at concentration 10 mg/mL 
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Figure A2.24 LCST of C2: P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)) at different times 
after the polymer was dissolved in water. The data were reported as average numbers from five 
measurements on DLS machine at concentration 10 mg/mL. 
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Figure A2.25 Agarose gel assay of Oigo DNA 9-27 / thermoresponsive block copolymers 
complexes in Milli-Q water at N/P Ratio 0.5, 1, 2, 5, and 10. B1: P(DMA96-b-(NIPAM88-co-
DMAEA25-co-BA6)), B2: P(DMA96-b-(NIPAM91-co-DMAEA25-co-BA12)), C1: P(DMA96-b-
(NIPAM84-co-DMAEA22-co-STY5)), C2: P(DMA96-b-(NIPAM40-co-DMAEA15-co-STY13)). 
Soluble copolymers in Milli-Q water were incubated with DNA at different N/P ratios at below 
their LCST for 30 min and then being heated up to 37 
o
C for 15 min before doing Agarose gel 
retardation assay. 
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Figure A2.26 Size Exclusion Chromatography (SEC) traces of D: P(NIPAM97-co-BA13)) and E: 
P(DMA99-b-(NIPAM97-co- BA13)). The samples were measured by DMAc SEC. The intensity for 
different distribution curves was normalized. 
 
Figure A2.27 
1
H NMR spectrum of D: P(NIPAM97-co-BA13)) in CDCl3 
 
Figure A2.28 
1
H NMR spectrum of E: P(DMA99-b-(NIPAM97-co- BA13)) in CDCl3 
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Figure A2.29 
1
D DOSY NMR spectrum of folic acid conjugated copolymer E, PDMA-b-
P(NIPAM-co-BA) in DMSO-d6. 
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Figure A2.30 LCST of folic acid conjugated copolymer E, PDMA-b-P(NIPAM-co-BA) in DMSO-
d6.  The polymer was dissolved in water. The data were reported as average numbers from five 
measurements on DLS machine at concentration 10 mg/mL. LCST = 15 – 19 oC. 
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Figure A2.31 Confocal microscopy photos of the osteosarcoma U2OS cells which were dosed with 
50 nmol Cy3 oligo DNA and copolymer polyplexes and cultured in 24-well plate (1x10
5
/well) in 
completed DMEM medium. The polyplexes were prepared in the ratio to siRNA as 50:1 in water. 
The mixtures were incubated in ice-bath for 10 minutes and then at 37
o
C for 30 minutes. They were 
then added to the cells and were incubated for 10 hours before washing fixation with 4% 
paraffinformaldehyde. The cell nuclei were stained with Hoechst 33341 and cell uptake was viewed 
under fluorescent microscope. 
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Appendix B 
Table A3.1 RAFT polymerization condition, BA amount, SEC-RI, 
1
H NMR, conversion, and total conversion of thermoresponsive block copolymers 
(A1 to A8) at 60 
o
C in Dioxane. 
 
 
 
 
 
 
 
 
 
 
 
a 
PDMA (Macro-CTA) with repeating unit = 96 calculated from 
1
H NMR; Mn = [(96 x 99.131 + 252.42] = 9770. 
b
 Triple detection SEC in DMAc containing 0.03 wt % LiCl with 
PSTY as standards. Calculations were based on the dn/dc and polymer concentration. The PDI values were underestimated. 
c
 Repeating units of NIPAM (NNIPAM) determined by 
1
H 
NMR were calculated based on 96 repeating unit of Macro-CTA by the integral area of a peak at 1.08 ppm (I1.08) and a peak in the range 2.85-3.07 ppm (I2.85-3.07) using the following 
equation: NNIPAM = 96 x I1.08  /I2.85-3.07; Repeating units of BA (NBA) determined by 
1
H NMR were calculated based on 96 repeating unit of Macro-CTA by the integral area of a peak 
at 0.88 ppm (I1.08) and a peak in the range 2.85-3.07 ppm (I2.85-3.07) using the following equation: NBA = (96 x 2 x I0.88 / I2.85-3.07) – 1; Repeating units of DMAEA (NDMAEA) determined 
by 
1
H NMR were calculated based on 96 repeating unit of Macro-CTA, and the NNIPAM and NBA by the integral area of the peak in the range 2.85-3.07 ppm (I2.85-3.07) and the peak in 
the range 3.95 - 4.30 ppm (I3.95-4.30) using the following equation:  NDMAEA = [(96 x 6 x I3.95-4.30/I2.85-3.07) – (NNIPAM + 2 NBA)]/2. 
d 
The conversion of NIPAM was calculated by the 
concentration ratio [NIPAM] = 119, and its repeating unit determined by 
1
H NMR (NNIPAM). Conversion of NIPAM = NNIPAM / 119 x 100; The conversion of DMAEA was calculated 
by the concentration ratio [DMAEA] = 30, and its repeating unit determined by 
1
H NMR (NDMAEA). Conversion of DMAEA = NDMAEA / 30 x 100; The conversion of BA was 
calculated by the concentration ratio [BA], and its repeating unit determined by 
1
H NMR (NBA). Conversion of BA = NBA / [BA] x 100. 
 e
 Total conversion is calculated by the 
following equation: Total conv. = [(conversion of NIPAM x 119) + (conversion of DMAEA x 30) + (conversion of NIPAM x [BA])] / (119+30+ [BA]).
 
Polymer 
[NIPAM]:[DMAEA]: 
[BA]:[macro 
CTA]
a
:[AIBN] 
BA  
mol (x 10
-3
) 
(Vol (mL)) 
SEC-Triple 
detection 
b
 
1
H NMR
 
Repeating units 
c 
Conversion (%)
d
 
Total conv. 
(%)
e
 Mn PDI NIPAM DMAEA BA NIPAM DMAEA  BA 
A1 119:30:8:1:0.12 0.575 (0.083)  23800 1.02 88 76 6 74 82 82 76 
A2 119:30:13:1:0.12 0.97 ( 0.14  27000 1.03 94 78 8 79 84 61 78 
A3 119:30:15:1:0.12 1.15 (0.165)  27800 1.03 94 78 10 79 84 67 78 
A4 119:30:17:1:0.12 1.24 (0.18)  27400 1.02 91 77 12 76 85 71 77 
A5 119:30:21:1:0.12 1.59 (0.23)  28700 1.05 93 78 14 78 82 67 78 
A6 119:30:24:1:0.12 1.77 (0.255)  27200 1.03 93 78 16 78 83 68 78 
A7 119:30:26:1:0.12 1.95 (0.28)  28400 1.06 93 78 18 78 84 69 78 
A8 119:30:29:1:0.12 2.12 (0.31)  30200 1.03 97 80 20 81 85 70 80 
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Table A3.2 RAFT polymerization condition, BA amount, SEC-RI, 
1
H NMR, conversion, and total conversion of thermoresponsive block copolymers 
(B1 to B7) at 60 
o
C in Dioxane. 
 
 
 
 
 
 
 
a 
PDMA (Macro-CTA) with repeating unit = 96 calculated from 
1
H NMR; Mn = [(96 x 99.131 + 252.42] = 9770. 
b
Triple detection SEC in DMAc containing 0.03 wt % LiCl with 
PSTY as standards. Calculations were based on the dn/dc and polymer concentration. The PDI values were underestimated. 
c
 Repeating units of NIPAM (NNIPAM) determined by 
1
H 
NMR were calculated based on 96 repeating unit of Macro-CTA by the integral area of a peak at 1.08 ppm (I1.08) and a peak in the range 2.85-3.07 ppm (I2.85-3.07) using the following 
equation: NNIPAM = 96 x I1.08  /I2.85-3.07; Repeating units of BA (NBA) determined by 
1
H NMR were calculated based on 96 repeating unit of Macro-CTA by the integral area of a peak 
at 0.88 ppm (I1.08) and a peak in the range 2.85-3.07 ppm (I2.85-3.07) using the following equation: NBA = (96 x 2 x I0.88 / I2.85-3.07) – 1; Repeating units of DMAEA (NDMAEA) determined 
by 
1
H NMR were calculated based on 96 repeating unit of Macro-CTA, and the NNIPAM and NBA by the integral area of the peak in the range 2.85-3.07 ppm (I2.85-3.07) and the peak in 
the range 3.95 - 4.30 ppm (I3.95-4.30) using the following equation:  NDMAEA = [(96 x 6 x I3.95-4.30/I2.85-3.07) – (NNIPAM + 2 NBA)]/2. 
d 
The conversion of NIPAM was calculated by the 
concentration ratio [NIPAM] = 119, and its repeating unit determined by 
1
H NMR (NNIPAM). Conversion of NIPAM = NNIPAM / 119 x 100; The conversion of DMAEA was calculated 
by the concentration ratio [DMAEA] = 54, and its repeating unit determined by 
1
H NMR (NDMAEA). Conversion of DMAEA = NDMAEA / 54 x 100; The conversion of BA was 
calculated by the concentration ratio [BA], and its repeating unit determined by 
1
H NMR (NBA). Conversion of BA = NBA / [BA] x 100. 
 e 
Total conversion is calculated by the 
following equation: Total conv. = [(conversion of NIPAM x 119) + (conversion of DMAEA x 54) + (conversion of NIPAM x [BA])] / (119+54+ [BA]).
 
Polymer 
[NIPAM]:[DMAEA]: 
[BA]:[macro 
CTA]
a
:[AIBN] 
BA  
mol x 10
-3
 
(Vol (mL)) 
SEC-Triple 
detection 
b
 
1
H NMR
 
Repeating units 
c 
Conversion (%)
d
 
Total conv. 
(%)
e
 Mn PDI NIPAM DMAEA BA NIPAM DMAEA  BA 
B1 119:54:12:1:0.12 0.89 (0.127)  28400 1.05 87 73 6 73 78 54 73 
B2 119:54:14:1:0.12 1.06 (0.153)  29200 1.04 88 74 8 74 77 58 74 
B3 119:54:17:1:0.12 1.24 (0.178) 29000 1.05 87 74 10 73 79 63 74 
B4 119:54:19:1:0.12 1.42 (0.204)  29400 1.07 85 73 12 72 79 64 73 
B5 119:54:21:1:0.12 1.59 (0.229)  29500 1.03 85 73 14 71 78 66 73 
B6 119:54:24:1:0.12  1.77(0.255) 29800 1.03 88 74 16 74 78 67 74 
B7 119:54:30:1:0.12  2.21(0.319) 30500 1.05 87 74 20 73 80 66 74 
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Figure A3.1 SEC traces of PDMA Macro-CTA and block copolymers PDMA-b-P(NIPAM-co-
DMAEA-co-BA), A1 to A8 (A) and B1 to B7 (B). The data were measured in eluent DMAc with 
0.03 wt% of LiCl and using PSTY standard for calibration and reflective index detector. The areas 
under these peaks were weight normalized. 
Appendix B 
146 
 
 
 
Figure A3.2 
1
H NMR spectrum of Macro-CTA: PDMA96 in CDCl3. 
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Figure A3.3 
1
H NMR spectrum of A2: P(DMA96-b-(NIPAM94-co-DMAEA25-co-BA8)), A5: 
P(DMA96-b-(NIPAM93-co-DMAEA25-co-BA14)), and A8: P(DMA96-b-(NIPAM97-co-DMAEA25-
co-BA20)) in CDCl3. 
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Figure A3.4 
1
H NMR spectrum of B1: P(DMA96-b-(NIPAM87-co-DMAEA42-co-BA6)), B5: 
P(DMA96-b-(NIPAM85-co-DMAEA42-co-BA14)), and B7: P(DMA96-b-(NIPAM87-co-DMAEA43-
co-BA20)) in CDCl3. 
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Figure A3.5 LCST of polymers A1 to A8 (A) and polymers B1 to B7 (B) in Milli-Q water. The 
data were averaged from five measurements by DLS at polymer solution concentration of 10 
mg/mL. 
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Figure A3.6 LCST of polymer A1:  P(DMA96-b-(NIPAM88-co-DMAEA24-co-BA6)), A8: 
P(DMA96-b-(NIPAM97-co-DMAEA25-co-BA20)), B1: P(DMA96-b-(NIPAM87-co-DMAEA42-co-
BA6)) and P(DMA96-b-(NIPAM87-co-DMAEA43-co-BA20)) in Milli-Q water after incubation in 
water bath at 37 
o
C at different times. The data were averaged from five measurements by DLS at 
polymer solution concentration 10 mg/mL. 
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Figure A3.7 (A) The LCST of polymer A1: P(DMA96-b-(NIPAM88-co-DMAEA24-co-BA6)), A3: 
P(DMA96-b-(NIPAM94-co-DMAEA25-co-BA10)), B5:P(DMA96-b-(NIPAM85-co-DMAEA42-co-
BA14)) and B7: P(DMA96-b-(NIPAM87-co-DMAEA43-co-BA20)) in buffer solution pH 8 at 
concentration 10 mg/mL. (B) The degradation kinetics profiles at 37 
o
C for polymer A1, A3, B5, 
and B7 in buffer solution pH 8 at concentration 5 mg/mL. All data were averaged from five 
measurements on DLS. 
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Figure A3.8 (A) The LCST of polymer A1: P(DMA96-b-(NIPAM88-co-DMAEA24-co-BA6)), A3: 
P(DMA96-b-(NIPAM94-co-DMAEA25-co-BA10)), B5:P(DMA96-b-(NIPAM85-co-DMAEA42-co-
BA14)) and B7: P(DMA96-b-(NIPAM87-co-DMAEA43-co-BA20)) in buffer solution pH 7.4 at 
concentration 10 mg/mL. (B) The degradation kinetics profiles at 37 
o
C for polymer A1, A3, B5, 
and B7 in buffer solution pH 7.4 at concentration 5 mg/mL. All data were averaged from five 
measurements on DLS. 
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Figure A3.9 (A) The LCST of polymer A1: P(DMA96-b-(NIPAM88-co-DMAEA24-co-BA6)), A3: 
P(DMA96-b-(NIPAM94-co-DMAEA25-co-BA10)), B5:P(DMA96-b-(NIPAM85-co-DMAEA42-co-
BA14)) and B7: P(DMA96-b-(NIPAM87-co-DMAEA43-co-BA20)) in buffer solution pH 7 at 
concentration 10 mg/mL. (B) The degradation kinetics profiles at 37 
o
C for polymer A3 and B7 in 
buffer solution pH 7 at concentration 5 mg/mL. All data were averaged from five measurements on 
DLS. 
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Figure A3.10 (A) The LCST of polymer A1: P(DMA96-b-(NIPAM88-co-DMAEA24-co-BA6)), A3: 
P(DMA96-b-(NIPAM94-co-DMAEA25-co-BA10)), B5:P(DMA96-b-(NIPAM85-co-DMAEA42-co-
BA14)) and B7: P(DMA96-b-(NIPAM87-co-DMAEA43-co-BA20)) in buffer solution pH 6.5 at 
concentration 10 mg/mL. (B) The degradation kinetics profiles at 37 
o
C for polymer A3 and B7 in 
buffer solution pH 6.5 at concentration 5 mg/mL. All data were averaged from five measurements 
on DLS. 
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Table A4.1 Reaction time, molecular weights, polydispersities (PDI), and 
1
H NMR data of RAFT polymerization of thermoresponsive random 
copolymers at 60 
o
C in Dioxane. 
Code 
[DMAEA]:[BA]:[NIPAM]: 
[STY]:[CTA]:[AIBN]
a
 
Time 
(h) 
SEC
b
 
1
H NMR 
M
n
 PDI 
Repeating unit 
M
n
 
h
 
Percentage 
of BA or 
STY (%)
i
 
Individual conversion (%) Total 
conversion 
(%)
n
 
DMAEA
c
 BA
d
 NIPAM STY
g
 DMAEA
j
 BA
k
 NIPAM
l
 STY
m
 
A 50:0:200:0:1:0.2 15 9600 1.14 17 - 63
e
 - 9800 - 34.0 - 31.5 - 32.0 
B1 50:13:200:0:1:0.2 16 12800 1.13 18 7 98
f
 - 14800 5.70 34.0 53.0 49.0 - 46.4 
B2 50:28:200:0:1:0.2 16 14900 1.12 22 18 120
f
 - 19270 11.25 44.0 64.0 60.0 - 57.6 
C1 50:0:200:13:1:0.2 48 9500 1.14 17 - 76
e
 7 12000 7.00 34.0 - 38.0 54.0 38.0 
C2 50:0:200:28:1:0.2 72 10200 1.18 16 - 64
e
 14 11230 14.90 32.0 - 32.0 50.0 33.8 
a 
Mol ratio of reactants. CTA concentration was 1.77 x 10
-4
 mol. 
b
 SEC data measured in THF solution using PSTY standards for calibration. 
c
 Repeating units of DMAEA (NDMAEA) determined by 
1
H NMR were calculated by the integral area of two peaks at 2.50 ppm (I2.50) and 3.63 ppm (I3.63) using the following 
equation: NDMAEA = (3I2.50 /2 x I3.63).  
d 
Repeating units of BA (NBA) determined by 
1
H NMR were calculated by the integral area of two peaks at 0.88 ppm  (I0.88)and 3.63 ppm (I3.63) using the following equation: NBA = 
(I0.88 - I3.63)/I3.63 
e 
Repeating units of NIPAM (NNIPAM) determined by 
1
H NMR were calculated based on the NDMAEA by the integral area of a peak at 3.63 ppm (I3.63) and the peak in the range 4.00-
4.35 ppm (I4.00-4.35) using the following equation: NNIPAM = (3 x I4.00-4.35/ I3.63) – 2 x NDMAEA 
f
 Repeating units of NIPAM (NNIPAM) determined by 
1
H NMR were calculated based on the NDMAEA and NBA by the integral area of a peak at 3.63 ppm (I3.63) and the peak in the 
range 4.00-4.35 ppm (I4.00-4.35)  using the following equation: NNIPAM = (3 x I4.00-4.35/I3.63) – 2 x (NDMAEA + NBA). 
g 
Repeating units of STY (NSTY) determined by 
1
H NMR were calculated by the NNIPAM by the integral area of a  peak at 3.63 ppm (I3.63)  and the peak in the range 6.20-7.18 ppm 
(I6.20-7.18) using the following equation: NSTY = [(3 x I6.20-7.18 /I3.63)- NNIPAM]/5 
h 
Molecular weight determined by 
1
H NMR were calculated based on NDMAEA, NBA or NSTY, NNIPAM,  and the molecular weight of CTA: Mn = [(NDMAEA x 143) + (NBA x 128.2) or 
(NSTY  x 104) + (NNIPAM  x 113)]+ 252 
i 
Percentages of BA or STY
 
were calculated  based on the NDMAEA, NNIPAM, NBA or NSTY : Percentage of BA = NBA / (NDMAEA + NNIPAM + NBA) and percentage of STY = NSTY / 
(NDMAEA + NNIPAM + NSTY)
 
 
j
 Individual conversion of DMAEA was calculated based on the repeating unit of DMAEA and [DMAEA] using the following equation: Conversion of DMAEA = (Repeating unit 
DMAEA/[DMAEA]) x 100 
k
 Individual conversion of BA was calculated based on the repeating unit of BA and [BA] using the following equation: Conversion of BA = (Repeating unit BA /[BA]) x 100 
l
Individual conversion of NIPAM was calculated based on the repeating unit of NIPAM and [NIPAM] using the following equation: Conversion of NIPAM = (Repeating unit 
NIPAM/[NIPAM]) x 100. 
m
Individual conversion of STY was calculated based on the repeating unit of STY and [STY] using the following equation: Conversion of STY = (Repeating unit STY /[STY]) x 100 
n
Total conversion was calculated using the following equation: Total conversion = [(Repeating unit of NIPAM + Repeating unit of DMAEA + Repeating unit of BA + Repeating unit 
of STY) / ([NIPAM] +[DMAEA] + [BA] + [STY])] x 100 
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Table A4.2 LCST and disassembly time of thermoresponsive random copolymers B1 and C1 
determined by dynamic light scattering (DLS). The polymer concentration was 2.5 wt% in different 
Sodium dodecyl sulfate (SDS) solutions concentrated at 0.0123, 0.0164, 0.0205, and 0.0246 mol/L. 
SDS concentration 
(mol/L) 
B1: P(NIPAM98-co-DMAEA18-co-
BA7) 
C1: P(NIPAM76-co-DMAEA17-co-
STY7)  
LCST (
o
C) 
Disassembly time 
(h)
a
 
LCST (
o
C) 
Disassembly time 
(h)
a
 
0.0123 30 17.25 28 23.93 
0.0164 33 11.23 32 18.61 
0.0205 35 9.9 34 13 
0.0246 37 8.17 36 10.12 
a 
Disassembly time is when polymer nanoparticles became unimers measured by DLS measured by 
dynamic light scattering (DLS) at 37
o
C. 
 
 
Table A4.3 LCST of the random copolymers (2.5 wt%) in 0.0123 mol/L SDS solution after the 
polymer was fully degraded at 37 
o
C. 
 
Polymer 
code 
Disassembly time (h) 
LCST (
o
C) after 
disassembly at 37 
o
C 
B1 P(NIPAM98-co-DMAEA18-co-BA7) 18 42 
B2 P(NIPAM120-co-DMAEA22-co-BA18) 47 39 
C1 P(NIPAM76-co-DMAEA17-co-STY7) 24 39 
C2 P(NIPAM64-co-DMAEA16-co-STY14) 102 39 
 
 
Table A4.4 Disassembly times for thermoresponsive random copolymers determined at 37 
o
C by 
Dynamic Light Scattering (DLS). The polymer concentration was 2.5 wt% in 0.0246 mol/L SDS 
solution. 
Polymer Disassembly time (h)
a
 
B1  P(NIPAM98-co-DMAEA18-co-BA7) 8.17 
B2 P(NIPAM120-co-DMAEA22-co-BA18) 15.82 
C1 P(NIPAM76-co-DMAEA17-co-STY7) 10.12 
C2 P(NIPAM64-co-DMAEA16-co-STY14) 37.77 
 
a 
Disassembly time = when polymer particle became unimers measured at 37 
o
C by DLS 
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Figure A4.1 SEC traces of A; P(NIPAM63-co-DMAEA17), B1; P(NIPAM98-co-DMAEA18-co-
BA7),  B2; P(NIPAM120-co-DMAEA22-co-BA18), C1; P(NIPAM76-co-DMAEA17-co-STY7), and 
C2; P(NIPAM64-co-DMAEA16-co-STY14). The data were measured by THF GPC. The intensity for 
different distribution curves was normalized. 
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Figure A4.2 
1
H NMR spectrum of A: (A) P(NIPAM63-co-DMAEA17), B: (B1) P(NIPAM98-co-
DMAEA18-co-BA7),  C: (B2) P(NIPAM120-co-DMAEA22-co-BA18), D: (C1) P(NIPAM76-co-
DMAEA17-co-STY7), and E: (C2) P(NIPAM64-co-DMAEA16-co-STY14) in CDCl3. 
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Figure A4.3 
1
H NMR spectrum of polymer A: (A) P(NIPAM63-co-DMAEA17) at 25 
o
C, B: (B1) 
P(NIPAM98-co-DMAEA18-co-BA7) at 20 
o
C,  C: (B2) P(NIPAM120-co-DMAEA22-co-BA18) at 15 
o
C, D: (C1) P(NIPAM76-co-DMAEA17-co-STY7) at 20 
o
C, and E: (C2) P(NIPAM64-co-DMAEA16-
co-STY14) at 15 
o
C in D2O. The polymer was measured immediately after being dissolved in D2O. 
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Figure A4.4 
1
H NMR spectrum of polymer A: (A) P(NIPAM63-co-DMAEA17), B: (B1) 
P(NIPAM98-co-DMAEA18-co-BA7),  C: (B2) P(NIPAM120-co-DMAEA22-co-BA18), D: (C1) 
P(NIPAM76-co-DMAEA17-co-STY7), and E: (C2) P(NIPAM64-co-DMAEA16-co-STY14). The 
polymers were measured at 25 
o
C in D2O after being kept in D2O for 350 h. 
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Figure A4.5 Diameter (Dh) of thermoresponsive random copolymers determined at 37 
o
C  by 
dynamic light scattering (DLS). The polymers concentration were 2.5 wt% in five different Sodium 
dodecyl sulfate (SDS) solutions concentrated at 8.2, 12.3, 16.4, 20.5, and 24.6 mM. 
 
 
 
 
Figure A4.6 Dh vs temperature of polymer B1: P(NIPAM98-co-DMAEA18-co-BA7  in different 
SDS solution concentrations: 12.3, 16.4, 20.5, and 24.6 mM. The data were reported as average 
numbers from five measurements on DLS machine. Polymer concentration was 2.5 wt% 
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Figure A4.7 Dh vs temperature of polymer C1: P(NIPAM76-co-DMAEA17-co-STY7)  in different 
SDS solution concentrations: 12.3, 16.4, 20.5, and 24.6 mM. The data were reported as average 
numbers from five measurements on DLS machine. Polymer concentration was 2.5 wt%. 
 
 
Figure A4.8 Degradation kinetics profile for the random copolymers A: P(NIPAM63-co-
DMAEA17). The polymer concentration was 2.5wt% in 12.3 mM SDS solution. The data were 
averaged from five measurements by DLS at 45 
o
C. 
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Figure A4.9 LCST of polymer B1: P(NIPAM98-co-DMAEA18-co-BA7), after the incubation in 
water bath at 37 
o
C at different time points. The polymer concentration was 2.5 wt% in 12.3 mM 
SDS solution The data were averaged from five measurements by DLS.  
 
 
 
Figure A4.10 LCST of polymer B2: P(NIPAM120-co-DMAEA22-co-BA18), after the incubation in 
water bath at 37 
o
C at different time points. The polymer concentration was 2.5 wt% in 12.3 mM 
SDS solution. The data were averaged from five measurements by DLS.  
Appendix C 
164 
 
 
Figure A4.11 LCST of polymer C1: P(NIPAM76-co-DMAEA17-co-STY7) after the incubation in 
water bath at 37 
o
C at different time points. The polymer concentration was 2.5 wt% in 12.3 mM 
SDS solution.The data were averaged from five measurements by DLS.  
 
 
Figure A4.12. LCST of polymer C2: P(NIPAM64-co-DMAEA16-co-STY14), after the incubation in 
water bath at 37 
o
C at different time points. The polymer concentration was 2.5 wt% in 12.3 mM 
SDS solution. The data were averaged from five measurements by DLS.  
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Figure A4.13 Degradation time of thermoresponsive random copolymers B1: P(NIPAM98-co-
DMAEA18-co-BA7), B2: P(NIPAM120-co-DMAEA22-co-BA18), C1: P(NIPAM76-co-DMAEA17-co-
STY7), and C2: P(NIPAM64-co-DMAEA16-co-STY14) at 37 
o
C, determined by dynamic light 
scattering (DLS). The polymer concentration was 2.5wt% in 24.6 mM SDS solution. 
 
 
 
A B
 
Figure A4.14 Disassembly profile of B1: P(NIPAM98-co-DMAEA18-co-BA7) (A) and  C1: 
P(NIPAM76-co-DMAEA17-co-STY7) (B) determined at 37
o
C by DLS. The polymer concentration 
was 2.5 wt% in different SDS solution concentrations: 12.3, 16.4, 20.5, and 24.6 mM. 
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Figure A5.1 
1
H NMR spectrum of polymer B in CDCl3 before purification used for calculation of 
the conversion of NIPAM in polymer B. 
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Figure A5.2. The rate of change in the LCST (
o
C) of the polymers determined by observation the 
cloud point of polymer solutions 5 wt% over time.  
 
 
Figure A5.3 
1
H NMR spectrum of PDMA in CDCl3.
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Figure A5.4 TGA of PDMA grafted gold nanoparticles (PDMA-AuNPs). 
 
 
 
 
Figure A5.5 Absorbance of PDMA-grafted gold nanoparticles (PDMA-AuNPs) measured on UV-
vis machine. 
 
